≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Late syphilis, including avohilmo

Endpoint Browser PheWeb

AB1_LATE_SYPHILIS_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 — A52
  • Hospital discharge: ICD-10 — A52
  • Hospital discharge: ICD-9 — 09[2-6]
  • Hospital discharge: ICD-8 — 09[2-6]
  • Cause of death: ICD-10 — A52
  • Cause of death: ICD-9 — 09[2-6]
  • Cause of death: ICD-8 — 09[2-6]

3 out of 7 registries used, show all original rules.

636

4. Check minimum number of events

None

636

5. Include endpoints

None

636

6. Filter based on genotype QC (FinnGen only)

599

Control definitions (FinnGen only)

Control exclude
AB1_SEXUAL_TRANSMISSION

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF13

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 599 257 342
Unadjusted period prevalence (%) 0.13 0.09 0.16
Median age at first event (years) 57.50 56.40 58.32

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
636
Matched controls
6360
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
3260.3
307.7
323
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
24.9
251.1
195
111
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
33.8
234.0
157
61
A10AE04
ATC
insulin glargine; parenteral
11.9
200.2
265
361
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
15.0
192.0
197
185
A10AC01
ATC
insulin (human); parenteral
12.4
184.8
222
263
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
11.6
183.3
236
307
A10AB05
ATC
insulin aspart; parenteral
12.0
178.6
219
266
H3603, E103,
ICD-10 Finland
88.3
172.0
91
12
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
98.0
162.9
85
10
NHQ40
NOMESCO Finland
Amputation of toe
32.8
161.3
107
39
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
13.9
158.9
166
158
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
53.6
152.4
88
19
T89
ICPC
Diabetes insulin dependent
14.0
146.9
150
137
M14.6*E11.6
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic neuropathic
234.1
145.6
145
8
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
14.7
142.4
140
120
A10AE05
ATC
insulin detemir; parenteral
11.9
140.0
162
178
S97
ICPC
Chronic ulcer skin
10.4
139.6
183
238
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
66.3
137.4
76
13
A10AB01
ATC
insulin (human); parenteral
15.8
135.4
126
98
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
22.0
134.5
104
56
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
19.1
131.5
109
68
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
19.0
128.8
107
67
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
491.8
125.5
121
*
103
Kela drug reimbursment
Diabetes, insulin-treated
6.6
125.3
388
1218
A10AB04
ATC
insulin lispro; parenteral
15.7
123.5
114
87
M14.6
ICD-10 Finland
Neuropathic arthropathy
1399.1
122.1
115
*
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
63.3
122.0
68
12
215
Kela drug reimbursment
Diabetes, non-insulin-treated
6.4
121.6
369
1131
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
17.6
119.6
103
69
NH3CG
NOMESCO Finland
Extensive MRI of foot
51.5
118.7
69
15
A10AA02, ,
ATC
14.4
117.2
114
95
A52.75
ICD-10 Finland
Unspecified syphilis in the mouth
+∞
115.2
107
*
H3601, E103,
ICD-10 Finland
50.7
109.8
64
14
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
41.7
104.9
64
17
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
41.7
104.9
64
17
A10AA01, ,
ATC
15.3
104.7
97
74
CKC12
NOMESCO Finland
Photocoagulation of retina
11.1
103.9
121
132
A46
ICD-10 Finland
Erysipelas
6.2
103.2
243
580
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
+∞
103.0
96
*
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
10.3
101.5
125
147
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
13.6
101.3
101
87
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
29.8
99.2
67
25
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
38.1
99.1
62
18
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
37.4
97.1
61
18
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
17.6
96.5
82
53
NH3BG
NOMESCO Finland
MRI of foot
42.4
95.5
58
15
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
36.7
95.0
60
18
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
18.0
93.1
78
49
H36.01
ICD-10 Finland
Diabetic maculopathy
24.0
91.6
67
31
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
42.9
90.9
55
14
H3603, E113,
ICD-10 Finland
36.7
90.3
57
17
H04AA01
ATC
glucagon; nasal, parenteral
18.1
88.7
74
46
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
16.0
88.4
79
56
H43.1
ICD-10 Finland
Vitreous haemorrhage
14.3
86.2
82
65
H3600, E103,
ICD-10 Finland
32.7
82.7
54
18
H3601, E113,
ICD-10 Finland
18.8
80.9
66
39
SPAT1148
SPAT
Treatment of chronic ulcer or burn
5.4
79.0
199
492
WX213
NOMESCO Finland
Lower leg blockade
31.4
78.6
52
18
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
10.2
78.1
94
106
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
14.6
78.0
73
56
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
7.0
77.8
136
238
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
21.6
77.4
59
30
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
28.2
75.9
52
20
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
18.5
75.6
62
37
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
14.1
75.5
72
57
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
10.3
72.4
86
95
A10AE06
ATC
insulin degludec; parenteral
9.2
71.8
94
118
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
15.0
70.8
65
48
H36.00
ICD-10 Finland
Diabetic background retinopathy
18.5
68.6
56
33
R4180
NOMESCO Finland
Podiatric therapy
17.8
68.4
57
35
E10
ICD-10 Finland
Type 1 diabetes mellitus
14.5
66.5
62
47
B03XA02
ATC
darbepoetin alfa; parenteral
14.9
66.5
61
45
XCK10
NOMESCO Finland
Photography of fundus of eye
5.5
66.3
151
338
NH1AD
NOMESCO Finland
Ankle and foot CT
13.6
65.9
64
52
L17
ICPC
Foot/toe symptom/complaint
4.0
65.5
329
1345
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
5.7
64.1
139
297
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
18.0
64.1
53
32
J01FF01
ATC
clindamycin; systemic
4.0
63.8
303
1188
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
10.8
63.6
72
74
C03CA01
ATC
furosemide; systemic
3.9
63.3
303
1193
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
6.6
62.4
113
203
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
12.2
60.6
63
57
N18.8
ICD-10 Finland
Other chronic renal failure
13.2
59.9
59
49
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
13.5
59.7
58
47
V03AE01
ATC
polystyrene sulfonate; oral
21.9
59.7
45
22
Z49.1
ICD-10 Finland
Extracorporeal dialysis
18.2
59.7
49
29
SPAT1262
SPAT
Handing over of treatment supplies
4.2
59.7
210
662
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
10.9
59.7
67
68
TK800
NOMESCO Finland
Hemodialysis
12.4
58.6
60
53
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
17.8
57.9
48
29
T90
ICPC
Diabetes non-insulin dependent
3.7
56.5
277
1092
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
23.0
55.5
41
19
177
Kela drug reimbursment
Insulin glargine 300 U / ml
10.6
55.4
63
65
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
7.1
54.9
89
142
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
7.5
54.3
83
124
A11CC03
ATC
alfacalcidol; systemic
10.8
54.2
61
62
Z49.0
ICD-10 Finland
Preparatory care for dialysis
24.4
54.1
39
17
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.2
52.7
100
187
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.6
52.7
268
1073
L84
ICD-10 Finland
Corns and callosities
8.1
51.9
74
102
137
Kela drug reimbursment
Uraemia requiring dialysis
21.8
51.7
39
19
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
9.7
51.0
62
70
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
188.4
50.7
52
*
Z94.0
ICD-10 Finland
Kidney transplant status
20.7
50.6
39
20
SPAT1229
SPAT
Assessment of need for aid
5.8
50.0
102
204
A12AA04
ATC
calcium carbonate; oral
12.5
49.5
50
43
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
9.3
49.4
62
73
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
14.6
48.9
45
33
L28
ICPC
Limited function/disability (L)
3.8
48.7
196
668
CKC15
NOMESCO Finland
Panretinal photocoagulation
18.8
48.5
39
22
TQW11
NOMESCO Finland
Vacuum treatment of wound
9.5
47.7
59
68
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
135.4
47.5
50
*
ZXD05
NOMESCO Finland
Urgent procedure
3.3
47.0
285
1254
H3600, E113,
ICD-10 Finland
17.2
46.5
39
24
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.1
43.4
141
411
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
18.5
43.1
35
20
WW200
NOMESCO Finland
Immunization
8.8
42.9
56
69
S20
ICPC
Corn/callosity
9.4
42.8
53
61
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
4.1
42.8
143
425
J01CF05
ATC
flucloxacillin; systemic
4.6
41.8
111
277
S91.3
ICD-10 Finland
Open wound of other parts of foot
8.0
41.8
59
80
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
11.2
41.5
45
43
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.8
41.3
154
493
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
14.4
41.1
38
28
J01MA12
ATC
levofloxacin; systemic
3.4
40.4
195
737
R60.0
ICD-10 Finland
Localized oedema
3.8
40.1
145
454
M86.6
ICD-10 Finland
Other chronic osteomyelitis
61.8
39.8
46
8
A10BA02
ATC
metformin; oral
3.0
39.8
281
1322
CKC10
NOMESCO Finland
Local photocoagulation of retina
11.5
39.5
42
39
QDA10
NOMESCO Finland
Incision of skin of lower limb
16.3
39.4
34
22
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.9
39.4
96
223
L04AA06
ATC
mycophenolic acid; systemic
10.2
38.1
44
46
L89
ICD-10 Finland
Decubitus ulcer and pressure area
9.5
37.6
46
52
127
Kela drug reimbursment
Transplant complication
11.8
37.4
39
35
ZZA00
NOMESCO Finland
Split skin graft
7.6
37.4
55
78
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.3
36.8
180
682
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
6.2
36.4
66
117
CKD40
NOMESCO Finland
Endophotocoagulation of retina
10.9
36.3
40
39
SPAT1149
SPAT
Suture or treatment of traumatic wound
3.6
35.6
139
456
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
4.5
35.4
95
238
L04AD02
ATC
tacrolimus; systemic
14.6
35.0
32
23
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
4.6
34.3
90
221
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
6.1
34.1
62
110
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
8.1
34.0
47
62
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
4.6
33.9
89
219
A10AD01
ATC
insulin (human); parenteral
9.5
33.7
41
46
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
33.7
129
417
CJB10
NOMESCO Finland
Laser discission of secondary cataract
4.5
33.6
91
229
205
Kela drug reimbursment
Chronic hypertension
2.9
33.6
228
1033
160
Kela drug reimbursment
exenatide
8.2
33.6
46
60
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
12.8
33.5
33
27
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
8.8
33.3
43
52
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
32.7
210
921
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.3
32.4
69
142
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
32.1
390
2353
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.6
31.9
82
198
A10BB01
ATC
glibenclamide; oral
6.6
31.8
53
86
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
6.0
31.6
58
104
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
6.7
31.4
52
84
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.1
31.1
94
257
TNX39
NOMESCO Finland
Other orthopedic bandage, unspecified region
10.8
30.9
34
33
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.7
30.8
114
359
SPAT1255
SPAT
Intravenous administration of medicine
4.4
30.7
84
213
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
40.3
30.6
38
10
A52.9
ICD-10 Finland
Late syphilis, unspecified
+∞
30.5
29
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.7
30.4
111
346
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
61.6
30.4
35
6
OAB50, ,
SPAT
3.9
30.3
98
281
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.1
29.8
152
583
J01MA02
ATC
ciprofloxacin; systemic
2.6
29.8
315
1758
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
9.5
29.7
36
40
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
5.8
29.5
57
107
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.4
29.5
51
86
H26.4
ICD-10 Finland
After-cataract
3.8
29.4
99
292
X59
ICD-10 Finland
Exposure to unspecified factor
2.9
29.2
185
799
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.4
29.2
119
398
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
10.8
29.1
32
31
Z3231
NOMESCO Finland
Registered nurse
2.6
28.8
236
1161
A10BJ02
ATC
liraglutide; parenteral
6.3
28.7
50
85
B01AB05
ATC
enoxaparin; parenteral
2.6
28.6
261
1352
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
41.1
28.3
35
9
C02AC05
ATC
moxonidine; oral
4.8
28.0
67
152
S18
ICPC
Laceration/cut
2.5
27.7
375
2321
R4180, ,
SPAT
9.6
27.6
33
36
NGQ20
NOMESCO Finland
Amputation of lower leg
31.7
27.5
36
12
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.2
27.5
59
122
WX002
NOMESCO Finland
Sedation and analgesia
2.8
27.3
169
718
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.6
27.3
221
1076
N03AX16
ATC
[U] pregabalin
2.7
27.1
201
937
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
27.0
244
1251
L03.0
ICD-10 Finland
Cellulitis of finger and toe
3.6
26.9
97
299
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.3
26.9
74
188
RJ414, ,
NOMESCO Finland
97.5
25.9
28
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.8
25.9
162
691
L03.9
ICD-10 Finland
Cellulitis, unspecified
7.9
25.7
36
48
Z49.2
ICD-10 Finland
Other dialysis
26.4
25.5
35
14
V03AE02
ATC
sevelamer; oral
52.3
25.5
30
6
S92.3
ICD-10 Finland
Fracture of metatarsal bone
5.1
25.3
56
119
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
9.3
25.2
31
35
C09AA02
ATC
enalapril; systemic
2.7
25.2
171
759
A53.9
ICD-10 Finland
Syphilis, unspecified
+∞
25.2
24
*
A10BB12
ATC
glimepiride; oral
4.1
25.0
75
203
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
93.9
24.8
27
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
24.7
252
1355
B05DB
ATC
Hypertonic solutions
28.9
24.7
33
12
C08CA01
ATC
amlodipine; oral
2.4
24.6
305
1785
A10BJ06
ATC
semaglutide; parenteral
4.0
24.6
76
210
B05DA
ATC
Isotonic solutions
23.1
24.6
35
16
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
26.7
24.2
33
13
WX320
NOMESCO Finland
Spinalanesthesy
2.5
24.2
206
1019
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
9.4
24.0
29
32
Z96.1
ICD-10 Finland
Presence of intraocular lens
3.0
23.9
125
482
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.0
23.8
74
205
ZXE00
NOMESCO Finland
One hour or less
2.3
23.8
290
1679
SPAT1211
SPAT
Application of soft bandage
3.6
23.6
84
256
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.0
23.3
123
476
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
21.1
23.2
34
17
Z3229
NOMESCO Finland
Other healthcare associate professional
3.5
23.1
87
275
M14.2*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic arthropathy
+∞
23.1
22
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
22.9
156
690
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.7
22.8
157
698
A10BX07
ATC
[U] liraglutide
8.5
22.8
30
37
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
21.7
22.8
33
16
NH1CM
NOMESCO Finland
Ankle and foot extensive MRI examination with 3 Tesla magnet
124.5
22.7
24
*
M86.1
ICD-10 Finland
Other acute osteomyelitis
33.7
22.6
29
9
A28
ICPC
Limited function/disability NOS
2.7
22.6
148
642
M86.8
ICD-10 Finland
Other osteomyelitis
54.1
22.2
26
5
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
22.2
161
734
E66.00
ICD-10 Finland
Metabolic syndrome
3.8
22.1
72
206
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.8
22.0
125
503
TAB00
NOMESCO Finland
Lumbar puncture
4.3
21.6
58
144
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.6
21.6
152
682
J01DB01
ATC
cefalexin; oral
3.4
21.5
570
4559
N06AX21
ATC
duloxetine; oral
3.0
21.5
110
417
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.9
21.5
115
447
I50.9
ICD-10 Finland
Heart failure, unspecified
2.9
21.5
121
484
ZXA00
NOMESCO Finland
Right side
2.4
21.3
212
1114
D64.9
ICD-10 Finland
Anaemia, unspecified
3.1
21.2
99
356
A10BK03
ATC
empagliflozin; oral
2.9
21.2
116
457
R4110
NOMESCO Finland
Physiotherapy
2.3
21.1
223
1202
N18.0
ICD-10 Finland
End-stage renal disease
18.7
21.1
32
18
RJ411, ,
NOMESCO Finland
25.2
21.0
29
12
M79.6
ICD-10 Finland
Pain in limb
2.2
20.9
330
2091
M04AA01
ATC
allopurinol; systemic
2.8
20.9
124
509
A10BH01
ATC
sitagliptin; oral
3.1
20.9
98
354
NH3DG
NOMESCO Finland
Very extensive MRI of foot
79.5
20.8
23
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
20.5
201
1046
J01CF02
ATC
cloxacillin; systemic
7.2
20.5
31
45
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.3
20.2
226
1243
Z3226
NOMESCO Finland
Physiotherapist
2.5
20.2
152
702
WX140
NOMESCO Finland
Parabulbar anesthesy
4.2
20.2
57
147
A10BH05
ATC
linagliptin; oral
4.0
20.1
60
161
I10
ICD-10 Finland
Essential (primary) hypertension
2.3
20.1
441
3166
R5110, ,
SPAT
3.3
20.1
83
277
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
21.6
20.1
29
14
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
20.0
207
1101
RJ410, ,
NOMESCO Finland
37.1
20.0
25
7
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
19.9
135
592
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
19.9
239
1352
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
19.8
263
1548
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.2
19.7
54
136
C07AB07
ATC
bisoprolol; oral
2.2
19.7
352
2324
162
Kela drug reimbursment
liraglutide
8.0
19.7
27
35
RJ420, ,
NOMESCO Finland
25.5
19.7
27
11
NH2AA
NOMESCO Finland
Heel X-ray examination
20.2
19.7
29
15
I79.2*E10.5
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
206.1
19.7
20
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
19.6
109
432
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
15.2
19.6
32
22
WX882
NOMESCO Finland
High dependency care
6.0
19.5
35
61
C10AA01
ATC
simvastatin; oral
2.1
19.4
298
1854
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.9
19.2
105
412
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.5
19.1
38
73
N02BF02
ATC
pregabalin; oral
3.5
18.9
71
223
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.7
18.8
45
102
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.2
18.7
225
1267
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.0
18.7
94
352
M14.2*E11.6
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic arthropathy
195.5
18.6
19
*
H3602, E103,
ICD-10 Finland
195.5
18.6
19
*
S76
ICPC
Skin infection other
3.7
18.6
61
175
EBA15
NOMESCO Finland
Extraction of multiple teeth
4.2
18.6
52
133
QXB99, ,
SPAT
5.1
18.5
40
83
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
4.1
18.4
52
134
N02AX02
ATC
tramadol; systemic, rectal
2.1
18.4
319
2065
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
25.9
18.3
25
10
J01DA01
ATC
[U] cefalexin
2.2
18.1
427
3092
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.6
17.8
44
102
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
17.8
72
237
A52.8
ICD-10 Finland
Late syphilis, latent
+∞
17.8
17
*
A52.3
ICD-10 Finland
Neurosyphilis, unspecified
+∞
17.8
17
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
6.6
17.7
29
46
TNH31
NOMESCO Finland
Prefabricated orthosis, ankle or foot
13.6
17.6
30
23
WX212
NOMESCO Finland
Femoral plexus blockade
6.1
17.6
31
53
M10.9
ICD-10 Finland
Gout, unspecified
3.3
17.6
72
239
I50.0
ICD-10 Finland
Congestive heart failure
3.3
17.4
69
224
B01AB10
ATC
tinzaparin; parenteral
2.7
17.4
102
414
ZXA05
NOMESCO Finland
Left side
2.2
17.3
187
1004
A10AB06
ATC
insulin glulisine; parenteral
13.1
17.3
30
24
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
4.8
17.3
40
88
Z2446
NOMESCO Finland
Social worker
3.4
17.2
66
210
A10BH02
ATC
vildagliptin; oral
6.8
17.1
27
41
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
26.4
17.0
23
9
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
20.0
17.0
25
13
L29
ICPC
Musculoskeletal sympt/complt other
3.0
16.8
79
284
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
65.2
16.8
19
*
XQ902
NOMESCO Finland
Other photography
13.2
16.8
29
23
R11
ICD-10 Finland
Nausea and vomiting
3.0
16.8
81
296
NH1DG
NOMESCO Finland
Ankle and foot very extensive MRI examination with high intensity magnet
+∞
16.7
16
*
A51.0
ICD-10 Finland
Primary genital syphilis
+∞
16.7
16
*
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
174.4
16.6
17
*
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
23.8
16.5
23
10
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.3
16.5
28
46
J01CE08
ATC
benzathine benzylpenicillin; parenteral
14.8
16.4
27
19
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
6.5
16.4
27
43
K65.0
ICD-10 Finland
Acute peritonitis
15.9
16.3
26
17
L16
ICPC
Ankle symptom/complaint
2.6
16.3
106
453
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.9
16.2
49
133
A10BJ05
ATC
dulaglutide; parenteral
5.3
16.2
33
65
C09BA02
ATC
enalapril and diuretics; systemic
3.0
16.1
75
268
E66.8
ICD-10 Finland
Other obesity
3.6
16.0
56
168
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
16.0
82
310
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.5
15.9
40
94
NH3CM
NOMESCO Finland
Extensive MRI of foot (more than 1.5 T)
61.6
15.8
18
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
27.1
15.7
21
8
A41.9
ICD-10 Finland
Sepsis, unspecified
4.3
15.7
42
104
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
22.7
15.6
22
10
R5599
NOMESCO Finland
Other rehabilitation service
4.8
15.6
36
79
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
15.5
260
1634
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
5.9
15.5
28
49
C03AA03
ATC
hydrochlorothiazide; oral
3.0
15.4
73
264
XF600
NOMESCO Finland
Bloodpressure measurement
3.3
15.3
61
199
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
18.3
15.2
23
13
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
5.3
15.2
31
61
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
15.2
293
1930
R4120
NOMESCO Finland
Occupational therapy
3.2
15.0
64
217
SPAT1231
SPAT
Assessment of adjustments needed in living environment
6.7
15.0
24
37
N03AX12
ATC
[U] gabapentin; oral
2.3
15.0
134
661
C10AA05
ATC
atorvastatin; oral
1.9
15.0
307
2061
A10BG02
ATC
rosiglitazone; oral
7.0
14.9
23
34
AA1AD
NOMESCO Finland
CT of head and brain
2.0
14.9
212
1254
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
17.0
14.9
23
14
A51.9
ICD-10 Finland
Early syphilis, unspecified
+∞
14.6
14
*
09299
ICD-8 Finland
Early syphilis, latent, unspecified
+∞
14.6
14
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
14.6
101
444
RJ521, ,
NOMESCO Finland
153.4
14.5
15
*
Z2221
NOMESCO Finland
Medical doctor
2.1
14.5
195
1128
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
14.4
125
608
R5120
NOMESCO Finland
Preparation of an aid
4.7
14.4
34
76
H26.2
ICD-10 Finland
Complicated cataract
11.7
14.4
26
23
WX110
NOMESCO Finland
Infiltration anesthesia
2.1
14.4
480
3781
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.3
14.4
38
93
TQW80
NOMESCO Finland
Local dermatologic skincare
4.9
14.4
32
68
SPAT1151
SPAT
Treatment of major wounds
10.8
14.3
27
26
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
12.3
14.2
25
21
SPAT1254
SPAT
Administration of medicine
2.4
14.1
106
484
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.2
14.0
59
199
C10AX09
ATC
ezetimibe; oral
2.2
14.0
146
766
A01
ICPC
Pain general/multiple sites
2.6
13.9
86
357
RJ421, ,
NOMESCO Finland
30.8
13.9
18
6
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.0
13.9
207
1238
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
18.1
13.9
21
12
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
18.1
13.9
21
12
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.7
13.9
45
128
N02AA05
ATC
oxycodone; systemic
2.2
13.9
140
724
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
13.9
65
233
B01AC04
ATC
clopidogrel; oral
2.2
13.8
132
668
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
5.6
13.6
26
48
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.8
13.6
43
120
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
6.0
13.6
24
41
F02.89*A52.1
ICD-10 Finland
Paralytic dementia
+∞
13.6
13
*
TNF34
NOMESCO Finland
Major custom moulded orthopaedic cast, hip or thigh
+∞
13.6
13
*
E10.01
ICD-10 Finland
Insulin-dependent diabetes diabetic coma with hyperglycemia
+∞
13.6
13
*
K08.3
ICD-10 Finland
Retained dental root
2.8
13.5
71
271
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
16.6
13.5
21
13
H3603, E107,
ICD-10 Finland
142.9
13.5
14
*
TQW40
NOMESCO Finland
Remowal of suture of skin
3.0
13.4
63
226
TK820
NOMESCO Finland
Peritoneal dialysis
21.7
13.4
19
9
E0000UV, ,
ATC
1.9
13.4
280
1872
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.2
13.3
55
183
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
5.6
13.2
25
46
K07
ICPC
Swollen ankles/oedema
3.5
13.1
46
138
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.5
13.1
46
138
E000001, ,
ATC
2.2
13.1
137
718
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
6.3
13.0
22
36
WZC00
NOMESCO Finland
Treatment plan or consultation
1.9
13.0
254
1658
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
4.6
13.0
31
70
R50.9
ICD-10 Finland
Fever, unspecified
2.2
13.0
121
605
R60.9
ICD-10 Finland
Oedema, unspecified
3.2
12.9
54
181
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
11.9
12.9
23
20
A63.0
ICD-10 Finland
Anogenital (venereal) warts
10.8
12.8
24
23
C03DA01
ATC
spironolactone; oral
2.4
12.8
100
464
QDB10, ,
SPAT
4.2
12.7
34
84
ZX120
NOMESCO Finland
Intravenous
2.6
12.7
79
329
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
3.2
12.7
51
167
K02.1
ICD-10 Finland
Caries of dentine
1.9
12.7
396
2984
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
71.3
12.6
14
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.9
12.6
37
98
C09AA05
ATC
ramipril; oral
2.0
12.6
185
1096
L60.0
ICD-10 Finland
Ingrowing nail
3.3
12.6
48
152
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
12.6
108
521
A52.2
ICD-10 Finland
Asymptomatic neurosyphilis
+∞
12.5
12
*
RJ523, ,
NOMESCO Finland
132.5
12.5
13
*
M86.2
ICD-10 Finland
Subacute osteomyelitis
132.5
12.5
13
*
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
4.4
12.3
31
73
WX892
NOMESCO Finland
Monitored bed care
2.8
12.3
66
255
E000003, ,
ATC
3.5
12.3
44
134
RJ120, ,
NOMESCO Finland
38.3
12.2
15
*
RJ126, ,
NOMESCO Finland
38.3
12.2
15
*
M86.4
ICD-10 Finland
Chronic osteomyelitis with draining sinus
38.3
12.2
15
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
12.2
353
2584
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
12.2
109
534
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.8
12.2
369
2738
XCD20
NOMESCO Finland
Photoangiography of eye
6.2
12.2
21
35
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
3.7
12.2
39
110
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
12.1
136
730
V03AE03
ATC
lanthanum carbonate; oral
18.5
12.1
18
10
TK810
NOMESCO Finland
Hemofiltration
18.5
12.1
18
10
H05BX01
ATC
cinacalcet; oral
13.7
12.0
20
15
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
12.0
84
370
R5140
NOMESCO Finland
Monitoring the use of the aid
2.3
12.0
101
483
QDG00
NOMESCO Finland
Debridement of bedsore of lower limb
47.6
11.9
14
*
H36.02
ICD-10 Finland
Preproliferative diabetic retinopathy
47.6
11.9
14
*
E87.5
ICD-10 Finland
Hyperkalaemia
5.5
11.9
23
43
SPAT1310
SPAT
Counselling related to known health issue
1.9
11.8
211
1330
S29
ICPC
Skin symptom/complaint other
2.0
11.7
147
821
B01AB04
ATC
dalteparin; parenteral
3.4
11.7
44
138
SAA03
NOMESCO Finland
Extended examination of mouth
1.8
11.7
266
1806
SFA30
NOMESCO Finland
Three-surface restoration
1.8
11.7
296
2075
L14
ICPC
Leg/thigh symptom/complaint
2.6
11.7
69
280
RJ512, ,
NOMESCO Finland
66.2
11.6
13
*
Z89.5
ICD-10 Finland
Acquired absence of leg at or below knee
66.2
11.6
13
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
11.6
105
517
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.1
11.6
32
81
R4190
NOMESCO Finland
Nutritional therapy
3.6
11.6
38
109
A02BC02
ATC
pantoprazole; systemic
1.9
11.6
452
3602
A06AD11
ATC
lactulose; oral
2.2
11.6
106
525
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
3.8
11.5
36
100
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
11.5
11
*
RJ129, ,
NOMESCO Finland
+∞
11.5
11
*
H25.8
ICD-10 Finland
Other senile cataract
2.5
11.5
79
345
H25.1
ICD-10 Finland
Senile nuclear cataract
1.9
11.5
172
1022
N30.0
ICD-10 Finland
Acute cystitis
2.2
11.3
107
536
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.5
11.3
28
65
RJ210, ,
NOMESCO Finland
35.7
11.3
14
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
17.4
11.2
17
10
ZX114
NOMESCO Finland
Intramuscular
5.7
11.2
21
38
D06AX01
ATC
fusidic acid; topical
2.6
11.2
71
298
QD6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in foot
25.5
11.2
15
6
G63.2
ICD-10 Finland
Diabetic polyneuropathy
20.5
11.2
16
8
TKC20
NOMESCO Finland
Catheterisation of bladder
2.8
11.1
56
209
RD210, ,
NOMESCO Finland
5.9
11.1
20
35
EBA00
NOMESCO Finland
Extraction of tooth
1.8
11.1
252
1704
A41.8
ICD-10 Finland
Other specified sepsis
4.9
11.0
24
50
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
4.8
11.0
25
54
A04
ICPC
Weakness/tiredness general
2.2
11.0
107
542
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
44.1
11.0
13
*
J04AB02
ATC
rifampicin; systemic
8.5
10.9
23
28
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.2
10.8
97
475
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
5.0
10.8
23
47
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.8
10.8
198
1252
A10BK01
ATC
dapagliflozin; oral
2.5
10.8
69
291
H02AB04
ATC
methylprednisolone; systemic
2.2
10.7
104
526
U14
ICPC
Kidney symptom/complaint
5.4
10.7
21
40
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.0
10.6
48
169
A10AD05
ATC
insulin aspart; parenteral
4.8
10.6
24
52
L12
ICPC
Hand/finger symptom/complaint
2.0
10.5
122
660
M77.4
ICD-10 Finland
Metatarsalgia
2.8
10.5
55
210
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
5.5
10.5
20
37
NHS20
NOMESCO Finland
Incision and debridement of infection of bone of ankle or foot
111.8
10.4
11
*
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
+∞
10.4
10
*
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
+∞
10.4
10
*
M146, E109,
ICD-10 Finland
+∞
10.4
10
*
S17
ICPC
Abrasion/scratch/blister
4.5
10.3
25
57
ZZR00
NOMESCO Finland
Flap of skin
4.7
10.3
24
53
A10AA03, ,
ATC
9.8
10.3
20
21
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
10.3
43
144
C07AG02
ATC
carvedilol; oral
2.8
10.3
53
200
WX214
NOMESCO Finland
Plexus blockade at the ankle
23.8
10.3
14
6
SPAT1263
SPAT
Sampling
1.7
10.2
265
1850
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
10.2
154
913
A97
ICPC
No disease
1.9
10.2
140
805
U04
ICPC
Incontinence urine
3.0
10.1
46
162
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
10.1
158
947
WZC30
NOMESCO Finland
Teaching
2.0
10.1
125
692
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
10.1
65
275
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
14.9
10.0
16
11
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
40.7
10.0
12
*
S21
ICPC
Skin texture symptom/complaint
2.1
9.9
110
585
NHG20
NOMESCO Finland
Fusion of talocrural joint
17.0
9.9
15
9
SPAT1216
SPAT
Assessment of functional ability
2.1
9.9
105
549
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
9.9
47
170
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
3.5
9.9
34
101
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
9.8
74
336
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.1
9.8
104
543
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
26.5
9.8
13
5
A10BX04
ATC
[U] exenatide
8.9
9.8
20
23
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.5
9.7
33
97
SPAT1054
SPAT
Examination of peripheral nervous system
5.4
9.7
19
36
A08
ICPC
Swelling
2.8
9.6
49
184
C08CA13
ATC
lercanidipine; oral
2.1
9.6
107
570
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
15.3
9.6
15
10
ZXA10
NOMESCO Finland
Bilateral
2.0
9.5
120
669
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
9.4
246
1710
Z89.4
ICD-10 Finland
Acquired absence of foot and ankle
101.5
9.4
10
*
E14.4
ICD-10 Finland
Unspecified diabetes mellitus, with neurological complications
101.5
9.4
10
*
X58
ICD-10 Finland
Exposure to other specified factors
2.0
9.4
115
633
G59.0*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic mononeuropathy
+∞
9.4
9
*
NH3J4
NOMESCO Finland
Thermal imaging of the feet and legs
+∞
9.4
9
*
M146, E119,
ICD-10 Finland
+∞
9.4
9
*
N05CF01
ATC
zopiclone; oral
1.7
9.4
210
1399
J01MA14
ATC
moxifloxacin; systemic
2.3
9.3
71
324
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.6
9.3
55
223
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
9.2
172
1085
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
13.9
9.2
15
11
J01CE02
ATC
phenoxymethylpenicillin; oral
1.7
9.2
435
3534
Z02.7
ICD-10 Finland
Issue of medical certificate
2.5
9.2
59
249
N05CD07
ATC
temazepam; oral
2.2
9.2
79
380
Z04.3
ICD-10 Finland
Examination and observation following other accident
4.5
9.1
22
50
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.9
9.1
27
72
ACC51
NOMESCO Finland
Release of median nerve
2.5
9.1
59
250
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
11.7
9.1
16
14
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.9
9.1
44
161
RJ511, ,
NOMESCO Finland
37.3
9.0
11
*
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
37.3
9.0
11
*
UJF32
NOMESCO Finland
Coloscopy
1.8
9.0
174
1108
R4110, ,
SPAT
2.1
9.0
97
509
R53
ICD-10 Finland
Malaise and fatigue
1.8
9.0
165
1035
WX402
NOMESCO Finland
General anaesthesia
1.8
9.0
153
938
S19
ICPC
Skin injury other
3.1
9.0
37
123
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.6
9.0
20
27
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
9.0
178
1143
A10AD04
ATC
insulin lispro; parenteral
24.4
8.9
12
5
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
24.4
8.9
12
5
B01AA03
ATC
warfarin; systemic
2.0
8.9
116
652
3025
Kela drug reimbursment
Calcium carbonate
12.8
8.9
15
12
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
8.9
295
2178
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.8
8.8
158
983
M13.9
ICD-10 Finland
Arthritis, unspecified
2.4
8.8
60
261
B81
ICPC
Anaemia vit B12/folate deficiency
3.4
8.7
32
99
S22
ICPC
Nail symptom/complaint
2.5
8.7
58
249
Z01.2
ICD-10 Finland
Dental examination
1.7
8.7
293
2166
CKD15
NOMESCO Finland
Injection of vitreous substitute
14.3
8.7
14
10
-56
ICPC
Dressing/pressure/compress/tamponade
6.7
8.7
21
32
T82
ICPC
Obesity
3.1
8.7
36
120
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.1
8.7
88
451
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.3
8.7
71
334
NH3AI
NOMESCO Finland
Cone beam CT of foot
50.7
8.7
10
*
NHS99
NOMESCO Finland
Other operation for infection of tendon, joint or bone of ankle or foot
50.7
8.7
10
*
WZB00, ,
SPAT
2.5
8.7
58
250
N06AX11
ATC
mirtazapine; oral
1.7
8.6
220
1512
H26.02
ICD-10 Finland
Presenil cataract
3.6
8.6
28
80
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
11.8
8.6
15
13
A10BX01
ATC
guar gum; oral
3.4
8.6
30
90
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
8.6
285
2099
QDH05
NOMESCO Finland
Correction of deformity of toe nail
27.9
8.5
11
*
WX210
NOMESCO Finland
Plexus blockade of nervus ichiadicus
20.3
8.5
12
6
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.3
8.5
32
101
SAA04
NOMESCO Finland
Special examination of mouth
2.9
8.5
41
150
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
91.2
8.4
9
*
RJ513, ,
NOMESCO Finland
91.2
8.4
9
*
A54.5
ICD-10 Finland
Gonococcal pharyngitis
91.2
8.4
9
*
RJ530, ,
NOMESCO Finland
91.2
8.4
9
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.9
8.4
39
139
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.1
8.4
23
58
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
3.0
8.4
38
134
E11.01
ICD-10 Finland
Non-insulin dependent diabetes diabetic coma with hyperglycaemia
+∞
8.3
8
*
M86.0
ICD-10 Finland
Acute haematogenous osteomyelitis
+∞
8.3
8
*
RJ122, ,
NOMESCO Finland
+∞
8.3
8
*
E14.6
ICD-10 Finland
Unspecified diabetes mellitus, with other specified complications
+∞
8.3
8
*
M86
ICD-10 Finland
Osteomyelitis
+∞
8.3
8
*
M146, E117,
ICD-10 Finland
+∞
8.3
8
*
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
8.3
27
77
J01XX08
ATC
linezolid; systemic
10.9
8.3
15
14
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
8.3
98
532
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
8.3
167
1075
I50.1
ICD-10 Finland
Left ventricular failure
2.8
8.3
41
152
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
3.2
8.2
33
108
SPAT1301
SPAT
No procedures
1.7
8.2
190
1269
N02BE01
ATC
paracetamol; systemic, rectal
2.2
8.2
570
5092
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
4.6
8.2
19
42
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
8.1
54
232
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
17.4
8.1
12
7
H3602, E113,
ICD-10 Finland
33.8
8.1
10
*
K65.8
ICD-10 Finland
Other peritonitis
33.8
8.1
10
*
N05AH04
ATC
quetiapine; oral
1.9
8.1
120
703
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
10.2
8.1
15
15
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.4
8.0
57
252
N03AX09
ATC
lamotrigine; oral
2.9
8.0
38
137
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
22.3
8.0
11
5
SPAT1260
SPAT
Consultation of another employee
1.9
8.0
115
667
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
8.0
90
480
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.8
8.0
40
149
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.8
8.0
40
149
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.2
8.0
71
346
N05BA01
ATC
diazepam; systemic, rectal
2.0
8.0
89
473
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
8.0
252
1823
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.4
7.9
53
228
E66.9
ICD-10 Finland
Obesity, unspecified
3.2
7.9
31
100
OAB42, ,
SPAT
2.0
7.9
95
518
C03BA11
ATC
indapamide; oral
3.7
7.9
25
70
P01AB01
ATC
metronidazole; oral, rectal
1.6
7.9
247
1782
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.5
7.9
48
198
Y25
ICPC
Fear sexually transm disease male
4.1
7.9
21
52
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.7
7.8
154
982
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.9
7.8
105
595
C08CA02
ATC
felodipine; oral
2.2
7.8
65
308
K05.31
ICD-10 Finland
Periodontitis pronounced
2.0
7.8
83
434
A12BA01
ATC
potassium chloride; oral
3.2
7.8
30
96
K02.8
ICD-10 Finland
Other dental caries
3.6
7.8
25
71
K59.1
ICD-10 Finland
Functional diarrhoea
2.6
7.8
46
187
K99
ICPC
Cardiovascular disease other
4.0
7.8
22
57
SPAT1240
SPAT
Therapeutic discussion
2.2
7.8
66
316
B82
ICPC
Anaemia other/unspecified
3.4
7.7
27
81
S91.2
ICD-10 Finland
Open wound of toe(s) with damage to nail
15.3
7.7
12
8
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
45.5
7.7
9
*
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
4.4
7.7
19
44
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
3.1
7.7
31
102
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.8
7.7
37
135
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
7.6
73
366
J01DA09
ATC
[U] cefadroxil
1.7
7.6
171
1130
171
Kela drug reimbursment
Degludekinsuliini
18.6
7.6
11
6
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
12.0
7.6
13
11
TQW99
NOMESCO Finland
Other minor procedure on skin
2.7
7.6
41
159
X57
ICD-10 Finland
Unspecified privation
3.9
7.6
22
58
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
7.6
62
292
W19
ICD-10 Finland
Unspecified fall
2.2
7.6
68
333
A10BJ01
ATC
exenatide; parenteral
7.2
7.5
17
24
WZA90
NOMESCO Finland
Other medical or dental certificate
1.7
7.5
157
1017
SPAT1360
SPAT
Extensive global examination
2.6
7.5
45
184
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.0
7.5
32
109
N04BC05
ATC
pramipexole; oral
2.3
7.5
56
254
SFA10
NOMESCO Finland
One-surface restoration
1.6
7.5
348
2750
D11
ICPC
Diarrhoea
2.0
7.5
79
412
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.7
7.4
39
149
H3603, E109,
ICD-10 Finland
81.0
7.4
8
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.4
220
1561
SPAT1234
SPAT
Support of social functional capacity
2.8
7.4
36
132
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
7.4
88
479
N05BA04
ATC
oxazepam; oral
1.7
7.3
161
1056
M65.3
ICD-10 Finland
Trigger finger
2.7
7.3
40
156
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
7.3
74
379
A53.0
ICD-10 Finland
Latent syphilis, unspecified as early or late
+∞
7.3
7
*
NH3BM
NOMESCO Finland
MRI of foot (more than 1.5 T)
+∞
7.3
7
*
M146, E114,
ICD-10 Finland
+∞
7.3
7
*
RJ211, ,
NOMESCO Finland
+∞
7.3
7
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.9
7.3
34
122
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.4
7.3
18
42
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
16.0
7.2
11
7
WX290
NOMESCO Finland
Other blockage of nerve
1.6
7.2
300
2301
N25.0
ICD-10 Finland
Renal osteodystrophy
30.4
7.2
9
*
WX872
NOMESCO Finland
Intensive care
2.6
7.2
41
164
RJ412, ,
NOMESCO Finland
20.3
7.1
10
5
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
7.1
412
3405
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
8.1
7.1
15
19
SPAT1359
SPAT
Use of symptom diary
3.8
7.1
21
56
R52.9
ICD-10 Finland
Pain, unspecified
2.0
7.1
75
390
AN4
HP
Balloon angioplasty and drug eluding stent
3.1
7.1
29
96
A07AA02
ATC
nystatin; oral
2.6
7.1
42
171
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
10.2
7.1
13
13
PE1AT
NOMESCO Finland
Femoral artery PTA
7.1
7.0
16
23
BEF00, ,
SPAT
7.1
7.0
16
23
ZA7.0
ICD-10 Finland
Ankle and foot
7.1
7.0
16
23
EBA30
NOMESCO Finland
Extraction of root of tooth
2.4
7.0
48
209
C01DA14
ATC
isosorbide mononitrate; oral
1.9
7.0
93
525
S92.4
ICD-10 Finland
Fracture of great toe
6.4
7.0
17
27
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.9
6.9
32
114
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
6.9
251
1861
J02AC01
ATC
fluconazole; systemic
1.6
6.9
217
1555
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.3
6.9
25
77
N06AX16
ATC
venlafaxine; oral
1.9
6.9
93
528
KMAK, ,
NOMESCO Finland
1.6
6.9
314
2453
S92.0
ICD-10 Finland
Fracture of calcaneus
6.8
6.8
16
24
N18
ICD-10 Finland
Chronic kidney disease
6.8
6.8
16
24
WW500
NOMESCO Finland
Blood transfusion
2.9
6.8
32
115
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.7
6.8
36
138
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
11.1
6.8
12
11
321
Kela drug reimbursment
Paricalcitol and cinacalcet
9.5
6.8
13
14
C02CA01
ATC
prazosin; oral
6.2
6.8
17
28
SPAT1281
SPAT
Other administrative function
2.3
6.8
53
245
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
40.5
6.8
8
*
25007
ICD-8 Finland
Diabetes mellitus, Coma diabeticum
40.5
6.8
8
*
CL2L4
NOMESCO Finland
Wide-field fundus photography for diabetic retinopathy screening
40.5
6.8
8
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.7
6.8
35
133
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
7.3
6.7
15
21
SFA20
NOMESCO Finland
Two-surface restoration
1.6
6.7
367
2976
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
22.8
6.7
9
*
T87.4
ICD-10 Finland
Infection of amputation stump
22.8
6.7
9
*
A12AA12
ATC
[U] calcium acetate
22.8
6.7
9
*
EBA10
NOMESCO Finland
Operative extraction of tooth
1.9
6.7
81
443
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
6.7
446
3783
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.8
6.7
105
625
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.0
6.7
70
364
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
6.7
56
267
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.1
6.6
67
343
SCA02
NOMESCO Finland
Preventive oral health care
2.2
6.6
58
281
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.9
6.6
93
535
H16.9
ICD-10 Finland
Keratitis, unspecified
4.2
6.6
17
41
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
8.8
6.6
13
15
358
Kela drug reimbursment
liraglutide
8.8
6.6
13
15
Z71.8
ICD-10 Finland
Other specified counselling
1.6
6.6
210
1509
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
3.0
6.6
29
101
S82.6
ICD-10 Finland
Fracture of lateral malleolus
2.4
6.5
45
197
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.5
6.5
41
172
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
5.4
6.5
18
34
B03BA03
ATC
hydroxocobalamin; parenteral
2.6
6.5
37
148
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
6.5
53
250
NH1CF
NOMESCO Finland
Ankle and foot extensive MRI examination with median intensity magnet
70.5
6.4
7
*
Z44.1
ICD-10 Finland
Fitting and adjustment of artificial leg (complete)(partial)
70.5
6.4
7
*
2503B
ICD-9 Finland
Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]
70.5
6.4
7
*
RJ516, ,
NOMESCO Finland
70.5
6.4
7
*
H03AA01
ATC
levothyroxine sodium; systemic
1.7
6.4
131
840
G47.3
ICD-10 Finland
Sleep apnoea
1.6
6.4
167
1141
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
14.5
6.4
10
7
A29
ICPC
General symptom/complaint other
1.8
6.4
94
548
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
5.3
6.4
18
35
3AC01, ,
NOMESCO Finland
8.3
6.4
13
16
WX722
NOMESCO Finland
PEEP
2.4
6.4
41
174
J01CA08
ATC
pivmecillinam; oral
1.6
6.3
200
1431
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
9.4
6.3
12
13
ZXD40
NOMESCO Finland
Procedure on patient requiring isolation
18.2
6.3
9
5
H3601, E106,
ICD-10 Finland
+∞
6.3
6
*
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
+∞
6.3
6
*
RJ731, ,
NOMESCO Finland
+∞
6.3
6
*
0781C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]
+∞
6.3
6
*
I79.2
ICD-10 Finland
Peripheral angiopathy in diseases classified elsewhere
+∞
6.3
6
*
JL9AE
NOMESCO Finland
Ultrasound examination of pancreas transplant
+∞
6.3
6
*
QDH
NOMESCO Finland
Operations on toe nails
+∞
6.3
6
*
Y70
ICPC
Syphilis male
+∞
6.3
6
*
G59.0*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic mononeuropathy
+∞
6.3
6
*
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
27.0
6.2
8
*
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.2
6.2
50
234
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.3
6.2
48
221
S10
ICPC
Boil/carbuncle
2.3
6.2
46
208
K61.0
ICD-10 Finland
Anal abscess
4.0
6.2
17
43
L85.3
ICD-10 Finland
Xerosis cutis
6.4
6.2
15
24
H16.0
ICD-10 Finland
Corneal ulcer
2.4
6.2
42
183
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
6.1
84
478
A03
ICPC
Fever
1.8
6.1
109
672
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
3.8
6.1
18
48
A07DA03
ATC
loperamide; oral
3.2
6.1
24
78
Z25.1
ICD-10 Finland
Need for immunization against influenza
2.5
6.1
38
159
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.2
6.1
23
73
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.5
6.1
37
153
M10
ICD-10 Finland
Gout
2.5
6.1
36
147
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.2
6.1
53
257
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.4
6.0
21
63
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
6.1
6.0
15
25

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
3.2e+00
3.4e+00
3.8e+00
1.0e+50
3.9e+00
3.8e+00
3.5e+00
cases:15.22%
controls:0.74%
cases:13.71%
controls:0.54%
cases:6.19%
controls:0.15%
cases:3.34%
controls:0.00%
cases:8.09%
controls:0.18%
cases:17.14%
controls:0.47%
cases:22.15%
controls:0.89%
91
44
507
5926
82
32
516
5938
37
9
561
5961
20
0
578
5970
48
11
545
5946
97
27
469
5721
105
44
369
4885
Insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E10.2 [2000503132]
3.8e+00
3.6e+00
—
1.0e+50
3.8e+00
3.5e+00
4.0e+00
cases:6.52%
controls:0.15%
cases:6.02%
controls:0.17%
—
—
cases:1.84%
controls:0.00%
cases:3.71%
controls:0.08%
cases:5.65%
controls:0.17%
cases:8.23%
controls:0.16%
39
9
559
5961
36
10
562
5960
—
11
0
587
5970
22
5
571
5952
32
10
534
5738
39
8
435
4921
Chronic ulcer skin
S97 [2002001061]
2.7e+00
3.0e+00
3.4e+00
—
2.9e+00
2.8e+00
3.0e+00
cases:7.69%
controls:0.54%
cases:5.85%
controls:0.32%
cases:2.34%
controls:0.08%
—
—
cases:1.85%
controls:0.10%
cases:6.36%
controls:0.40%
cases:17.09%
controls:1.01%
46
32
552
5938
35
19
563
5951
14
5
584
5965
—
11
6
582
5951
36
23
530
5725
81
50
393
4879
Hemodialysis
TK800 [2001305768]
3.0e+00
3.1e+00
3.0e+00
—
3.0e+00
2.7e+00
3.0e+00
cases:3.51%
controls:0.18%
cases:2.51%
controls:0.12%
cases:1.67%
controls:0.08%
—
—
cases:1.69%
controls:0.08%
cases:2.47%
controls:0.17%
cases:4.22%
controls:0.22%
21
11
577
5959
15
7
583
5963
10
5
588
5965
—
10
5
583
5952
14
10
552
5738
20
11
454
4918
Endocrinology
46 [38004485]
2.0e+00
2.5e+00
3.2e+00
—
4.2e+00
3.1e+00
2.5e+00
cases:21.24%
controls:3.47%
cases:22.74%
controls:2.46%
cases:11.71%
controls:0.52%
—
—
cases:22.26%
controls:0.42%
cases:34.63%
controls:2.24%
cases:34.81%
controls:4.16%
127
207
471
5763
136
147
462
5823
70
31
528
5939
—
132
25
461
5932
196
129
370
5619
165
205
309
4724
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
3.0e+00
3.3e+00
—
1.0e+50
3.8e+00
3.8e+00
3.2e+00
cases:13.21%
controls:0.72%
cases:10.37%
controls:0.42%
—
—
cases:4.01%
controls:0.00%
cases:5.56%
controls:0.13%
cases:14.13%
controls:0.38%
cases:23.42%
controls:1.20%
79
43
519
5927
62
25
536
5945
—
24
0
574
5970
33
8
560
5949
80
22
486
5726
111
59
363
4870
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
3.6e+00
4.0e+00
—
1.0e+50
—
4.7e+00
4.0e+00
cases:10.54%
controls:0.32%
cases:10.20%
controls:0.22%
—
—
cases:2.01%
controls:0.00%
—
—
cases:11.84%
controls:0.12%
cases:23.42%
controls:0.55%
63
19
535
5951
61
13
537
5957
—
12
0
586
5970
—
67
7
499
5741
111
27
363
4902
Nephrology
39 [38004479]
2.2e+00
2.7e+00
3.2e+00
—
2.8e+00
2.7e+00
2.6e+00
cases:9.03%
controls:1.14%
cases:10.03%
controls:0.75%
cases:5.35%
controls:0.23%
—
—
cases:4.55%
controls:0.29%
cases:10.95%
controls:0.85%
cases:15.19%
controls:1.26%
54
68
544
5902
60
45
538
5925
32
14
566
5956
—
27
17
566
5940
62
49
504
5699
72
62
402
4867
Kidney transplant status
Z94.0 [45566477]
2.8e+00
2.9e+00
—
1.0e+50
2.9e+00
3.0e+00
3.5e+00
cases:2.84%
controls:0.18%
cases:3.01%
controls:0.17%
—
—
cases:1.17%
controls:0.00%
cases:1.52%
controls:0.08%
cases:3.36%
controls:0.17%
cases:4.64%
controls:0.14%
17
11
581
5959
18
10
580
5960
—
7
0
591
5970
9
5
584
5952
19
10
547
5738
22
7
452
4922
Emergency Room Visit
ER [9203]
1.2e+00
1.5e+00
2.2e+00
5.3e+00
1.8e+00
1.5e+00
1.3e+00
cases:63.38%
controls:35.11%
cases:36.62%
controls:11.61%
cases:12.21%
controls:1.49%
cases:13.88%
controls:0.08%
cases:8.09%
controls:1.38%
cases:35.87%
controls:10.73%
cases:58.44%
controls:27.81%
379
2096
219
3874
219
693
379
5277
73
89
525
5881
83
5
515
5965
48
82
545
5875
203
617
363
5131
277
1371
197
3558
Plastic And Reconstructive Surgery
24 [38004467]
1.4e+00
2.2e+00
2.7e+00
1.0e+50
3.2e+00
2.7e+00
2.3e+00
cases:10.37%
controls:2.66%
cases:7.19%
controls:0.84%
cases:2.84%
controls:0.20%
cases:2.68%
controls:0.00%
cases:4.05%
controls:0.17%
cases:11.48%
controls:0.89%
cases:22.78%
controls:2.98%
62
159
536
5811
43
50
555
5920
17
12
581
5958
16
0
582
5970
24
10
569
5947
65
51
501
5697
108
147
366
4782
clindamycin; oral, parenteral
J01FF01 [21602985]
1.9e+00
2.4e+00
2.6e+00
—
2.8e+00
2.3e+00
2.2e+00
cases:19.40%
controls:3.40%
cases:9.87%
controls:0.94%
cases:2.01%
controls:0.15%
—
—
cases:2.53%
controls:0.15%
cases:9.01%
controls:0.99%
cases:23.63%
controls:3.25%
116
203
482
5767
59
56
539
5914
12
9
586
5961
—
15
9
578
5948
51
57
515
5691
112
160
362
4769
Outpatient Visit
OP [9202]
1.2e+00
1.3e+00
1.6e+00
4.6e+00
1.9e+00
1.9e+00
1.7e+00
cases:90.13%
controls:72.50%
cases:79.10%
controls:49.88%
cases:35.79%
controls:10.00%
cases:33.28%
controls:0.52%
cases:44.69%
controls:10.69%
cases:86.57%
controls:49.91%
cases:95.78%
controls:80.87%
539
4328
59
1642
473
2978
125
2992
214
597
384
5373
199
31
399
5939
265
637
328
5320
490
2869
76
2879
454
3986
20
943
Infectious Disease
44 [38004484]
1.9e+00
2.5e+00
—
1.0e+50
4.2e+00
3.1e+00
2.4e+00
cases:11.37%
controls:1.91%
cases:8.86%
controls:0.77%
—
—
cases:6.52%
controls:0.00%
cases:6.24%
controls:0.10%
cases:12.19%
controls:0.63%
cases:18.35%
controls:2.03%
68
114
530
5856
53
46
545
5924
—
39
0
559
5970
37
6
556
5951
69
36
497
5712
87
100
387
4829
Diabetes insulin dependent
T89 [2002001130]
2.2e+00
2.2e+00
2.6e+00
—
2.5e+00
2.3e+00
2.3e+00
cases:10.37%
controls:1.31%
cases:8.53%
controls:1.02%
cases:3.18%
controls:0.23%
—
—
cases:3.88%
controls:0.32%
cases:9.89%
controls:1.11%
cases:17.09%
controls:2.11%
62
78
536
5892
51
61
547
5909
19
14
579
5956
—
23
19
570
5938
56
64
510
5684
81
104
393
4825
Proliferative diabetic retinopathy and Type 1 diabetes mellitus, With ophthalmic complications
H36.03*E10.3 [2000503982]
3.2e+00
3.6e+00
1.0e+50
—
1.0e+50
3.4e+00
3.6e+00
cases:7.02%
controls:0.32%
cases:4.85%
controls:0.13%
cases:1.17%
controls:0.00%
—
—
cases:2.02%
controls:0.00%
cases:5.65%
controls:0.19%
cases:9.07%
controls:0.28%
42
19
556
5951
29
8
569
5962
7
0
591
5970
—
12
0
581
5957
32
11
534
5737
43
14
431
4915
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
2.7e+00
3.3e+00
—
1.0e+50
—
4.4e+00
3.4e+00
cases:5.85%
controls:0.44%
cases:5.85%
controls:0.22%
—
—
cases:1.17%
controls:0.00%
—
—
cases:10.25%
controls:0.14%
cases:16.88%
controls:0.69%
35
26
563
5944
35
13
563
5957
—
7
0
591
5970
—
58
8
508
5740
80
34
394
4895
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
1.9e+00
2.3e+00
2.6e+00
1.0e+50
2.3e+00
2.3e+00
2.3e+00
cases:10.03%
controls:1.66%
cases:6.86%
controls:0.70%
cases:3.18%
controls:0.23%
cases:0.84%
controls:0.00%
cases:2.19%
controls:0.24%
cases:7.60%
controls:0.80%
cases:17.93%
controls:2.17%
60
99
538
5871
41
42
557
5928
19
14
579
5956
5
0
593
5970
13
14
580
5943
43
46
523
5702
85
107
389
4822
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
2.1e+00
2.1e+00
3.1e+00
—
2.2e+00
2.2e+00
2.0e+00
cases:6.69%
controls:0.89%
cases:5.18%
controls:0.67%
cases:1.84%
controls:0.08%
—
—
cases:1.01%
controls:0.12%
cases:6.36%
controls:0.75%
cases:13.08%
controls:1.99%
40
53
558
5917
31
40
567
5930
11
5
587
5965
—
6
7
587
5950
36
43
530
5705
62
98
412
4831
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.6e+00
2.1e+00
3.0e+00
—
2.6e+00
2.4e+00
1.8e+00
cases:6.52%
controls:1.34%
cases:6.02%
controls:0.75%
cases:2.34%
controls:0.12%
—
—
cases:2.36%
controls:0.18%
cases:8.13%
controls:0.80%
cases:14.98%
controls:2.72%
39
80
559
5890
36
45
562
5925
14
7
584
5963
—
14
11
579
5946
46
46
520
5702
71
134
403
4795
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
2.4e+00
2.7e+00
2.9e+00
—
—
2.7e+00
2.9e+00
cases:3.01%
controls:0.28%
cases:3.51%
controls:0.25%
cases:1.84%
controls:0.10%
—
—
—
—
cases:3.36%
controls:0.23%
cases:4.43%
controls:0.26%
18
17
580
5953
21
15
577
5955
11
6
587
5964
—
—
19
13
547
5735
21
13
453
4916
Type 2 diabetes mellitus, with neurological complications
E11.4 [45576442]
3.3e+00
3.6e+00
—
1.0e+50
—
3.3e+00
3.2e+00
cases:6.69%
controls:0.27%
cases:5.02%
controls:0.15%
—
—
cases:1.17%
controls:0.00%
—
—
cases:6.01%
controls:0.24%
cases:10.97%
controls:0.51%
40
16
558
5954
30
9
568
5961
—
7
0
591
5970
—
34
14
532
5734
52
25
422
4904
Foot and toes X-ray examination
NH3AA [2001308267]
2.6e+00
3.8e+00
—
1.0e+50
—
3.5e+00
3.3e+00
cases:10.37%
controls:0.82%
cases:8.03%
controls:0.20%
—
—
cases:5.52%
controls:0.00%
—
—
cases:10.60%
controls:0.35%
cases:20.04%
controls:0.93%
62
49
536
5921
48
12
550
5958
—
33
0
565
5970
—
60
20
506
5728
95
46
379
4883
Office Visit
OMOP4822458 [581477]
1.2e+00
1.7e+00
2.9e+00
—
3.6e+00
2.2e+00
1.5e+00
cases:22.91%
controls:8.51%
cases:12.54%
controls:2.60%
cases:4.85%
controls:0.27%
—
—
cases:11.30%
controls:0.35%
cases:19.08%
controls:2.45%
cases:22.36%
controls:6.13%
137
508
461
5462
75
155
523
5815
29
16
569
5954
—
67
21
526
5936
108
141
458
5607
106
302
368
4627
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
1.6e+00
2.3e+00
2.5e+00
—
3.2e+00
1.9e+00
1.4e+00
cases:7.19%
controls:1.49%
cases:5.35%
controls:0.59%
cases:1.67%
controls:0.13%
—
—
cases:2.36%
controls:0.10%
cases:4.95%
controls:0.77%
cases:10.34%
controls:2.64%
43
89
555
5881
32
35
566
5935
10
8
588
5962
—
14
6
579
5951
28
44
538
5704
49
130
425
4799
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
1.5e+00
2.0e+00
2.9e+00
—
2.3e+00
2.2e+00
2.0e+00
cases:9.20%
controls:2.29%
cases:8.19%
controls:1.14%
cases:2.84%
controls:0.17%
—
—
cases:2.53%
controls:0.25%
cases:10.42%
controls:1.24%
cases:21.94%
controls:3.69%
55
137
543
5833
49
68
549
5902
17
10
581
5960
—
15
15
578
5942
59
71
507
5677
104
182
370
4747
insulin aspart; parenteral
A10AD05 [21600733]
2.2e+00
2.3e+00
1.9e+00
—
1.9e+00
2.2e+00
2.2e+00
cases:24.75%
controls:3.42%
cases:23.91%
controls:3.17%
cases:5.18%
controls:0.84%
—
—
cases:5.56%
controls:0.86%
cases:24.20%
controls:3.31%
cases:29.54%
controls:4.54%
148
204
450
5766
143
189
455
5781
31
50
567
5920
—
33
51
560
5906
137
190
429
5558
140
224
334
4705
Diabetic maculopathy and Type 1 diabetes mellitus, With ophthalmic complications
H36.01*E10.3 [2000503946]
3.2e+00
3.0e+00
—
—
—
3.3e+00
3.1e+00
cases:4.68%
controls:0.20%
cases:3.01%
controls:0.15%
—
—
—
—
—
—
cases:2.83%
controls:0.10%
cases:4.64%
controls:0.22%
28
12
570
5958
18
9
580
5961
—
—
—
16
6
550
5742
22
11
452
4918
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
3.2e+00
3.0e+00
—
—
—
3.0e+00
3.4e+00
cases:4.52%
controls:0.20%
cases:3.51%
controls:0.18%
—
—
—
—
—
—
cases:3.53%
controls:0.17%
cases:5.91%
controls:0.20%
27
12
571
5958
21
11
577
5959
—
—
—
20
10
546
5738
28
10
446
4919
insulin aspart; parenteral
A10AB05 [21600719]
2.2e+00
2.3e+00
1.8e+00
—
1.9e+00
2.2e+00
2.2e+00
cases:24.58%
controls:3.40%
cases:23.75%
controls:3.15%
cases:5.02%
controls:0.84%
—
—
cases:5.23%
controls:0.86%
cases:23.85%
controls:3.27%
cases:28.90%
controls:4.46%
147
203
451
5767
142
188
456
5782
30
50
568
5920
—
31
51
562
5906
135
188
431
5560
137
220
337
4709
Extracorporeal dialysis
Z49.1 [45537649]
3.3e+00
2.9e+00
—
—
—
2.7e+00
3.6e+00
cases:3.01%
controls:0.12%
cases:2.34%
controls:0.13%
—
—
—
—
—
—
cases:2.12%
controls:0.14%
cases:4.43%
controls:0.12%
18
7
580
5963
14
8
584
5962
—
—
—
12
8
554
5740
21
6
453
4923
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
1.4e+00
2.0e+00
2.8e+00
1.0e+50
2.3e+00
2.0e+00
1.9e+00
cases:8.53%
controls:2.19%
cases:6.19%
controls:0.90%
cases:1.67%
controls:0.10%
cases:0.84%
controls:0.00%
cases:1.18%
controls:0.12%
cases:6.71%
controls:0.94%
cases:16.67%
controls:2.96%
51
131
547
5839
37
54
561
5916
10
6
588
5964
5
0
593
5970
7
7
586
5950
38
54
528
5694
79
146
395
4783
Type 1 diabetes mellitus, With renal complications
E10.2 [45586137]
3.1e+00
3.2e+00
—
—
—
2.9e+00
3.3e+00
cases:4.68%
controls:0.22%
cases:2.34%
controls:0.10%
—
—
—
—
—
—
cases:2.65%
controls:0.16%
cases:5.27%
controls:0.20%
28
13
570
5957
14
6
584
5964
—
—
—
15
9
551
5739
25
10
449
4919
Bacteria identified in Isolate by Culture
43409-2 [3042936]
1.5e+00
2.0e+00
2.1e+00
—
2.3e+00
2.4e+00
2.1e+00
cases:10.20%
controls:2.50%
cases:5.69%
controls:0.84%
cases:1.51%
controls:0.18%
—
—
cases:2.19%
controls:0.22%
cases:8.83%
controls:0.85%
cases:19.62%
controls:3.04%
61
149
537
5821
34
50
564
5920
9
11
589
5959
—
13
13
580
5944
50
49
516
5699
93
150
381
4779
Atherosclerosis of arteries of extremities
I70.2 [45538421]
1.4e+00
1.6e+00
2.3e+00
—
2.5e+00
2.1e+00
2.3e+00
cases:5.35%
controls:1.36%
cases:3.85%
controls:0.82%
cases:1.84%
controls:0.18%
—
—
cases:3.04%
controls:0.25%
cases:5.65%
controls:0.75%
cases:12.66%
controls:1.40%
32
81
566
5889
23
49
575
5921
11
11
587
5959
—
18
15
575
5942
32
43
534
5705
60
69
414
4860
alfacalcidol; oral, parenteral
A11CC03 [21600818]
3.0e+00
2.9e+00
—
—
—
3.0e+00
3.2e+00
cases:3.34%
controls:0.17%
cases:2.84%
controls:0.17%
—
—
—
—
—
—
cases:3.89%
controls:0.19%
cases:5.70%
controls:0.24%
20
10
578
5960
17
10
581
5960
—
—
—
22
11
544
5737
27
12
447
4917
insulin (beef); parenteral
A10AD02 [21600730]
2.1e+00
2.1e+00
2.0e+00
—
1.5e+00
2.2e+00
2.1e+00
cases:25.75%
controls:4.09%
cases:24.92%
controls:3.89%
cases:7.53%
controls:1.06%
—
—
cases:4.89%
controls:1.12%
cases:26.50%
controls:3.97%
cases:30.38%
controls:4.95%
154
244
444
5726
149
232
449
5738
45
63
553
5907
—
29
67
564
5890
150
228
416
5520
144
244
330
4685
insulin glargine; parenteral
A10AE04 [21600739]
2.1e+00
2.1e+00
2.0e+00
—
1.5e+00
2.2e+00
2.1e+00
cases:25.75%
controls:4.09%
cases:24.92%
controls:3.89%
cases:7.53%
controls:1.06%
—
—
cases:4.89%
controls:1.12%
cases:26.50%
controls:3.97%
cases:30.38%
controls:4.95%
154
244
444
5726
149
232
449
5738
45
63
553
5907
—
29
67
564
5890
150
228
416
5520
144
244
330
4685
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
8.3e-01
1.8e+00
2.9e+00
—
3.1e+00
2.0e+00
1.4e+00
cases:5.35%
controls:2.41%
cases:5.35%
controls:0.90%
cases:1.51%
controls:0.08%
—
—
cases:2.53%
controls:0.12%
cases:6.54%
controls:0.97%
cases:10.97%
controls:2.88%
32
144
566
5826
32
54
566
5916
9
5
589
5965
—
15
7
578
5950
37
56
529
5692
52
142
422
4787
Erysipelas
A46 [45561706]
2.0e+00
2.4e+00
—
1.0e+50
3.2e+00
2.2e+00
2.0e+00
cases:12.21%
controls:1.78%
cases:7.53%
controls:0.72%
—
—
cases:2.68%
controls:0.00%
cases:2.02%
controls:0.08%
cases:6.89%
controls:0.84%
cases:16.88%
controls:2.68%
73
106
525
5864
45
43
553
5927
—
16
0
582
5970
12
5
581
5952
39
48
527
5700
80
132
394
4797
Hypertension secondary to other renal disorders
I15.1 [45557535]
3.0e+00
3.1e+00
—
—
—
2.7e+00
3.0e+00
cases:2.51%
controls:0.13%
cases:2.51%
controls:0.12%
—
—
—
—
—
—
cases:2.65%
controls:0.17%
cases:4.22%
controls:0.22%
15
8
583
5962
15
7
583
5963
—
—
—
15
10
551
5738
20
11
454
4918
Reagin Ab [Titer] in Serum by VDRL
50690-7 [3029634]
1.9e+00
2.8e+00
1.0e+50
1.0e+50
—
4.1e+00
3.0e+00
cases:2.01%
controls:0.32%
cases:2.34%
controls:0.15%
cases:3.68%
controls:0.00%
cases:0.84%
controls:0.00%
—
—
cases:4.77%
controls:0.09%
cases:7.17%
controls:0.37%
12
19
586
5951
14
9
584
5961
22
0
576
5970
5
0
593
5970
—
27
5
539
5743
34
18
440
4911
Vascular Surgery
77 [38004496]
1.4e+00
1.7e+00
2.3e+00
—
2.0e+00
2.1e+00
2.1e+00
cases:11.04%
controls:2.83%
cases:6.02%
controls:1.17%
cases:1.84%
controls:0.18%
—
—
cases:2.02%
controls:0.27%
cases:8.30%
controls:1.10%
cases:21.10%
controls:3.12%
66
169
532
5801
36
70
562
5900
11
11
587
5959
—
12
16
581
5941
47
63
519
5685
100
154
374
4775
insulin detemir; parenteral
A10AE05 [21600740]
2.2e+00
2.1e+00
2.0e+00
—
1.5e+00
1.9e+00
2.0e+00
cases:16.56%
controls:2.19%
cases:12.21%
controls:1.69%
cases:2.68%
controls:0.37%
—
—
cases:2.19%
controls:0.50%
cases:11.84%
controls:1.88%
cases:15.61%
controls:2.48%
99
131
499
5839
73
101
525
5869
16
22
582
5948
—
13
30
580
5927
67
108
499
5640
74
122
400
4807
Diabetic maculopathy and Type 2 diabetes mellitus, with ophthalmic complications
H36.01*E11.3 [2000503956]
3.0e+00
2.5e+00
—
—
—
2.9e+00
3.3e+00
cases:2.51%
controls:0.13%
cases:1.17%
controls:0.10%
—
—
—
—
—
—
cases:2.47%
controls:0.14%
cases:4.85%
controls:0.18%
15
8
583
5962
7
6
591
5964
—
—
—
14
8
552
5740
23
9
451
4920
Foot/toe symptom/complaint
L17 [2002000641]
1.5e+00
1.5e+00
2.9e+00
1.0e+50
1.8e+00
2.0e+00
1.6e+00
cases:15.05%
controls:3.85%
cases:8.70%
controls:2.04%
cases:5.18%
controls:0.30%
cases:3.01%
controls:0.00%
cases:1.85%
controls:0.30%
cases:11.13%
controls:1.60%
cases:24.89%
controls:6.13%
90
230
508
5740
52
122
546
5848
31
18
567
5952
18
0
580
5970
11
18
582
5939
63
92
503
5656
118
302
356
4627
Internal Medicine
11 [38004456]
1.3e+00
1.6e+00
2.4e+00
—
2.5e+00
1.8e+00
1.7e+00
cases:49.00%
controls:21.06%
cases:32.11%
controls:8.39%
cases:12.71%
controls:1.27%
—
—
cases:15.01%
controls:1.43%
cases:33.57%
controls:7.45%
cases:53.38%
controls:17.59%
293
1257
305
4713
192
501
406
5469
76
76
522
5894
—
89
85
504
5872
190
428
376
5320
253
867
221
4062
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.6e+00
2.0e+00
—
—
3.0e+00
2.5e+00
2.1e+00
cases:11.54%
controls:2.60%
cases:4.68%
controls:0.64%
—
—
—
—
cases:1.69%
controls:0.08%
cases:5.83%
controls:0.50%
cases:14.98%
controls:2.19%
69
155
529
5815
28
38
570
5932
—
—
10
5
583
5952
33
29
533
5719
71
108
403
4821
Ophthalmology
18 [38004463]
1.2e+00
1.5e+00
1.6e+00
2.5e+00
1.4e+00
1.6e+00
1.4e+00
cases:38.80%
controls:15.48%
cases:25.59%
controls:6.88%
cases:5.85%
controls:1.26%
cases:1.00%
controls:0.08%
cases:4.89%
controls:1.29%
cases:26.50%
controls:6.85%
cases:46.62%
controls:18.22%
232
924
366
5046
153
411
445
5559
35
75
563
5895
6
5
592
5965
29
77
564
5880
150
394
416
5354
221
898
253
4031
Photocoagulation of retina
CKC12 [2001301394]
2.7e+00
2.9e+00
—
—
—
3.0e+00
2.6e+00
cases:8.53%
controls:0.65%
cases:4.18%
controls:0.25%
—
—
—
—
—
—
cases:4.77%
controls:0.26%
cases:10.13%
controls:0.83%
51
39
547
5931
25
15
573
5955
—
—
—
27
15
539
5733
48
41
426
4888
insulin lispro; parenteral
A10AD04 [21600732]
2.0e+00
1.9e+00
1.8e+00
—
1.6e+00
1.8e+00
1.8e+00
cases:10.54%
controls:1.54%
cases:8.86%
controls:1.44%
cases:1.67%
controls:0.27%
—
—
cases:1.85%
controls:0.37%
cases:8.30%
controls:1.43%
cases:9.70%
controls:1.74%
63
92
535
5878
53
86
545
5884
10
16
588
5954
—
11
22
582
5935
47
82
519
5666
46
86
428
4843
insulin lispro; parenteral
A10AC04 [21600726]
2.0e+00
1.9e+00
1.8e+00
—
1.6e+00
1.8e+00
1.8e+00
cases:10.70%
controls:1.59%
cases:8.86%
controls:1.46%
cases:1.67%
controls:0.27%
—
—
cases:1.85%
controls:0.37%
cases:8.30%
controls:1.43%
cases:9.70%
controls:1.74%
64
95
534
5875
53
87
545
5883
10
16
588
5954
—
11
22
582
5935
47
82
519
5666
46
86
428
4843
insulin lispro; parenteral
A10AB04 [21600718]
2.0e+00
1.9e+00
1.8e+00
—
1.6e+00
1.8e+00
1.8e+00
cases:10.70%
controls:1.59%
cases:8.86%
controls:1.46%
cases:1.67%
controls:0.27%
—
—
cases:1.85%
controls:0.37%
cases:8.30%
controls:1.43%
cases:9.70%
controls:1.74%
64
95
534
5875
53
87
545
5883
10
16
588
5954
—
11
22
582
5935
47
82
519
5666
46
86
428
4843
liraglutide; parenteral
A10BJ02 [1123630]
2.3e+00
2.3e+00
1.8e+00
—
2.5e+00
2.0e+00
1.9e+00
cases:5.02%
controls:0.52%
cases:3.18%
controls:0.32%
cases:0.84%
controls:0.13%
—
—
cases:1.18%
controls:0.10%
cases:3.18%
controls:0.45%
cases:5.49%
controls:0.87%
30
31
568
5939
19
19
579
5951
5
8
593
5962
—
7
6
586
5951
18
26
548
5722
26
43
448
4886
Type 2 diabetes mellitus, with peripheral circulatory complications
E11.5 [45557114]
3.7e+00
—
1.0e+50
—
1.0e+50
3.5e+00
3.7e+00
cases:5.02%
controls:0.13%
—
—
cases:2.01%
controls:0.00%
—
—
cases:1.35%
controls:0.00%
cases:4.06%
controls:0.12%
cases:10.76%
controls:0.28%
30
8
568
5962
—
12
0
586
5970
—
8
0
585
5957
23
7
543
5741
51
14
423
4915
Bacteria identified in Blood by Culture
600-7 [3023368]
1.2e+00
1.5e+00
2.4e+00
—
2.5e+00
1.7e+00
1.6e+00
cases:12.54%
controls:4.07%
cases:8.03%
controls:1.86%
cases:3.18%
controls:0.28%
—
—
cases:3.37%
controls:0.29%
cases:9.36%
controls:1.88%
cases:25.95%
controls:6.74%
75
243
523
5727
48
111
550
5859
19
17
579
5953
—
20
17
573
5940
53
108
513
5640
123
332
351
4597
Type 1 diabetes mellitus, With other specified complications
E10.6 [45537959]
3.4e+00
—
1.0e+50
—
1.0e+50
4.1e+00
3.4e+00
cases:3.01%
controls:0.10%
—
—
cases:1.17%
controls:0.00%
—
—
cases:1.52%
controls:0.00%
cases:4.95%
controls:0.09%
cases:5.91%
controls:0.20%
18
6
580
5964
—
7
0
591
5970
—
9
0
584
5957
28
5
538
5743
28
10
446
4919
benzylpenicillin; parenteral
J01CE01 [21602841]
2.6e+00
2.7e+00
—
—
—
2.5e+00
3.2e+00
cases:1.34%
controls:0.10%
cases:1.51%
controls:0.10%
—
—
—
—
—
—
cases:1.41%
controls:0.12%
cases:2.32%
controls:0.10%
8
6
590
5964
9
6
589
5964
—
—
—
8
7
558
5741
11
5
463
4924
benzathine benzylpenicillin; parenteral
J01CE08 [21602848]
2.6e+00
2.7e+00
—
—
—
2.5e+00
3.2e+00
cases:1.34%
controls:0.10%
cases:1.51%
controls:0.10%
—
—
—
—
—
—
cases:1.41%
controls:0.12%
cases:2.32%
controls:0.10%
8
6
590
5964
9
6
589
5964
—
—
—
8
7
558
5741
11
5
463
4924
procaine benzylpenicillin; parenteral
J01CE09 [21602849]
2.6e+00
2.7e+00
—
—
—
2.5e+00
3.2e+00
cases:1.34%
controls:0.10%
cases:1.51%
controls:0.10%
—
—
—
—
—
—
cases:1.41%
controls:0.12%
cases:2.32%
controls:0.10%
8
6
590
5964
9
6
589
5964
—
—
—
8
7
558
5741
11
5
463
4924
Limited function/disability (L)
L28 [2002000647]
1.0e+00
1.2e+00
2.6e+00
—
2.7e+00
1.8e+00
1.4e+00
cases:6.35%
controls:2.40%
cases:3.68%
controls:1.09%
cases:1.84%
controls:0.13%
—
—
cases:2.70%
controls:0.18%
cases:6.54%
controls:1.10%
cases:13.29%
controls:3.53%
38
143
560
5827
22
65
576
5905
11
8
587
5962
—
16
11
577
5946
37
63
529
5685
63
174
411
4755
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
1.0e+00
1.5e+00
2.4e+00
1.0e+50
2.6e+00
1.8e+00
1.5e+00
cases:15.55%
controls:6.10%
cases:11.87%
controls:2.85%
cases:4.85%
controls:0.45%
cases:5.35%
controls:0.00%
cases:5.73%
controls:0.47%
cases:13.96%
controls:2.61%
cases:24.68%
controls:6.72%
93
364
505
5606
71
170
527
5800
29
27
569
5943
32
0
566
5970
34
28
559
5929
79
150
487
5598
117
331
357
4598
T1D - yes
T1D-1 [2002330228]
3.5e+00
3.6e+00
—
—
—
3.7e+00
—
cases:3.85%
controls:0.12%
cases:3.51%
controls:0.10%
—
—
—
—
—
—
cases:3.53%
controls:0.09%
—
—
23
7
575
5963
21
6
577
5964
—
—
—
20
5
546
5743
—
Other healthcare associate professional
Z3229 [2001311561]
1.5e+00
2.0e+00
—
—
3.0e+00
2.5e+00
1.8e+00
cases:5.18%
controls:1.19%
cases:2.17%
controls:0.30%
—
—
—
—
cases:2.02%
controls:0.10%
cases:2.83%
controls:0.24%
cases:4.22%
controls:0.71%
31
71
567
5899
13
18
585
5952
—
—
12
6
581
5951
16
14
550
5734
20
35
454
4894
Type 1 diabetes mellitus, With ophthalmic complications
E10.3 [45552380]
2.3e+00
1.9e+00
1.9e+00
—
2.0e+00
1.3e+00
1.4e+00
cases:9.87%
controls:1.04%
cases:5.35%
controls:0.84%
cases:1.17%
controls:0.18%
—
—
cases:1.01%
controls:0.13%
cases:3.00%
controls:0.87%
cases:6.54%
controls:1.68%
59
62
539
5908
32
50
566
5920
7
11
591
5959
—
6
8
587
5949
17
50
549
5698
31
83
443
4846
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.3e+00
1.9e+00
2.0e+00
—
2.3e+00
1.5e+00
1.6e+00
cases:6.86%
controls:1.91%
cases:6.86%
controls:1.06%
cases:1.17%
controls:0.17%
—
—
cases:1.18%
controls:0.12%
cases:6.01%
controls:1.36%
cases:18.57%
controls:4.24%
41
114
557
5856
41
63
557
5907
7
10
591
5960
—
7
7
586
5950
34
78
532
5670
88
209
386
4720
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
1.3e+00
1.9e+00
2.1e+00
—
2.2e+00
1.5e+00
1.6e+00
cases:7.19%
controls:2.09%
cases:6.86%
controls:1.12%
cases:1.34%
controls:0.17%
—
—
cases:1.35%
controls:0.15%
cases:6.18%
controls:1.41%
cases:19.83%
controls:4.61%
43
125
555
5845
41
67
557
5903
8
10
590
5960
—
8
9
585
5948
35
81
531
5667
94
227
380
4702
Type 2 diabetes mellitus, with other specified complications
E11.6 [45552387]
3.2e+00
3.3e+00
—
1.0e+50
1.0e+50
—
4.1e+00
cases:4.35%
controls:0.18%
cases:3.01%
controls:0.12%
—
—
cases:2.01%
controls:0.00%
cases:1.52%
controls:0.00%
—
—
cases:10.13%
controls:0.18%
26
11
572
5959
18
7
580
5963
—
12
0
586
5970
9
0
584
5957
—
48
9
426
4920
Orthopedic Surgery
20 [38004465]
7.4e-01
1.4e+00
2.1e+00
—
2.9e+00
2.1e+00
1.2e+00
cases:27.93%
controls:15.66%
cases:20.23%
controls:5.75%
cases:6.86%
controls:0.85%
—
—
cases:14.84%
controls:0.94%
cases:33.57%
controls:5.69%
cases:42.83%
controls:18.00%
167
935
431
5035
121
343
477
5627
41
51
557
5919
—
88
56
505
5901
190
327
376
5421
203
887
271
4042
Diabetic maculopathy
H36.01 [2000502321]
2.9e+00
2.6e+00
—
—
—
2.6e+00
2.4e+00
cases:3.68%
controls:0.20%
cases:1.84%
controls:0.13%
—
—
—
—
—
—
cases:1.77%
controls:0.14%
cases:4.64%
controls:0.43%
22
12
576
5958
11
8
587
5962
—
—
—
10
8
556
5740
22
21
452
4908
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
4.8e-01
7.5e-01
1.7e+00
4.2e+00
1.7e+00
9.7e-01
7.4e-01
cases:39.63%
controls:28.91%
cases:33.44%
controls:19.23%
cases:18.90%
controls:3.97%
cases:12.21%
controls:0.22%
cases:17.54%
controls:3.61%
cases:38.69%
controls:19.29%
cases:63.50%
controls:45.47%
237
1726
361
4244
200
1148
398
4822
113
237
485
5733
73
13
525
5957
104
215
489
5742
219
1109
347
4639
301
2241
173
2688
Amputation of toe
NHQ40 [2001308365]
3.8e+00
2.8e+00
—
—
—
—
4.0e+00
cases:4.18%
controls:0.10%
cases:1.34%
controls:0.08%
—
—
—
—
—
—
—
—
cases:9.70%
controls:0.20%
25
6
573
5964
8
5
590
5965
—
—
—
—
46
10
428
4919
Other chronic renal failure
N18.8 [45534123]
2.4e+00
3.1e+00
—
—
—
2.4e+00
2.6e+00
cases:3.51%
controls:0.32%
cases:3.18%
controls:0.15%
—
—
—
—
—
—
cases:1.94%
controls:0.17%
cases:5.06%
controls:0.41%
21
19
577
5951
19
9
579
5961
—
—
—
11
10
555
5738
24
20
450
4909
Chronic kidney disease, unspecified
N18.9 [45553438]
2.1e+00
2.1e+00
—
1.0e+50
2.0e+00
1.8e+00
2.4e+00
cases:4.18%
controls:0.55%
cases:2.68%
controls:0.35%
—
—
cases:0.84%
controls:0.00%
cases:1.01%
controls:0.13%
cases:3.00%
controls:0.49%
cases:8.65%
controls:0.81%
25
33
573
5937
16
21
582
5949
—
5
0
593
5970
6
8
587
5949
17
28
549
5720
41
40
433
4889
enoxaparin; parenteral
B01AB05 [21600976]
8.5e-01
1.1e+00
2.1e+00
—
3.6e+00
1.7e+00
1.0e+00
cases:11.71%
controls:5.34%
cases:4.68%
controls:1.68%
cases:1.51%
controls:0.18%
—
—
cases:4.72%
controls:0.13%
cases:7.42%
controls:1.41%
cases:13.29%
controls:5.09%
70
319
528
5651
28
100
570
5870
9
11
589
5959
—
28
8
565
5949
42
81
524
5667
63
251
411
4678
Right side
ZXA00 [2001311346]
1.1e+00
1.4e+00
2.5e+00
—
2.3e+00
1.7e+00
1.4e+00
cases:10.87%
controls:3.82%
cases:4.01%
controls:0.97%
cases:1.00%
controls:0.08%
—
—
cases:1.01%
controls:0.10%
cases:4.24%
controls:0.84%
cases:9.92%
controls:2.74%
65
228
533
5742
24
58
574
5912
6
5
592
5965
—
6
6
587
5951
24
48
542
5700
47
135
427
4794
insulin (human); parenteral
A10AD01 [21600729]
2.2e+00
2.0e+00
—
—
2.4e+00
1.9e+00
1.8e+00
cases:13.38%
controls:1.73%
cases:6.02%
controls:0.85%
—
—
—
—
cases:1.85%
controls:0.17%
cases:5.30%
controls:0.80%
cases:6.12%
controls:1.08%
80
103
518
5867
36
51
562
5919
—
—
11
10
582
5947
30
46
536
5702
29
53
445
4876
Ankle X-ray examination without contrast
NH1AA [2001308235]
1.7e+00
2.8e+00
—
1.0e+50
—
3.6e+00
2.2e+00
cases:3.18%
controls:0.60%
cases:2.51%
controls:0.15%
—
—
cases:3.01%
controls:0.00%
—
—
cases:4.95%
controls:0.14%
cases:7.38%
controls:0.91%
19
36
579
5934
15
9
583
5961
—
18
0
580
5970
—
28
8
538
5740
35
45
439
4884
calcium carbonate; oral
A12AA04 [21600863]
2.5e+00
2.6e+00
—
—
—
2.2e+00
3.0e+00
cases:3.51%
controls:0.30%
cases:2.17%
controls:0.17%
—
—
—
—
—
—
cases:2.12%
controls:0.24%
cases:5.27%
controls:0.26%
21
18
577
5952
13
10
585
5960
—
—
—
12
14
554
5734
25
13
449
4916
calcium carbonate
A02AC01 [21600065]
2.5e+00
2.6e+00
—
—
—
2.2e+00
3.0e+00
cases:3.51%
controls:0.30%
cases:2.17%
controls:0.17%
—
—
—
—
—
—
cases:2.12%
controls:0.24%
cases:5.27%
controls:0.26%
21
18
577
5952
13
10
585
5960
—
—
—
12
14
554
5734
25
13
449
4916
Corns and callosities
L84 [45533651]
1.9e+00
2.4e+00
—
—
—
3.2e+00
2.8e+00
cases:2.51%
controls:0.39%
cases:1.51%
controls:0.13%
—
—
—
—
—
—
cases:2.83%
controls:0.12%
cases:7.38%
controls:0.49%
15
23
583
5947
9
8
589
5962
—
—
—
16
7
550
5741
35
24
439
4905
Implementation of podiatry rehabilitation plan
SPAT1225 [2001700326]
2.3e+00
2.5e+00
—
—
—
2.7e+00
2.8e+00
cases:3.01%
controls:0.32%
cases:2.68%
controls:0.22%
—
—
—
—
—
—
cases:3.36%
controls:0.24%
cases:8.02%
controls:0.55%
18
19
580
5951
16
13
582
5957
—
—
—
19
14
547
5734
38
27
436
4902
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
1.3e+00
1.8e+00
1.9e+00
—
2.1e+00
1.5e+00
1.6e+00
cases:7.69%
controls:2.31%
cases:7.19%
controls:1.27%
cases:1.34%
controls:0.20%
—
—
cases:1.18%
controls:0.15%
cases:6.36%
controls:1.43%
cases:20.89%
controls:4.87%
46
138
552
5832
43
76
555
5894
8
12
590
5958
—
7
9
586
5948
36
82
530
5666
99
240
375
4689
Vitreous haemorrhage
H43.1 [45543053]
2.9e+00
2.7e+00
—
—
—
2.4e+00
2.2e+00
cases:4.01%
controls:0.23%
cases:1.67%
controls:0.12%
—
—
—
—
—
—
cases:1.59%
controls:0.14%
cases:4.01%
controls:0.47%
24
14
574
5956
10
7
588
5963
—
—
—
9
8
557
5740
19
23
455
4906
furosemide; oral, parenteral
C03CA01 [21601518]
1.7e+00
1.8e+00
1.6e+00
—
1.6e+00
1.8e+00
1.7e+00
cases:23.91%
controls:5.58%
cases:20.90%
controls:4.37%
cases:6.86%
controls:1.49%
—
—
cases:5.90%
controls:1.29%
cases:22.79%
controls:4.63%
cases:31.22%
controls:7.49%
143
333
455
5637
125
261
473
5709
41
89
557
5881
—
35
77
558
5880
129
266
437
5482
148
369
326
4560
darbepoetin alfa; parenteral
B03XA02 [21601134]
3.3e+00
3.0e+00
—
—
—
3.7e+00
—
cases:3.68%
controls:0.13%
cases:3.01%
controls:0.15%
—
—
—
—
—
—
cases:3.89%
controls:0.10%
—
—
22
8
576
5962
18
9
580
5961
—
—
—
22
6
544
5742
—
Type 1 diabetes mellitus, With unspecified complications
E10.8 [45552384]
2.8e+00
2.5e+00
—
—
—
2.3e+00
2.3e+00
cases:1.84%
controls:0.12%
cases:1.17%
controls:0.10%
—
—
—
—
—
—
cases:1.24%
controls:0.12%
cases:3.16%
controls:0.32%
11
7
587
5963
7
6
591
5964
—
—
—
7
7
559
5741
15
16
459
4913
insulins and analogues for injection, intermediate-acting - combinations; parenteral
A10AC30 [21600727]
2.1e+00
1.7e+00
—
—
2.3e+00
1.8e+00
1.9e+00
cases:9.03%
controls:1.24%
cases:3.18%
controls:0.60%
—
—
—
—
cases:1.18%
controls:0.12%
cases:3.53%
controls:0.57%
cases:5.49%
controls:0.87%
54
74
544
5896
19
36
579
5934
—
—
7
7
586
5950
20
33
546
5715
26
43
448
4886
Custom moulded cast, unspecified region
TNX33 [2001308564]
2.3e+00
—
1.0e+50
1.0e+50
1.0e+50
4.6e+00
2.7e+00
cases:3.18%
controls:0.32%
—
—
cases:2.68%
controls:0.00%
cases:7.19%
controls:0.00%
cases:7.08%
controls:0.00%
cases:9.36%
controls:0.10%
cases:6.54%
controls:0.47%
19
19
579
5951
—
16
0
582
5970
43
0
555
5970
42
0
551
5957
53
6
513
5742
31
23
443
4906
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
8.6e-01
9.7e-01
2.7e+00
—
2.3e+00
1.7e+00
1.2e+00
cases:8.19%
controls:3.63%
cases:4.35%
controls:1.69%
cases:2.34%
controls:0.17%
—
—
cases:1.35%
controls:0.13%
cases:5.65%
controls:1.13%
cases:12.24%
controls:4.20%
49
217
549
5753
26
101
572
5869
14
10
584
5960
—
8
8
585
5949
32
65
534
5683
58
207
416
4722
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
3.6e-01
6.6e-01
1.5e+00
4.1e+00
1.6e+00
7.5e-01
5.5e-01
cases:40.13%
controls:31.93%
cases:39.63%
controls:25.34%
cases:18.73%
controls:4.77%
cases:10.70%
controls:0.20%
cases:19.22%
controls:4.60%
cases:43.82%
controls:26.83%
cases:65.82%
controls:52.71%
240
1906
358
4064
237
1513
361
4457
112
285
486
5685
64
12
534
5958
114
274
479
5683
248
1542
318
4206
312
2598
162
2331
Handing over of treatment supplies
SPAT1262 [2001700363]
1.5e+00
1.6e+00
1.4e+00
—
1.9e+00
1.6e+00
1.6e+00
cases:16.72%
controls:4.41%
cases:11.04%
controls:2.51%
cases:2.17%
controls:0.55%
—
—
cases:3.88%
controls:0.62%
cases:11.31%
controls:2.49%
cases:22.78%
controls:5.54%
100
263
498
5707
66
150
532
5820
13
33
585
5937
—
23
37
570
5920
64
143
502
5605
108
273
366
4656
insulin degludec; parenteral
A10AE06 [43534747]
2.7e+00
2.4e+00
—
—
—
2.2e+00
2.2e+00
cases:3.51%
controls:0.25%
cases:4.18%
controls:0.40%
—
—
—
—
—
—
cases:4.42%
controls:0.50%
cases:10.34%
controls:1.22%
21
15
577
5955
25
24
573
5946
—
—
—
25
29
541
5719
49
60
425
4869
Laceration/cut
S18 [2002000983]
9.6e-01
1.5e+00
2.1e+00
—
2.0e+00
1.5e+00
1.4e+00
cases:18.73%
controls:8.09%
cases:12.04%
controls:3.10%
cases:4.18%
controls:0.55%
—
—
cases:2.53%
controls:0.34%
cases:13.07%
controls:3.13%
cases:34.18%
controls:11.02%
112
483
486
5487
72
185
526
5785
25
33
573
5937
—
15
20
578
5937
74
180
492
5568
162
543
312
4386
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
8.3e-01
1.2e+00
2.7e+00
—
1.9e+00
1.5e+00
1.3e+00
cases:11.04%
controls:5.11%
cases:7.53%
controls:2.41%
cases:4.01%
controls:0.27%
—
—
cases:3.04%
controls:0.47%
cases:9.01%
controls:2.19%
cases:23.00%
controls:7.49%
66
305
532
5665
45
144
553
5826
24
16
574
5954
—
18
28
575
5929
51
126
515
5622
109
369
365
4560
cefalexin; oral
J01DB01 [21602870]
1.1e+00
1.4e+00
2.2e+00
—
1.6e+00
1.5e+00
1.6e+00
cases:53.51%
controls:28.26%
cases:27.76%
controls:8.39%
cases:9.03%
controls:1.06%
—
—
cases:5.06%
controls:1.07%
cases:28.80%
controls:8.02%
cases:61.60%
controls:24.95%
320
1687
278
4283
166
501
432
5469
54
63
544
5907
—
30
64
563
5893
163
461
403
5287
292
1230
182
3699
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
1.1e+00
1.3e+00
1.9e+00
—
2.5e+00
1.5e+00
1.1e+00
cases:16.39%
controls:5.85%
cases:7.02%
controls:1.96%
cases:1.34%
controls:0.20%
—
—
cases:1.35%
controls:0.12%
cases:6.54%
controls:1.60%
cases:16.46%
controls:5.94%
98
349
500
5621
42
117
556
5853
8
12
590
5958
—
8
7
585
5950
37
92
529
5656
78
293
396
4636
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.3e-01
6.2e-01
1.5e+00
4.2e+00
1.4e+00
7.4e-01
6.4e-01
cases:29.77%
controls:23.42%
cases:31.61%
controls:19.90%
cases:14.55%
controls:3.67%
cases:7.86%
controls:0.13%
cases:15.01%
controls:4.05%
cases:35.51%
controls:20.76%
cases:57.81%
controls:41.89%
178
1398
420
4572
189
1188
409
4782
87
219
511
5751
47
8
551
5962
89
241
504
5716
201
1193
365
4555
274
2065
200
2864
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
3.4e-01
6.7e-01
1.5e+00
4.0e+00
1.6e+00
7.3e-01
5.6e-01
cases:40.13%
controls:32.26%
cases:40.30%
controls:25.68%
cases:18.90%
controls:4.89%
cases:10.70%
controls:0.22%
cases:19.39%
controls:4.70%
cases:43.82%
controls:27.31%
cases:66.46%
controls:53.01%
240
1926
358
4044
241
1533
357
4437
113
292
485
5678
64
13
534
5957
115
280
478
5677
248
1570
318
4178
315
2613
159
2316
Heart failure, unspecified
I50.9 [45576879]
1.3e+00
1.4e+00
1.9e+00
1.0e+50
2.0e+00
1.5e+00
1.2e+00
cases:4.52%
controls:1.22%
cases:3.18%
controls:0.80%
cases:1.17%
controls:0.18%
cases:1.17%
controls:0.00%
cases:1.18%
controls:0.17%
cases:4.06%
controls:0.94%
cases:8.65%
controls:2.74%
27
73
571
5897
19
48
579
5922
7
11
591
5959
7
0
591
5970
7
10
586
5947
23
54
543
5694
41
135
433
4794
One hour or less
ZXE00 [2001311394]
9.8e-01
1.6e+00
1.9e+00
—
2.7e+00
2.1e+00
1.9e+00
cases:14.55%
controls:6.01%
cases:6.86%
controls:1.42%
cases:1.00%
controls:0.15%
—
—
cases:1.18%
controls:0.08%
cases:8.48%
controls:1.15%
cases:18.57%
controls:3.25%
87
359
511
5611
41
85
557
5885
6
9
592
5961
—
7
5
586
5952
48
66
518
5682
88
160
386
4769
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E11.2 [2000503133]
2.5e+00
—
—
1.0e+50
—
3.3e+00
3.4e+00
cases:2.01%
controls:0.17%
—
—
—
—
cases:1.00%
controls:0.00%
—
—
cases:2.83%
controls:0.10%
cases:6.33%
controls:0.22%
12
10
586
5960
—
—
6
0
592
5970
—
16
6
550
5742
30
11
444
4918
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
1.6e+00
2.2e+00
—
—
—
3.0e+00
2.5e+00
cases:4.35%
controls:0.94%
cases:2.84%
controls:0.34%
—
—
—
—
—
—
cases:4.42%
controls:0.23%
cases:8.23%
controls:0.75%
26
56
572
5914
17
20
581
5950
—
—
—
25
13
541
5735
39
37
435
4892
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
1.5e+00
2.2e+00
2.6e+00
—
1.5e+00
1.4e+00
1.4e+00
cases:5.52%
controls:1.29%
cases:4.18%
controls:0.47%
cases:1.51%
controls:0.12%
—
—
cases:1.01%
controls:0.24%
cases:3.53%
controls:0.87%
cases:12.24%
controls:3.33%
33
77
565
5893
25
28
573
5942
9
7
589
5963
—
6
14
587
5943
20
50
546
5698
58
164
416
4765
Base excess in Venous blood by calculation
1927-3 [3002032]
1.5e+00
2.2e+00
2.6e+00
1.0e+50
1.5e+00
1.4e+00
1.5e+00
cases:5.35%
controls:1.31%
cases:4.01%
controls:0.47%
cases:1.51%
controls:0.12%
cases:0.84%
controls:0.00%
cases:1.01%
controls:0.24%
cases:3.53%
controls:0.85%
cases:12.24%
controls:3.16%
32
78
566
5892
24
28
574
5942
9
7
589
5963
5
0
593
5970
6
14
587
5943
20
49
546
5699
58
156
416
4773
pH of Venous blood
2746-6 [3012544]
1.5e+00
2.1e+00
2.6e+00
1.0e+50
1.5e+00
1.5e+00
1.3e+00
cases:5.52%
controls:1.27%
cases:4.35%
controls:0.55%
cases:1.51%
controls:0.12%
cases:0.84%
controls:0.00%
cases:1.01%
controls:0.24%
cases:3.71%
controls:0.85%
cases:11.60%
controls:3.35%
33
76
565
5894
26
33
572
5937
9
7
589
5963
5
0
593
5970
6
14
587
5943
21
49
545
5699
55
165
419
4764
Gas panel - Venous blood
24339-4 [3000991]
1.6e+00
2.4e+00
—
—
2.0e+00
1.3e+00
1.6e+00
cases:4.85%
controls:1.06%
cases:4.01%
controls:0.37%
—
—
—
—
cases:1.01%
controls:0.13%
cases:2.65%
controls:0.71%
cases:11.18%
controls:2.39%
29
63
569
5907
24
22
574
5948
—
—
6
8
587
5949
15
41
551
5707
53
118
421
4811
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
9.0e-01
1.2e+00
2.2e+00
1.0e+50
1.9e+00
1.4e+00
1.2e+00
cases:18.39%
controls:8.38%
cases:12.71%
controls:4.32%
cases:5.85%
controls:0.65%
cases:0.84%
controls:0.00%
cases:5.56%
controls:0.86%
cases:17.49%
controls:4.80%
cases:33.33%
controls:13.27%
110
500
488
5470
76
258
522
5712
35
39
563
5931
5
0
593
5970
33
51
560
5906
99
276
467
5472
158
654
316
4275
Pain in limb
M79.6 [45587063]
8.4e-01
1.3e+00
2.5e+00
—
1.8e+00
1.2e+00
1.1e+00
cases:13.21%
controls:6.15%
cases:8.86%
controls:2.53%
cases:4.52%
controls:0.37%
—
—
cases:1.85%
controls:0.30%
cases:7.60%
controls:2.47%
cases:23.21%
controls:8.85%
79
367
519
5603
53
151
545
5819
27
22
571
5948
—
11
18
582
5939
43
142
523
5606
110
436
364
4493
pH of Serum or Plasma
2753-2 [3018418]
1.0e+00
1.2e+00
2.2e+00
—
1.8e+00
1.5e+00
1.1e+00
cases:13.21%
controls:5.09%
cases:8.36%
controls:2.80%
cases:3.68%
controls:0.44%
—
—
cases:3.20%
controls:0.54%
cases:12.01%
controls:2.89%
cases:22.15%
controls:8.28%
79
304
519
5666
50
167
548
5803
22
26
576
5944
—
19
32
574
5925
68
166
498
5582
105
408
369
4521
Inpatient Hospital
21 [8717]
9.5e-01
1.2e+00
1.8e+00
—
2.1e+00
1.6e+00
1.3e+00
cases:52.34%
controls:29.77%
cases:25.92%
controls:9.68%
cases:6.86%
controls:1.22%
—
—
cases:8.43%
controls:1.16%
cases:28.98%
controls:7.93%
cases:47.05%
controls:20.27%
313
1777
285
4193
155
578
443
5392
41
73
557
5897
—
50
69
543
5888
164
456
402
5292
223
999
251
3930
Plain photography of ocular fundus
CK2S4 [2001301455]
2.1e+00
2.4e+00
—
—
—
2.5e+00
1.8e+00
cases:4.18%
controls:0.55%
cases:2.68%
controls:0.25%
—
—
—
—
—
—
cases:2.65%
controls:0.23%
cases:5.70%
controls:0.95%
25
33
573
5937
16
15
582
5955
—
—
—
15
13
551
5735
27
47
447
4882
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
9.5e-01
1.3e+00
2.8e+00
—
—
2.0e+00
1.8e+00
cases:5.02%
controls:2.01%
cases:3.01%
controls:0.85%
cases:1.34%
controls:0.08%
—
—
—
—
cases:4.42%
controls:0.63%
cases:12.24%
controls:2.33%
30
120
568
5850
18
51
580
5919
8
5
590
5965
—
—
25
36
541
5712
58
115
416
4814
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.5e-01
4.2e-01
1.5e+00
4.0e+00
1.4e+00
6.1e-01
4.1e-01
cases:30.77%
controls:23.80%
cases:27.09%
controls:19.61%
cases:15.55%
controls:3.99%
cases:8.36%
controls:0.17%
cases:15.18%
controls:4.11%
cases:31.27%
controls:19.80%
cases:50.63%
controls:40.54%
184
1421
414
4549
162
1171
436
4799
93
238
505
5732
50
10
548
5960
90
245
503
5712
177
1138
389
4610
240
1998
234
2931
Exposure to unspecified factor
X59 [45756412]
1.0e+00
1.6e+00
2.7e+00
—
—
2.0e+00
1.3e+00
cases:6.19%
controls:2.38%
cases:3.34%
controls:0.69%
cases:1.51%
controls:0.10%
—
—
—
—
cases:4.59%
controls:0.63%
cases:9.28%
controls:2.60%
37
142
561
5828
20
41
578
5929
9
6
589
5964
—
—
26
36
540
5712
44
128
430
4801
Diabetes non-insulin dependent
T90 [2002001131]
1.4e+00
1.4e+00
1.3e+00
—
1.7e+00
1.4e+00
1.5e+00
cases:21.57%
controls:6.30%
cases:15.22%
controls:4.30%
cases:3.85%
controls:1.04%
—
—
cases:4.38%
controls:0.87%
cases:16.25%
controls:4.56%
cases:31.65%
controls:9.64%
129
376
469
5594
91
257
507
5713
23
62
575
5908
—
26
52
567
5905
92
262
474
5486
150
475
324
4454
Revision of wound of skin of lower limb
QDB05 [2001309969]
3.4e+00
1.9e+00
—
—
1.0e+50
—
3.4e+00
cases:3.34%
controls:0.12%
cases:1.17%
controls:0.18%
—
—
—
—
cases:0.84%
controls:0.00%
—
—
cases:8.86%
controls:0.32%
20
7
578
5963
7
11
591
5959
—
—
5
0
588
5957
—
42
16
432
4913
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.5e-01
5.3e-01
1.4e+00
4.1e+00
1.5e+00
6.3e-01
4.5e-01
cases:41.47%
controls:35.53%
cases:41.97%
controls:29.93%
cases:20.74%
controls:5.86%
cases:11.04%
controls:0.20%
cases:21.59%
controls:5.96%
cases:46.11%
controls:31.33%
cases:68.35%
controls:57.86%
248
2121
350
3849
251
1787
347
4183
124
350
474
5620
66
12
532
5958
128
355
465
5602
261
1801
305
3947
324
2852
150
2077
General Practice
1 [38004446]
9.1e-01
1.1e+00
2.0e+00
—
2.0e+00
1.5e+00
1.1e+00
cases:26.92%
controls:12.90%
cases:14.21%
controls:5.21%
cases:4.68%
controls:0.69%
—
—
cases:5.90%
controls:0.81%
cases:19.26%
controls:5.13%
cases:33.97%
controls:14.81%
161
770
437
5200
85
311
513
5659
28
41
570
5929
—
35
48
558
5909
109
295
457
5453
161
730
313
4199
Outpatient Hospital
22 [8756]
9.7e-01
1.2e+00
1.9e+00
—
1.9e+00
1.4e+00
1.2e+00
cases:45.32%
controls:23.97%
cases:19.90%
controls:7.24%
cases:5.69%
controls:0.89%
—
—
cases:4.38%
controls:0.71%
cases:21.55%
controls:6.11%
cases:37.97%
controls:15.42%
271
1431
327
4539
119
432
479
5538
34
53
564
5917
—
26
42
567
5915
122
351
444
5397
180
760
294
4169
Foot and toes extensive X-ray examination
NH3BA [2001308270]
2.1e+00
3.4e+00
1.0e+50
1.0e+50
—
—
3.0e+00
cases:2.34%
controls:0.30%
cases:2.51%
controls:0.08%
cases:1.00%
controls:0.00%
cases:0.84%
controls:0.00%
—
—
—
—
cases:9.07%
controls:0.49%
14
18
584
5952
15
5
583
5965
6
0
592
5970
5
0
593
5970
—
—
43
24
431
4905
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
8.1e-01
1.1e+00
2.2e+00
1.0e+50
1.9e+00
1.4e+00
1.1e+00
cases:18.90%
controls:9.40%
cases:14.05%
controls:4.92%
cases:6.02%
controls:0.74%
cases:1.17%
controls:0.00%
cases:6.07%
controls:0.99%
cases:18.55%
controls:5.41%
cases:35.44%
controls:15.38%
113
561
485
5409
84
294
514
5676
36
44
562
5926
7
0
591
5970
36
59
557
5898
105
311
461
5437
168
758
306
4171
Asthma, unspecified
J45.9 [45562456]
9.5e-01
1.0e+00
2.0e+00
1.0e+50
2.3e+00
1.3e+00
8.0e-01
cases:7.02%
controls:2.83%
cases:3.68%
controls:1.37%
cases:1.51%
controls:0.20%
cases:1.84%
controls:0.00%
cases:2.02%
controls:0.20%
cases:3.89%
controls:1.06%
cases:8.23%
controls:3.85%
42
169
556
5801
22
82
576
5888
9
12
589
5958
11
0
587
5970
12
12
581
5945
22
61
544
5687
39
190
435
4739
Type 2 diabetes mellitus, with ophthalmic complications
E11.3 [45591028]
2.3e+00
1.9e+00
—
—
—
2.1e+00
2.1e+00
cases:4.68%
controls:0.50%
cases:2.17%
controls:0.32%
—
—
—
—
—
—
cases:2.47%
controls:0.30%
cases:4.64%
controls:0.61%
28
30
570
5940
13
19
585
5951
—
—
—
14
17
552
5731
22
30
452
4899
Intravenous administration of medicine
SPAT1255 [2001700356]
1.5e+00
2.2e+00
—
—
—
2.7e+00
2.0e+00
cases:2.68%
controls:0.62%
cases:1.84%
controls:0.20%
—
—
—
—
—
—
cases:2.12%
controls:0.14%
cases:5.06%
controls:0.75%
16
37
582
5933
11
12
587
5958
—
—
—
12
8
554
5740
24
37
450
4892
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
1.1e+00
1.4e+00
1.5e+00
—
1.6e+00
1.4e+00
1.4e+00
cases:20.40%
controls:7.52%
cases:17.56%
controls:4.81%
cases:2.68%
controls:0.64%
—
—
cases:2.53%
controls:0.50%
cases:18.55%
controls:5.57%
cases:39.87%
controls:14.42%
122
449
476
5521
105
287
493
5683
16
38
582
5932
—
15
30
578
5927
105
320
461
5428
189
711
285
4218
Albumin [Mass/volume] in Urine
1754-1 [3012516]
1.1e+00
1.4e+00
1.4e+00
—
1.7e+00
1.3e+00
1.4e+00
cases:19.90%
controls:7.30%
cases:16.72%
controls:4.82%
cases:2.51%
controls:0.64%
—
—
cases:2.53%
controls:0.45%
cases:17.84%
controls:5.48%
cases:39.24%
controls:13.80%
119
436
479
5534
100
288
498
5682
15
38
583
5932
—
15
27
578
5930
101
315
465
5433
186
680
288
4249
Simple examination of mouth
SAA01 [2001310274]
4.6e-01
4.9e-01
1.3e+00
3.9e+00
1.1e+00
6.2e-01
5.0e-01
cases:34.28%
controls:24.69%
cases:17.22%
controls:11.26%
cases:4.18%
controls:1.17%
cases:4.68%
controls:0.10%
cases:3.88%
controls:1.38%
cases:19.43%
controls:11.50%
cases:42.62%
controls:31.06%
205
1474
393
4496
103
672
495
5298
25
70
573
5900
28
6
570
5964
23
82
570
5875
110
661
456
5087
202
1531
272
3398
prazosin; oral
C02CA01 [21600411]
2.0e+00
1.9e+00
—
—
-1.0e+50
1.8e+00
2.6e+00
cases:2.17%
controls:0.30%
cases:1.51%
controls:0.22%
—
—
—
—
cases:0.00%
controls:0.08%
cases:1.77%
controls:0.30%
cases:4.85%
controls:0.39%
13
18
585
5952
9
13
589
5957
—
—
0
5
593
5952
10
17
556
5731
23
19
451
4910
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
1.7e+00
3.0e+00
—
—
2.3e+00
1.9e+00
1.7e+00
cases:3.18%
controls:0.57%
cases:3.51%
controls:0.18%
—
—
—
—
cases:0.84%
controls:0.08%
cases:2.65%
controls:0.40%
cases:7.59%
controls:1.52%
19
34
579
5936
21
11
577
5959
—
—
5
5
588
5952
15
23
551
5725
36
75
438
4854
Other orthopaedic minor procedure
TNX99 [2001308573]
1.9e+00
3.1e+00
—
—
—
—
3.3e+00
cases:1.34%
controls:0.20%
cases:1.84%
controls:0.08%
—
—
—
—
—
—
—
—
cases:3.16%
controls:0.12%
8
12
590
5958
11
5
587
5965
—
—
—
—
15
6
459
4923
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
7.9e-01
1.1e+00
1.9e+00
—
1.8e+00
1.4e+00
1.3e+00
cases:16.89%
controls:8.41%
cases:12.54%
controls:4.52%
cases:4.35%
controls:0.65%
—
—
cases:4.38%
controls:0.79%
cases:16.25%
controls:4.70%
cases:35.86%
controls:12.78%
101
502
497
5468
75
270
523
5700
26
39
572
5931
—
26
47
567
5910
92
270
474
5478
170
630
304
4299
duloxetine; oral
N06AX21 [21604749]
1.3e+00
1.6e+00
1.6e+00
—
1.5e+00
1.1e+00
1.1e+00
cases:5.18%
controls:1.44%
cases:3.85%
controls:0.84%
cases:1.51%
controls:0.30%
—
—
cases:1.69%
controls:0.37%
cases:2.65%
controls:0.89%
cases:5.91%
controls:1.97%
31
86
567
5884
23
50
575
5920
9
18
589
5952
—
10
22
583
5935
15
51
551
5697
28
97
446
4832
pregabalin; oral
N02BF02 [955152]
1.2e+00
1.4e+00
1.5e+00
—
1.4e+00
1.5e+00
1.3e+00
cases:12.21%
controls:4.12%
cases:8.36%
controls:2.13%
cases:2.84%
controls:0.67%
—
—
cases:2.87%
controls:0.71%
cases:7.95%
controls:1.98%
cases:14.77%
controls:4.48%
73
246
525
5724
50
127
548
5843
17
40
581
5930
—
17
42
576
5915
45
114
521
5634
70
221
404
4708
Chronic kidney disease
N18 [45582391]
2.7e+00
2.2e+00
—
—
—
—
3.4e+00
cases:4.01%
controls:0.28%
cases:1.00%
controls:0.12%
—
—
—
—
—
—
—
—
cases:4.64%
controls:0.16%
24
17
574
5953
6
7
592
5963
—
—
—
—
22
8
452
4921
More than one and less than three hours
ZXE10 [2001311401]
1.1e+00
1.2e+00
—
—
2.3e+00
1.9e+00
1.7e+00
cases:14.72%
controls:5.54%
cases:4.01%
controls:1.21%
—
—
—
—
cases:1.01%
controls:0.10%
cases:6.71%
controls:1.10%
cases:16.46%
controls:3.35%
88
331
510
5639
24
72
574
5898
—
—
6
6
587
5951
38
63
528
5685
78
165
396
4764
Chronic ulcer of skin, not elsewhere classified
L98.4 [45533667]
2.6e+00
3.0e+00
1.0e+50
1.0e+50
—
—
2.7e+00
cases:2.34%
controls:0.18%
cases:1.67%
controls:0.08%
cases:1.17%
controls:0.00%
cases:1.51%
controls:0.00%
—
—
—
—
cases:4.43%
controls:0.32%
14
11
584
5959
10
5
588
5965
7
0
591
5970
9
0
589
5970
—
—
21
16
453
4913
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
7.3e-01
1.4e+00
1.7e+00
—
2.1e+00
1.2e+00
1.1e+00
cases:9.87%
controls:5.01%
cases:8.70%
controls:2.40%
cases:2.51%
controls:0.45%
—
—
cases:2.36%
controls:0.30%
cases:6.89%
controls:2.16%
cases:18.78%
controls:7.20%
59
299
539
5671
52
143
546
5827
15
27
583
5943
—
14
18
579
5939
39
124
527
5624
89
355
385
4574
Bacteria [Presence] in Urine
87829-8 [36304419]
8.3e-01
1.2e+00
1.8e+00
—
2.1e+00
1.2e+00
1.1e+00
cases:10.03%
controls:4.64%
cases:6.69%
controls:2.18%
cases:1.67%
controls:0.27%
—
—
cases:1.69%
controls:0.20%
cases:7.07%
controls:2.35%
cases:19.62%
controls:7.81%
60
277
538
5693
40
130
558
5840
10
16
588
5954
—
10
12
583
5945
40
135
526
5613
93
385
381
4544
dulaglutide; parenteral
A10BJ05 [1123611]
1.7e+00
2.2e+00
—
—
—
2.1e+00
2.2e+00
cases:1.34%
controls:0.25%
cases:1.34%
controls:0.15%
—
—
—
—
—
—
cases:1.41%
controls:0.17%
cases:2.74%
controls:0.32%
8
15
590
5955
8
9
590
5961
—
—
—
8
10
558
5738
13
16
461
4913
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
1.5e+00
2.2e+00
2.2e+00
—
—
1.2e+00
1.2e+00
cases:4.52%
controls:1.09%
cases:3.01%
controls:0.35%
cases:1.00%
controls:0.12%
—
—
—
—
cases:2.30%
controls:0.73%
cases:8.86%
controls:2.86%
27
65
571
5905
18
21
580
5949
6
7
592
5963
—
—
13
42
553
5706
42
141
432
4788
Medical doctor
Z2221 [2001311556]
1.1e+00
1.4e+00
2.1e+00
—
1.8e+00
1.8e+00
1.6e+00
cases:14.21%
controls:5.26%
cases:5.35%
controls:1.44%
cases:1.67%
controls:0.20%
—
—
cases:0.84%
controls:0.13%
cases:7.42%
controls:1.25%
cases:10.97%
controls:2.31%
85
314
513
5656
32
86
566
5884
10
12
588
5958
—
5
8
588
5949
42
72
524
5676
52
114
422
4815
temazepam; oral
N05CD07 [21604642]
1.3e+00
1.4e+00
1.5e+00
—
1.5e+00
1.2e+00
1.2e+00
cases:10.54%
controls:3.03%
cases:6.86%
controls:1.79%
cases:2.17%
controls:0.50%
—
—
cases:1.85%
controls:0.42%
cases:5.48%
controls:1.77%
cases:8.65%
controls:2.78%
63
181
535
5789
41
107
557
5863
13
30
585
5940
—
11
25
582
5932
31
102
535
5646
41
137
433
4792
Proliferative diabetic retinopathy
H36.03 [2000502323]
2.9e+00
2.5e+00
—
—
—
1.6e+00
2.7e+00
cases:3.68%
controls:0.22%
cases:1.67%
controls:0.13%
—
—
—
—
—
—
cases:0.88%
controls:0.17%
cases:3.38%
controls:0.24%
22
13
576
5957
10
8
588
5962
—
—
—
5
10
561
5738
16
12
458
4917
CBC panel - Blood by Automated count
58410-2 [40761511]
2.6e-01
4.4e-01
1.4e+00
3.8e+00
1.5e+00
5.6e-01
3.8e-01
cases:37.79%
controls:31.93%
cases:30.94%
controls:22.36%
cases:15.38%
controls:4.15%
cases:5.52%
controls:0.13%
cases:14.84%
controls:3.91%
cases:33.39%
controls:22.20%
cases:58.86%
controls:49.50%
226
1906
372
4064
185
1335
413
4635
92
248
506
5722
33
8
565
5962
88
233
505
5724
189
1276
377
4472
279
2440
195
2489
Ultrasound examination of lower leg veins
PH2AE [2001309451]
1.4e+00
2.5e+00
—
1.0e+50
—
2.3e+00
1.8e+00
cases:5.52%
controls:1.37%
cases:4.68%
controls:0.42%
—
—
cases:1.51%
controls:0.00%
—
—
cases:2.83%
controls:0.28%
cases:7.38%
controls:1.30%
33
82
565
5888
28
25
570
5945
—
9
0
589
5970
—
16
16
550
5732
35
64
439
4865
Case Management Agency
251B00000X [38004193]
4.0e-01
5.3e-01
1.2e+00
4.1e+00
1.1e+00
6.5e-01
5.0e-01
cases:76.76%
controls:68.96%
cases:72.58%
controls:60.82%
cases:52.34%
controls:24.25%
cases:45.32%
controls:1.34%
cases:49.07%
controls:24.04%
cases:77.03%
controls:63.69%
cases:90.93%
controls:85.92%
459
4117
139
1853
434
3631
164
2339
313
1448
285
4522
271
80
327
5890
291
1432
302
4525
436
3661
130
2087
431
4235
43
694
Removal of cutom molded cast and internal stretch
TNX50 [2001308568]
2.2e+00
—
—
—
—
4.2e+00
1.6e+00
cases:2.68%
controls:0.32%
—
—
—
—
—
—
—
—
cases:5.48%
controls:0.09%
cases:4.01%
controls:0.81%
16
19
582
5951
—
—
—
—
31
5
535
5743
19
40
455
4889
Albumin/Creatinine [Ratio] in Urine
32294-1 [3020682]
1.1e+00
1.3e+00
1.3e+00
—
1.6e+00
1.3e+00
1.3e+00
cases:20.90%
controls:8.11%
cases:17.73%
controls:5.33%
cases:2.68%
controls:0.74%
—
—
cases:2.53%
controls:0.50%
cases:18.90%
controls:6.16%
cases:40.08%
controls:15.26%
125
484
473
5486
106
318
492
5652
16
44
582
5926
—
15
30
578
5927
107
354
459
5394
190
752
284
4177
Telehealth
OMOP5556618 [722455]
6.6e-01
7.7e-01
1.4e+00
2.0e+00
1.3e+00
9.2e-01
8.9e-01
cases:41.30%
controls:26.63%
cases:23.41%
controls:12.40%
cases:8.86%
controls:2.35%
cases:1.00%
controls:0.13%
cases:7.76%
controls:2.32%
cases:23.85%
controls:11.10%
cases:43.67%
controls:24.18%
247
1590
351
4380
140
740
458
5230
53
140
545
5830
6
8
592
5962
46
138
547
5819
135
638
431
5110
207
1192
267
3737
Metatarsalgia
M77.4 [45601544]
1.7e+00
2.5e+00
—
—
—
2.0e+00
1.6e+00
cases:1.67%
controls:0.30%
cases:1.67%
controls:0.13%
—
—
—
—
—
—
cases:1.06%
controls:0.14%
cases:3.59%
controls:0.73%
10
18
588
5952
10
8
588
5962
—
—
—
6
8
560
5740
17
36
457
4893
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
7.6e-01
1.1e+00
1.7e+00
—
2.1e+00
1.2e+00
1.0e+00
cases:14.05%
controls:7.12%
cases:9.36%
controls:3.23%
cases:2.84%
controls:0.52%
—
—
cases:2.02%
controls:0.25%
cases:10.78%
controls:3.50%
cases:25.32%
controls:11.02%
84
425
514
5545
56
193
542
5777
17
31
581
5939
—
12
15
581
5942
61
201
505
5547
120
543
354
4386
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
8.1e-01
1.1e+00
1.9e+00
—
2.0e+00
1.2e+00
9.5e-01
cases:11.71%
controls:5.58%
cases:7.86%
controls:2.88%
cases:2.17%
controls:0.32%
—
—
cases:2.19%
controls:0.30%
cases:9.01%
controls:3.03%
cases:22.57%
controls:10.14%
70
333
528
5637
47
172
551
5798
13
19
585
5951
—
13
18
580
5939
51
174
515
5574
107
500
367
4429
Acute renal failure, unspecified
N17.9 [45567829]
1.8e+00
2.0e+00
—
—
—
2.0e+00
2.1e+00
cases:1.17%
controls:0.20%
cases:1.34%
controls:0.18%
—
—
—
—
—
—
cases:1.06%
controls:0.14%
cases:3.16%
controls:0.41%
7
12
591
5958
8
11
590
5959
—
—
—
6
8
560
5740
15
20
459
4909
General Surgery
2 [38004447]
7.2e-01
9.5e-01
1.6e+00
—
2.6e+00
1.2e+00
7.1e-01
cases:29.43%
controls:16.82%
cases:12.04%
controls:5.03%
cases:3.01%
controls:0.60%
—
—
cases:6.58%
controls:0.50%
cases:14.13%
controls:4.56%
cases:23.00%
controls:12.84%
176
1004
422
4966
72
300
526
5670
18
36
580
5934
—
39
30
554
5927
80
262
486
5486
109
633
365
4296
Scheduled procedure
ZXD10 [2001311387]
7.9e-01
1.5e+00
2.3e+00
—
—
1.8e+00
1.5e+00
cases:12.54%
controls:6.10%
cases:6.19%
controls:1.51%
cases:1.34%
controls:0.13%
—
—
—
—
cases:6.36%
controls:1.15%
cases:12.24%
controls:2.90%
75
364
523
5606
37
90
561
5880
8
8
590
5962
—
—
36
66
530
5682
58
143
416
4786
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
1.5e+00
1.9e+00
—
—
—
2.0e+00
2.4e+00
cases:3.01%
controls:0.72%
cases:1.84%
controls:0.27%
—
—
—
—
—
—
cases:2.30%
controls:0.31%
cases:6.96%
controls:0.65%
18
43
580
5927
11
16
587
5954
—
—
—
13
18
553
5730
33
32
441
4897
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
1.1e+00
1.6e+00
—
—
2.4e+00
1.4e+00
1.3e+00
cases:5.35%
controls:1.83%
cases:3.68%
controls:0.75%
—
—
—
—
cases:1.69%
controls:0.15%
cases:3.89%
controls:0.99%
cases:13.08%
controls:4.00%
32
109
566
5861
22
45
576
5925
—
—
10
9
583
5948
22
57
544
5691
62
197
412
4732
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.0e+00
1.1e+00
1.8e+00
—
1.3e+00
1.5e+00
1.1e+00
cases:18.39%
controls:7.49%
cases:8.36%
controls:2.81%
cases:2.84%
controls:0.50%
—
—
cases:2.19%
controls:0.62%
cases:10.78%
controls:2.52%
cases:18.14%
controls:6.98%
110
447
488
5523
50
168
548
5802
17
30
581
5940
—
13
37
580
5920
61
145
505
5603
86
344
388
4585
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
1.4e+00
2.3e+00
—
—
—
2.1e+00
2.0e+00
cases:2.84%
controls:0.70%
cases:2.34%
controls:0.23%
—
—
—
—
—
—
cases:2.30%
controls:0.28%
cases:7.38%
controls:1.12%
17
42
581
5928
14
14
584
5956
—
—
—
13
16
553
5732
35
55
439
4874
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
1.5e+00
2.0e+00
—
—
—
2.7e+00
1.6e+00
cases:1.84%
controls:0.44%
cases:1.00%
controls:0.13%
—
—
—
—
—
—
cases:1.77%
controls:0.12%
cases:3.16%
controls:0.63%
11
26
587
5944
6
8
592
5962
—
—
—
10
7
556
5741
15
31
459
4898
Physiotherapy
R4110 [2001310233]
1.0e+00
1.4e+00
1.5e+00
—
2.2e+00
1.7e+00
1.5e+00
cases:12.54%
controls:4.97%
cases:6.86%
controls:1.81%
cases:1.17%
controls:0.27%
—
—
cases:2.19%
controls:0.25%
cases:8.13%
controls:1.55%
cases:16.03%
controls:4.10%
75
297
523
5673
41
108
557
5862
7
16
591
5954
—
13
15
580
5942
46
89
520
5659
76
202
398
4727
HIV disease resulting in (persistent) generalized lymphadenopathy
B23.1 [45532868]
3.6e+00
—
—
1.0e+50
—
4.2e+00
—
cases:3.01%
controls:0.08%
—
—
—
—
cases:3.18%
controls:0.00%
—
—
cases:5.30%
controls:0.09%
—
—
18
5
580
5965
—
—
19
0
579
5970
—
30
5
536
5743
—
Abdominal ultrasound examination
JN3AE [2001305555]
1.7e+00
2.1e+00
—
—
—
2.2e+00
1.8e+00
cases:7.53%
controls:1.51%
cases:4.35%
controls:0.55%
—
—
—
—
—
—
cases:3.36%
controls:0.40%
cases:8.44%
controls:1.46%
45
90
553
5880
26
33
572
5937
—
—
—
19
23
547
5725
40
72
434
4857
Puncture of vitreous body with injection of medication
CKD05 [2001301407]
1.8e+00
2.1e+00
—
—
—
1.9e+00
2.0e+00
cases:4.18%
controls:0.70%
cases:3.18%
controls:0.42%
—
—
—
—
—
—
cases:3.36%
controls:0.52%
cases:6.96%
controls:1.01%
25
42
573
5928
19
25
579
5945
—
—
—
19
30
547
5718
33
50
441
4879
Assessment of need for aid
SPAT1229 [2001700330]
1.4e+00
1.6e+00
—
—
—
2.7e+00
2.0e+00
cases:3.68%
controls:0.90%
cases:2.01%
controls:0.40%
—
—
—
—
—
—
cases:3.71%
controls:0.26%
cases:7.59%
controls:1.10%
22
54
576
5916
12
24
586
5946
—
—
—
21
15
545
5733
36
54
438
4875
Leukocytes [#/volume] in Urine
30405-5 [3018095]
7.2e-01
1.1e+00
2.0e+00
—
1.9e+00
1.1e+00
9.9e-01
cases:12.21%
controls:6.35%
cases:9.36%
controls:3.40%
cases:3.01%
controls:0.42%
—
—
cases:2.70%
controls:0.42%
cases:9.89%
controls:3.65%
cases:26.37%
controls:11.77%
73
379
525
5591
56
203
542
5767
18
25
580
5945
—
16
25
577
5932
56
210
510
5538
125
580
349
4349
Presence of electronic cardiac devices
Z95.0 [45571406]
1.1e+00
1.5e+00
2.5e+00
—
—
1.5e+00
1.1e+00
cases:2.17%
controls:0.72%
cases:2.17%
controls:0.50%
cases:1.00%
controls:0.08%
—
—
—
—
cases:2.12%
controls:0.47%
cases:2.74%
controls:0.93%
13
43
585
5927
13
30
585
5940
6
5
592
5965
—
—
12
27
554
5721
13
46
461
4883
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
1.1e+00
1.7e+00
-1.0e+50
—
2.3e+00
1.4e+00
1.3e+00
cases:3.68%
controls:1.29%
cases:2.84%
controls:0.55%
cases:0.00%
controls:0.12%
—
—
cases:1.35%
controls:0.13%
cases:2.83%
controls:0.75%
cases:10.55%
controls:3.10%
22
77
576
5893
17
33
581
5937
0
7
598
5963
—
8
8
585
5949
16
43
550
5705
50
153
424
4776
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
1.1e+00
1.7e+00
-1.0e+50
—
2.3e+00
1.4e+00
1.3e+00
cases:3.85%
controls:1.37%
cases:2.84%
controls:0.55%
cases:0.00%
controls:0.12%
—
—
cases:1.35%
controls:0.13%
cases:3.00%
controls:0.77%
cases:9.70%
controls:2.96%
23
82
575
5888
17
33
581
5937
0
7
598
5963
—
8
8
585
5949
17
44
549
5704
46
146
428
4783
insulin (human); parenteral
A10AB01 [21600715]
2.1e+00
2.1e+00
—
—
—
1.8e+00
1.7e+00
cases:6.52%
controls:0.84%
cases:2.84%
controls:0.35%
—
—
—
—
—
—
cases:1.94%
controls:0.33%
cases:1.69%
controls:0.32%
39
50
559
5920
17
21
581
5949
—
—
—
11
19
555
5729
8
16
466
4913
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
7.3e-01
8.7e-01
2.0e+00
—
1.7e+00
1.2e+00
1.2e+00
cases:14.21%
controls:7.40%
cases:9.03%
controls:4.00%
cases:2.84%
controls:0.40%
—
—
cases:3.37%
controls:0.62%
cases:14.31%
controls:4.78%
cases:34.18%
controls:13.98%
85
442
513
5528
54
239
544
5731
17
24
581
5946
—
20
37
573
5920
81
275
485
5473
162
689
312
4240
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
285 [2001600217]
2.4e+00
2.1e+00
—
—
—
1.6e+00
1.5e+00
cases:3.85%
controls:0.37%
cases:1.34%
controls:0.17%
—
—
—
—
—
—
cases:1.41%
controls:0.28%
cases:4.43%
controls:0.99%
23
22
575
5948
8
10
590
5960
—
—
—
8
16
558
5732
21
49
453
4880
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
8.3e-01
1.1e+00
—
—
2.2e+00
1.9e+00
1.6e+00
cases:3.85%
controls:1.71%
cases:2.17%
controls:0.75%
—
—
—
—
cases:1.18%
controls:0.13%
cases:3.89%
controls:0.57%
cases:8.44%
controls:1.89%
23
102
575
5868
13
45
585
5925
—
—
7
8
586
5949
22
33
544
5715
40
93
434
4836
Differential panel, method unspecified - Blood
69738-3 [42870588]
8.7e-01
9.9e-01
1.7e+00
—
1.6e+00
1.1e+00
1.3e+00
cases:13.04%
controls:5.91%
cases:9.70%
controls:3.84%
cases:4.18%
controls:0.77%
—
—
cases:3.88%
controls:0.82%
cases:11.13%
controls:4.07%
cases:29.11%
controls:9.78%
78
353
520
5617
58
229
540
5741
25
46
573
5924
—
23
49
570
5908
63
234
503
5514
138
482
336
4447
Decubitus ulcer and pressure area
L89 [45601235]
2.6e+00
2.2e+00
—
—
—
—
2.8e+00
cases:1.34%
controls:0.10%
cases:1.00%
controls:0.12%
—
—
—
—
—
—
—
—
cases:3.59%
controls:0.22%
8
6
590
5964
6
7
592
5963
—
—
—
—
17
11
457
4918
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
1.3e+00
1.1e+00
1.3e+00
—
1.7e+00
1.2e+00
9.4e-01
cases:18.73%
controls:5.70%
cases:10.03%
controls:3.47%
cases:2.17%
controls:0.60%
—
—
cases:2.87%
controls:0.55%
cases:10.60%
controls:3.55%
cases:18.14%
controls:7.93%
112
340
486
5630
60
207
538
5763
13
36
585
5934
—
17
33
576
5924
60
204
506
5544
86
391
388
4538
Skin infection other
S76 [2002001040]
1.4e+00
2.3e+00
—
—
—
2.3e+00
1.5e+00
cases:2.17%
controls:0.55%
cases:1.34%
controls:0.13%
—
—
—
—
—
—
cases:1.77%
controls:0.17%
cases:3.16%
controls:0.71%
13
33
585
5937
8
8
590
5962
—
—
—
10
10
556
5738
15
35
459
4894
Corn/callosity
S20 [2002000985]
2.1e+00
—
—
—
—
2.8e+00
2.6e+00
cases:1.67%
controls:0.22%
—
—
—
—
—
—
—
—
cases:1.77%
controls:0.10%
cases:4.64%
controls:0.34%
10
13
588
5957
—
—
—
—
10
6
556
5742
22
17
452
4912
Cellulitis of finger and toe
L03.0 [45557691]
2.0e+00
1.6e+00
—
—
—
1.8e+00
2.1e+00
cases:4.35%
controls:0.62%
cases:1.34%
controls:0.27%
—
—
—
—
—
—
cases:1.77%
controls:0.30%
cases:5.91%
controls:0.75%
26
37
572
5933
8
16
590
5954
—
—
—
10
17
556
5731
28
37
446
4892
exenatide; parenteral
A10BJ01 [1123633]
2.9e+00
—
—
—
—
2.5e+00
2.1e+00
cases:2.17%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.09%
cases:1.90%
controls:0.24%
13
7
585
5963
—
—
—
—
6
5
560
5743
9
12
465
4917
Venereal disease screening
171128005 [4064905]
1.6e+00
2.8e+00
—
—
—
—
3.0e+00
cases:1.84%
controls:0.37%
cases:1.67%
controls:0.10%
—
—
—
—
—
—
—
—
cases:3.16%
controls:0.16%
11
22
587
5948
10
6
588
5964
—
—
—
—
15
8
459
4921
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
7.6e-01
1.1e+00
1.7e+00
—
2.0e+00
1.1e+00
9.0e-01
cases:9.70%
controls:4.79%
cases:6.69%
controls:2.36%
cases:1.67%
controls:0.32%
—
—
cases:1.52%
controls:0.22%
cases:7.07%
controls:2.54%
cases:18.99%
controls:8.68%
58
286
540
5684
40
141
558
5829
10
19
588
5951
—
9
13
584
5944
40
146
526
5602
90
428
384
4501
Type 1 diabetes mellitus
E10 [45576436]
1.9e+00
1.7e+00
—
—
—
1.8e+00
2.1e+00
cases:5.02%
controls:0.79%
cases:2.17%
controls:0.40%
—
—
—
—
—
—
cases:1.94%
controls:0.33%
cases:5.27%
controls:0.71%
30
47
568
5923
13
24
585
5946
—
—
—
11
19
555
5729
25
35
449
4894
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
2.1e+00
1.8e+00
—
—
—
1.5e+00
1.9e+00
cases:3.34%
controls:0.42%
cases:1.67%
controls:0.27%
—
—
—
—
—
—
cases:1.77%
controls:0.38%
cases:5.91%
controls:0.89%
20
25
578
5945
10
16
588
5954
—
—
—
10
22
556
5726
28
44
446
4885
Protein [Mass/volume] in Urine
2888-6 [3037121]
1.4e+00
1.9e+00
—
—
—
1.8e+00
2.3e+00
cases:2.68%
controls:0.69%
cases:2.17%
controls:0.34%
—
—
—
—
—
—
cases:2.30%
controls:0.38%
cases:6.54%
controls:0.69%
16
41
582
5929
13
20
585
5950
—
—
—
13
22
553
5726
31
34
443
4895
insulin glulisine; parenteral
A10AB06 [21600720]
1.1e+00
2.4e+00
—
—
—
2.7e+00
2.3e+00
cases:0.84%
controls:0.28%
cases:1.84%
controls:0.17%
—
—
—
—
—
—
cases:2.47%
controls:0.17%
cases:2.95%
controls:0.30%
5
17
593
5953
11
10
587
5960
—
—
—
14
10
552
5738
14
15
460
4914
Neurology
13 [38004458]
7.7e-01
1.1e+00
1.9e+00
—
1.5e+00
1.3e+00
8.5e-01
cases:19.90%
controls:10.28%
cases:10.87%
controls:4.02%
cases:4.18%
controls:0.64%
—
—
cases:2.70%
controls:0.64%
cases:12.72%
controls:3.78%
cases:19.62%
controls:9.47%
119
614
479
5356
65
240
533
5730
25
38
573
5932
—
16
38
577
5919
72
217
494
5531
93
467
381
4462
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.8e-01
4.4e-01
1.4e+00
3.6e+00
1.4e+00
5.8e-01
3.3e-01
cases:43.31%
controls:39.01%
cases:43.48%
controls:33.15%
cases:23.91%
controls:7.10%
cases:10.87%
controls:0.34%
cases:22.43%
controls:6.90%
cases:48.23%
controls:34.39%
cases:69.83%
controls:62.47%
259
2329
339
3641
260
1979
338
3991
143
424
455
5546
65
20
533
5950
133
411
460
5546
273
1977
293
3771
331
3079
143
1850
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.8e-01
4.4e-01
1.4e+00
3.6e+00
1.4e+00
5.8e-01
3.3e-01
cases:43.31%
controls:38.99%
cases:43.48%
controls:33.15%
cases:23.75%
controls:7.07%
cases:10.87%
controls:0.34%
cases:22.43%
controls:6.90%
cases:48.23%
controls:34.38%
cases:69.83%
controls:62.47%
259
2328
339
3642
260
1979
338
3991
142
422
456
5548
65
20
533
5950
133
411
460
5546
273
1976
293
3772
331
3079
143
1850
MCH [Entitic mass]
28539-5 [3035941]
1.8e-01
4.4e-01
1.4e+00
3.6e+00
1.4e+00
5.8e-01
3.3e-01
cases:43.31%
controls:38.93%
cases:43.48%
controls:33.10%
cases:23.75%
controls:7.10%
cases:10.87%
controls:0.34%
cases:22.43%
controls:6.88%
cases:48.23%
controls:34.38%
cases:69.83%
controls:62.45%
259
2324
339
3646
260
1976
338
3994
142
424
456
5546
65
20
533
5950
133
410
460
5547
273
1976
293
3772
331
3078
143
1851
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.7e-01
4.4e-01
1.4e+00
3.6e+00
1.4e+00
5.7e-01
3.4e-01
cases:43.31%
controls:39.13%
cases:43.48%
controls:33.22%
cases:23.91%
controls:7.14%
cases:10.87%
controls:0.34%
cases:22.43%
controls:6.90%
cases:48.23%
controls:34.46%
cases:70.04%
controls:62.49%
259
2336
339
3634
260
1983
338
3987
143
426
455
5544
65
20
533
5950
133
411
460
5546
273
1981
293
3767
332
3080
142
1849
Platelets [#/volume] in Blood
26515-7 [3007461]
1.8e-01
4.4e-01
1.4e+00
3.6e+00
1.4e+00
5.8e-01
3.3e-01
cases:43.14%
controls:38.73%
cases:43.48%
controls:33.07%
cases:23.75%
controls:7.10%
cases:10.70%
controls:0.34%
cases:22.43%
controls:6.88%
cases:48.23%
controls:34.22%
cases:69.83%
controls:62.39%
258
2312
340
3658
260
1974
338
3996
142
424
456
5546
64
20
534
5950
133
410
460
5547
273
1967
293
3781
331
3075
143
1854
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.8e-01
4.4e-01
1.4e+00
3.6e+00
1.4e+00
5.8e-01
3.3e-01
cases:43.31%
controls:39.01%
cases:43.48%
controls:33.18%
cases:23.75%
controls:7.12%
cases:10.87%
controls:0.34%
cases:22.43%
controls:6.90%
cases:48.23%
controls:34.38%
cases:69.83%
controls:62.43%
259
2329
339
3641
260
1981
338
3989
142
425
456
5545
65
20
533
5950
133
411
460
5546
273
1976
293
3772
331
3077
143
1852
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.8e-01
4.4e-01
1.4e+00
3.6e+00
1.4e+00
5.7e-01
3.3e-01
cases:43.31%
controls:39.01%
cases:43.48%
controls:33.22%
cases:23.75%
controls:7.17%
cases:10.87%
controls:0.34%
cases:22.43%
controls:6.92%
cases:48.23%
controls:34.48%
cases:69.83%
controls:62.53%
259
2329
339
3641
260
1983
338
3987
142
428
456
5542
65
20
533
5950
133
412
460
5545
273
1982
293
3766
331
3082
143
1847
Supporting bandage or orthosis of lower limb
TNX92 [2001308571]
3.4e+00
—
—
1.0e+50
1.0e+50
—
3.9e+00
cases:2.51%
controls:0.08%
—
—
—
—
cases:1.84%
controls:0.00%
cases:3.71%
controls:0.00%
—
—
cases:6.54%
controls:0.14%
15
5
583
5965
—
—
11
0
587
5970
22
0
571
5957
—
31
7
443
4922
Pure hypercholesterolaemia
E78.01 [2000501514]
7.0e-01
8.4e-01
2.2e+00
—
1.9e+00
1.1e+00
6.1e-01
cases:7.19%
controls:3.72%
cases:3.68%
controls:1.62%
cases:2.17%
controls:0.25%
—
—
cases:2.19%
controls:0.34%
cases:4.95%
controls:1.70%
cases:10.76%
controls:6.15%
43
222
555
5748
22
97
576
5873
13
15
585
5955
—
13
20
580
5937
28
98
538
5650
51
303
423
4626
empagliflozin; oral
A10BK03 [1123740]
1.6e+00
1.4e+00
1.5e+00
—
6.6e-01
1.4e+00
1.4e+00
cases:5.02%
controls:1.11%
cases:4.85%
controls:1.26%
cases:2.01%
controls:0.44%
—
—
cases:0.84%
controls:0.44%
cases:6.18%
controls:1.55%
cases:11.18%
controls:3.04%
30
66
568
5904
29
75
569
5895
12
26
586
5944
—
5
26
588
5931
35
89
531
5659
53
150
421
4779
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.1e+00
2.6e+00
—
—
—
2.1e+00
2.6e+00
cases:1.17%
controls:0.39%
cases:1.51%
controls:0.12%
—
—
—
—
—
—
cases:1.24%
controls:0.16%
cases:3.80%
controls:0.28%
7
23
591
5947
9
7
589
5963
—
—
—
7
9
559
5739
18
14
456
4915
Diabetic background retinopathy and Type 1 diabetes mellitus, With ophthalmic complications
H36.00*E10.3 [2000503930]
2.7e+00
2.4e+00
—
—
—
—
2.2e+00
cases:3.01%
controls:0.22%
cases:1.34%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.22%
18
13
580
5957
8
7
590
5963
—
—
—
—
9
11
465
4918
Dietary counselling and surveillance
Z71.3 [45552101]
8.5e-01
2.6e+00
—
—
—
2.7e+00
1.9e+00
cases:1.17%
controls:0.50%
cases:1.34%
controls:0.10%
—
—
—
—
—
—
cases:1.77%
controls:0.12%
cases:2.95%
controls:0.45%
7
30
591
5940
8
6
590
5964
—
—
—
10
7
556
5741
14
22
460
4907
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
1.7e+00
2.0e+00
—
—
—
2.1e+00
1.3e+00
cases:5.18%
controls:0.95%
cases:3.85%
controls:0.52%
—
—
—
—
—
—
cases:4.95%
controls:0.61%
cases:6.75%
controls:1.97%
31
57
567
5913
23
31
575
5939
—
—
—
28
35
538
5713
32
97
442
4832
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
1.4e+00
2.0e+00
—
—
—
1.8e+00
2.0e+00
cases:2.01%
controls:0.50%
cases:1.51%
controls:0.20%
—
—
—
—
—
—
cases:1.24%
controls:0.21%
cases:4.64%
controls:0.67%
12
30
586
5940
9
12
589
5958
—
—
—
7
12
559
5736
22
33
452
4896
Localized oedema
R60.0 [45597193]
1.1e+00
2.1e+00
—
—
—
2.4e+00
1.7e+00
cases:4.01%
controls:1.42%
cases:3.68%
controls:0.49%
—
—
—
—
—
—
cases:3.71%
controls:0.35%
cases:7.38%
controls:1.48%
24
85
574
5885
22
29
576
5941
—
—
—
21
20
545
5728
35
73
439
4856
Type 2 diabetes mellitus, with renal complications
E11.2 [45605400]
2.3e+00
1.6e+00
—
—
—
1.6e+00
1.6e+00
cases:3.85%
controls:0.40%
cases:1.34%
controls:0.27%
—
—
—
—
—
—
cases:1.77%
controls:0.35%
cases:3.59%
controls:0.73%
23
24
575
5946
8
16
590
5954
—
—
—
10
20
556
5728
17
36
457
4893
oxcarbazepine; oral
N03AF02 [21604418]
1.6e+00
1.5e+00
2.2e+00
—
—
9.4e-01
1.9e+00
cases:2.01%
controls:0.40%
cases:1.67%
controls:0.37%
cases:1.00%
controls:0.12%
—
—
—
—
cases:1.06%
controls:0.42%
cases:2.53%
controls:0.41%
12
24
586
5946
10
22
588
5948
6
7
592
5963
—
—
6
24
560
5724
12
20
462
4909
Treponema pallidum Ab [Presence] in Serum
22587-0 [3019832]
7.5e-01
1.0e+00
3.4e+00
—
—
1.9e+00
1.1e+00
cases:4.18%
controls:2.01%
cases:2.17%
controls:0.80%
cases:3.51%
controls:0.12%
—
—
—
—
cases:3.71%
controls:0.57%
cases:6.33%
controls:2.29%
25
120
573
5850
13
48
585
5922
21
7
577
5963
—
—
21
33
545
5715
30
113
444
4816
Urinary tract ultrasound examination
KH1AE [2001306329]
1.8e+00
2.0e+00
—
—
—
1.8e+00
1.5e+00
cases:2.17%
controls:0.35%
cases:1.17%
controls:0.17%
—
—
—
—
—
—
cases:1.41%
controls:0.23%
cases:3.16%
controls:0.73%
13
21
585
5949
7
10
591
5960
—
—
—
8
13
558
5735
15
36
459
4893
Physiotherapist
Z3226 [2001311560]
1.4e+00
1.9e+00
—
1.0e+50
—
1.9e+00
2.0e+00
cases:9.20%
controls:2.48%
cases:3.51%
controls:0.55%
—
—
cases:1.00%
controls:0.00%
—
—
cases:3.18%
controls:0.50%
cases:7.38%
controls:1.08%
55
148
543
5822
21
33
577
5937
—
6
0
592
5970
—
18
29
548
5719
35
53
439
4876
Essential (primary) hypertension
I10 [45591453]
9.0e-01
9.3e-01
1.6e+00
—
1.6e+00
1.1e+00
9.4e-01
cases:35.12%
controls:18.04%
cases:21.57%
controls:9.78%
cases:7.53%
controls:1.56%
—
—
cases:7.59%
controls:1.65%
cases:25.27%
controls:9.97%
cases:45.99%
controls:24.89%
210
1077
388
4893
129
584
469
5386
45
93
553
5877
—
45
98
548
5859
143
573
423
5175
218
1227
256
3702
Psychiatry
26 [38004469]
9.3e-01
1.1e+00
1.4e+00
—
1.3e+00
1.2e+00
1.2e+00
cases:12.54%
controls:5.34%
cases:7.02%
controls:2.56%
cases:4.01%
controls:0.97%
—
—
cases:3.71%
controls:1.06%
cases:8.30%
controls:2.73%
cases:15.19%
controls:5.03%
75
319
523
5651
42
153
556
5817
24
58
574
5912
—
22
63
571
5894
47
157
519
5591
72
248
402
4681
Emergency Medicine
93 [38004510]
5.3e-01
1.2e+00
1.7e+00
—
1.7e+00
1.1e+00
8.7e-01
cases:20.90%
controls:13.43%
cases:19.57%
controls:7.09%
cases:5.85%
controls:1.12%
—
—
cases:4.72%
controls:0.87%
cases:20.85%
controls:7.99%
cases:43.04%
controls:23.98%
125
802
473
5168
117
423
481
5547
35
67
563
5903
—
28
52
565
5905
118
459
448
5289
204
1182
270
3747
allopurinol; oral, parenteral
M04AA01 [21604131]
1.2e+00
1.3e+00
1.6e+00
—
1.2e+00
1.5e+00
1.6e+00
cases:8.19%
controls:2.70%
cases:7.02%
controls:1.98%
cases:2.17%
controls:0.47%
—
—
cases:2.02%
controls:0.64%
cases:7.77%
controls:1.90%
cases:13.71%
controls:3.16%
49
161
549
5809
42
118
556
5852
13
28
585
5942
—
12
38
581
5919
44
109
522
5639
65
156
409
4773
Other extensive ultrasound examination of artery
PG1DE [2001309713]
2.0e+00
2.1e+00
—
—
—
2.3e+00
2.7e+00
cases:2.68%
controls:0.39%
cases:0.84%
controls:0.10%
—
—
—
—
—
—
cases:1.59%
controls:0.16%
cases:6.33%
controls:0.45%
16
23
582
5947
5
6
593
5964
—
—
—
9
9
557
5739
30
22
444
4907
Atherosclerotic heart disease
I25.1 [45596196]
7.2e-01
7.7e-01
1.9e+00
—
1.8e+00
9.9e-01
8.3e-01
cases:8.86%
controls:4.54%
cases:5.35%
controls:2.56%
cases:2.68%
controls:0.42%
—
—
cases:2.70%
controls:0.45%
cases:6.71%
controls:2.59%
cases:13.71%
controls:6.45%
53
271
545
5699
32
153
566
5817
16
25
582
5945
—
16
27
577
5930
38
149
528
5599
65
318
409
4611
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
9.5e-01
1.3e+00
—
—
1.9e+00
1.5e+00
1.4e+00
cases:6.86%
controls:2.78%
cases:4.35%
controls:1.24%
—
—
—
—
cases:1.18%
controls:0.18%
cases:5.30%
controls:1.27%
cases:13.29%
controls:3.57%
41
166
557
5804
26
74
572
5896
—
—
7
11
586
5946
30
73
536
5675
63
176
411
4753
glucagon; nasal, parenteral
H04AA01 [21602778]
2.2e+00
2.3e+00
—
—
—
—
2.4e+00
cases:3.68%
controls:0.42%
cases:1.34%
controls:0.13%
—
—
—
—
—
—
—
—
cases:2.95%
controls:0.26%
22
25
576
5945
8
8
590
5962
—
—
—
—
14
13
460
4916
Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
66885-5 [40769539]
1.6e+00
2.3e+00
—
—
—
2.5e+00
2.1e+00
cases:1.17%
controls:0.23%
cases:1.00%
controls:0.10%
—
—
—
—
—
—
cases:1.06%
controls:0.09%
cases:3.80%
controls:0.47%
7
14
591
5956
6
6
592
5964
—
—
—
6
5
560
5743
18
23
456
4906
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
6.5e-01
1.1e+00
1.6e+00
—
1.5e+00
1.0e+00
1.1e+00
cases:21.24%
controls:12.35%
cases:15.89%
controls:5.76%
cases:4.52%
controls:0.97%
—
—
cases:3.54%
controls:0.84%
cases:15.55%
controls:6.16%
cases:40.93%
controls:18.97%
127
737
471
5233
95
344
503
5626
27
58
571
5912
—
21
50
572
5907
88
354
478
5394
194
935
280
3994
Treponema pallidum Ab [Titer] in Serum by Hemagglutination
26009-1 [3019539]
2.0e+00
2.3e+00
1.0e+50
—
—
—
2.6e+00
cases:1.67%
controls:0.23%
cases:1.67%
controls:0.17%
cases:2.68%
controls:0.00%
—
—
—
—
—
—
cases:4.43%
controls:0.34%
10
14
588
5956
10
10
588
5960
16
0
582
5970
—
—
—
21
17
453
4912
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
7.2e-01
8.2e-01
1.7e+00
—
1.4e+00
1.0e+00
1.2e+00
cases:17.89%
controls:9.63%
cases:11.87%
controls:5.59%
cases:6.02%
controls:1.16%
—
—
cases:5.06%
controls:1.28%
cases:15.72%
controls:6.18%
cases:35.86%
controls:14.79%
107
575
491
5395
71
334
527
5636
36
69
562
5901
—
30
76
563
5881
89
355
477
5393
170
729
304
4200
tacrolimus; oral, parenteral
L04AD02 [21603925]
—
—
—
—
—
3.3e+00
3.6e+00
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.10%
cases:3.59%
controls:0.10%
—
—
—
—
—
15
6
551
5742
17
5
457
4924
Monocytes/Leukocytes in Blood
26485-3 [3019069]
7.1e-01
8.2e-01
1.7e+00
—
1.4e+00
1.1e+00
1.2e+00
cases:17.89%
controls:9.68%
cases:11.87%
controls:5.58%
cases:6.02%
controls:1.16%
—
—
cases:4.89%
controls:1.28%
cases:15.90%
controls:6.12%
cases:35.86%
controls:14.75%
107
578
491
5392
71
333
527
5637
36
69
562
5901
—
29
76
564
5881
90
352
476
5396
170
727
304
4202
Basophils/Leukocytes in Blood
30180-4 [3022096]
7.1e-01
8.2e-01
1.7e+00
—
1.4e+00
1.0e+00
1.2e+00
cases:17.73%
controls:9.56%
cases:11.87%
controls:5.59%
cases:6.02%
controls:1.17%
—
—
cases:5.06%
controls:1.26%
cases:15.55%
controls:6.14%
cases:35.65%
controls:14.79%
106
571
492
5399
71
334
527
5636
36
70
562
5900
—
30
75
563
5882
88
353
478
5395
169
729
305
4200
lidocaine, combinations
N01BB52 [21604241]
1.3e+00
2.2e+00
—
—
—
2.5e+00
2.2e+00
cases:1.17%
controls:0.32%
cases:1.00%
controls:0.12%
—
—
—
—
—
—
cases:1.41%
controls:0.12%
cases:2.11%
controls:0.24%
7
19
591
5951
6
7
592
5963
—
—
—
8
7
558
5741
10
12
464
4917
Sampling
SPAT1263 [2001700364]
6.0e-01
1.1e+00
1.7e+00
—
1.4e+00
1.2e+00
8.7e-01
cases:15.72%
controls:9.25%
cases:10.70%
controls:3.95%
cases:3.18%
controls:0.62%
—
—
cases:2.70%
controls:0.67%
cases:11.13%
controls:3.81%
cases:22.78%
controls:11.00%
94
552
504
5418
64
236
534
5734
19
37
579
5933
—
16
40
577
5917
63
219
503
5529
108
542
366
4387
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
9.9e-01
1.2e+00
1.2e+00
—
2.2e+00
1.1e+00
1.2e+00
cases:9.87%
controls:3.92%
cases:7.19%
controls:2.21%
cases:1.00%
controls:0.32%
—
—
cases:1.35%
controls:0.15%
cases:7.24%
controls:2.57%
cases:22.57%
controls:7.87%
59
234
539
5736
43
132
555
5838
6
19
592
5951
—
8
9
585
5948
41
148
525
5600
107
388
367
4541
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
1.4e+00
1.7e+00
—
—
—
2.1e+00
1.6e+00
cases:6.35%
controls:1.73%
cases:2.68%
controls:0.52%
—
—
—
—
—
—
cases:3.36%
controls:0.43%
cases:8.65%
controls:1.83%
38
103
560
5867
16
31
582
5939
—
—
—
19
25
547
5723
41
90
433
4839
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
7.1e-01
7.6e-01
1.6e+00
—
1.5e+00
9.9e-01
1.1e+00
cases:17.89%
controls:9.68%
cases:11.37%
controls:5.66%
cases:5.85%
controls:1.21%
—
—
cases:5.06%
controls:1.18%
cases:15.02%
controls:6.18%
cases:34.81%
controls:15.01%
107
578
491
5392
68
338
530
5632
35
72
563
5898
—
30
70
563
5887
85
355
481
5393
165
740
309
4189
Thorax X-ray examination
GD1AA [2001303617]
9.6e-01
1.4e+00
1.6e+00
—
6.6e-01
1.2e+00
1.5e+00
cases:20.23%
controls:8.84%
cases:12.04%
controls:3.18%
cases:2.17%
controls:0.47%
—
—
cases:0.84%
controls:0.44%
cases:10.95%
controls:3.53%
cases:33.33%
controls:9.96%
121
528
477
5442
72
190
526
5780
13
28
585
5942
—
5
26
588
5931
62
203
504
5545
158
491
316
4438
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.4e+00
1.9e+00
—
—
—
1.8e+00
1.5e+00
cases:4.01%
controls:1.07%
cases:3.18%
controls:0.47%
—
—
—
—
—
—
cases:2.83%
controls:0.47%
cases:9.70%
controls:2.27%
24
64
574
5906
19
28
579
5942
—
—
—
16
27
550
5721
46
112
428
4817
benzathine phenoxymethylpenicillin; oral
J01CE10 [21602850]
6.6e-01
9.7e-01
1.9e+00
—
1.5e+00
8.7e-01
7.4e-01
cases:22.91%
controls:13.32%
cases:9.70%
controls:3.90%
cases:2.01%
controls:0.32%
—
—
cases:1.69%
controls:0.37%
cases:9.01%
controls:3.97%
cases:22.78%
controls:12.34%
137
795
461
5175
58
233
540
5737
12
19
586
5951
—
10
22
583
5935
51
228
515
5520
108
608
366
4321
phenoxymethylpenicillin; oral
J01CE02 [21602842]
6.6e-01
9.7e-01
1.9e+00
—
1.5e+00
8.7e-01
7.4e-01
cases:22.91%
controls:13.32%
cases:9.70%
controls:3.90%
cases:2.01%
controls:0.32%
—
—
cases:1.69%
controls:0.37%
cases:9.01%
controls:3.97%
cases:22.78%
controls:12.34%
137
795
461
5175
58
233
540
5737
12
19
586
5951
—
10
22
583
5935
51
228
515
5520
108
608
366
4321
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
7.8e-01
1.2e+00
2.5e+00
—
1.6e+00
1.1e+00
1.0e+00
cases:4.68%
controls:2.21%
cases:2.84%
controls:0.85%
cases:1.00%
controls:0.08%
—
—
cases:0.84%
controls:0.17%
cases:2.65%
controls:0.89%
cases:10.76%
controls:4.20%
28
132
570
5838
17
51
581
5919
6
5
592
5965
—
5
10
588
5947
15
51
551
5697
51
207
423
4722
Non-insulin dependent diabetes diabetic hypoglycaemic coma
E11.00 [2000501437]
1.8e+00
2.3e+00
—
—
—
—
2.5e+00
cases:1.67%
controls:0.27%
cases:1.00%
controls:0.10%
—
—
—
—
—
—
—
—
cases:2.32%
controls:0.20%
10
16
588
5954
6
6
592
5964
—
—
—
—
11
10
463
4919
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
G63.2*E11.4 [2000502182]
3.2e+00
1.0e+50
—
1.0e+50
—
—
3.4e+00
cases:2.51%
controls:0.10%
cases:0.84%
controls:0.00%
—
—
cases:0.84%
controls:0.00%
—
—
—
—
cases:5.06%
controls:0.18%
15
6
583
5964
5
0
593
5970
—
5
0
593
5970
—
—
24
9
450
4920
Diabetic background retinopathy
H36.00 [2000502320]
2.6e+00
2.0e+00
—
—
—
—
1.9e+00
cases:2.51%
controls:0.18%
cases:1.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:2.53%
controls:0.39%
15
11
583
5959
6
8
592
5962
—
—
—
—
12
19
462
4910
moxonidine; oral
C02AC05 [21600401]
1.6e+00
1.3e+00
2.1e+00
—
—
1.0e+00
1.6e+00
cases:4.01%
controls:0.87%
cases:2.68%
controls:0.75%
cases:1.17%
controls:0.15%
—
—
—
—
cases:2.30%
controls:0.82%
cases:4.85%
controls:0.97%
24
52
574
5918
16
45
582
5925
7
9
591
5961
—
—
13
47
553
5701
23
48
451
4881
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
7.1e-01
7.6e-01
1.7e+00
—
1.3e+00
1.0e+00
1.1e+00
cases:18.39%
controls:9.98%
cases:11.54%
controls:5.75%
cases:5.85%
controls:1.16%
—
—
cases:4.38%
controls:1.28%
cases:15.55%
controls:6.35%
cases:35.86%
controls:15.26%
110
596
488
5374
69
343
529
5627
35
69
563
5901
—
26
76
567
5881
88
365
478
5383
170
752
304
4177
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
7.2e-01
9.6e-01
1.2e+00
—
1.5e+00
1.0e+00
1.1e+00
cases:13.21%
controls:6.92%
cases:10.87%
controls:4.46%
cases:2.17%
controls:0.64%
—
—
cases:2.36%
controls:0.52%
cases:12.19%
controls:4.85%
cases:33.12%
controls:14.36%
79
413
519
5557
65
266
533
5704
13
38
585
5932
—
14
31
579
5926
69
279
497
5469
157
708
317
4221
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
5.5e-01
6.0e-01
2.0e+00
—
1.6e+00
8.4e-01
9.3e-01
cases:27.26%
controls:17.79%
cases:16.39%
controls:9.72%
cases:7.69%
controls:1.07%
—
—
cases:6.58%
controls:1.44%
cases:19.79%
controls:9.62%
cases:47.26%
controls:26.13%
163
1062
435
4908
98
580
500
5390
46
64
552
5906
—
39
86
554
5871
112
553
454
5195
224
1288
250
3641
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.2e-01
3.8e-01
1.2e+00
3.3e+00
1.2e+00
4.1e-01
7.9e-02
cases:31.94%
controls:29.36%
cases:30.60%
controls:23.08%
cases:15.55%
controls:5.26%
cases:7.53%
controls:0.28%
cases:14.00%
controls:4.78%
cases:32.69%
controls:24.29%
cases:49.37%
controls:47.39%
191
1753
407
4217
183
1378
415
4592
93
314
505
5656
45
17
553
5953
83
285
510
5672
185
1396
381
4352
234
2336
240
2593
Home Visit
OMOP4822459 [581476]
6.9e-01
8.4e-01
1.4e+00
1.3e+00
1.4e+00
1.1e+00
1.0e+00
cases:9.36%
controls:4.94%
cases:6.52%
controls:2.91%
cases:3.34%
controls:0.87%
cases:1.17%
controls:0.32%
cases:3.88%
controls:0.94%
cases:10.60%
controls:3.67%
cases:20.68%
controls:8.48%
56
295
542
5675
39
174
559
5796
20
52
578
5918
7
19
591
5951
23
56
570
5901
60
211
506
5537
98
418
376
4511
Spinalanesthesia
WX320 [2001310799]
1.1e+00
1.6e+00
2.1e+00
—
—
2.1e+00
1.6e+00
cases:8.36%
controls:2.83%
cases:3.85%
controls:0.79%
cases:0.84%
controls:0.10%
—
—
—
—
cases:5.83%
controls:0.73%
cases:14.98%
controls:3.39%
50
169
548
5801
23
47
575
5923
5
6
593
5964
—
—
33
42
533
5706
71
167
403
4762
Parabulbar anesthesia
WX140 [2001310772]
1.4e+00
2.0e+00
—
—
—
2.8e+00
1.7e+00
cases:1.51%
controls:0.39%
cases:1.00%
controls:0.13%
—
—
—
—
—
—
cases:1.41%
controls:0.09%
cases:2.74%
controls:0.53%
9
23
589
5947
6
8
592
5962
—
—
—
8
5
558
5743
13
26
461
4903
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
8.0e-01
1.1e+00
—
—
2.7e+00
1.1e+00
7.7e-01
cases:4.85%
controls:2.24%
cases:3.68%
controls:1.21%
—
—
—
—
cases:1.18%
controls:0.08%
cases:4.06%
controls:1.39%
cases:10.76%
controls:5.27%
29
134
569
5836
22
72
576
5898
—
—
7
5
586
5952
23
80
543
5668
51
260
423
4669
Eosinophils [#/volume] in Blood
26449-9 [3013115]
6.5e-01
7.8e-01
1.7e+00
—
1.3e+00
9.7e-01
1.1e+00
cases:18.90%
controls:10.80%
cases:13.04%
controls:6.45%
cases:6.86%
controls:1.37%
—
—
cases:5.40%
controls:1.59%
cases:16.61%
controls:6.99%
cases:38.61%
controls:17.04%
113
645
485
5325
78
385
520
5585
41
82
557
5888
—
32
95
561
5862
94
402
472
5346
183
840
291
4089
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
7.4e-01
5.3e-01
1.6e+00
—
2.1e+00
1.0e+00
9.8e-01
cases:10.70%
controls:5.41%
cases:4.85%
controls:2.91%
cases:1.34%
controls:0.27%
—
—
cases:2.36%
controls:0.30%
cases:6.54%
controls:2.45%
cases:21.31%
controls:9.21%
64
323
534
5647
29
174
569
5796
8
16
590
5954
—
14
18
579
5939
37
141
529
5607
101
454
373
4475
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
8.7e-01
1.2e+00
1.2e+00
—
2.2e+00
1.3e+00
8.6e-01
cases:17.89%
controls:8.34%
cases:6.86%
controls:2.24%
cases:1.00%
controls:0.32%
—
—
cases:2.02%
controls:0.22%
cases:7.77%
controls:2.28%
cases:17.51%
controls:8.26%
107
498
491
5472
41
134
557
5836
6
19
592
5951
—
12
13
581
5944
44
131
522
5617
83
407
391
4522
methylprednisolone; oral, parenteral
H02AB04 [21602732]
1.2e+00
2.1e+00
—
—
—
1.5e+00
1.6e+00
cases:4.35%
controls:1.32%
cases:3.18%
controls:0.40%
—
—
—
—
—
—
cases:2.30%
controls:0.50%
cases:4.85%
controls:1.05%
26
79
572
5891
19
24
579
5946
—
—
—
13
29
553
5719
23
52
451
4877
Bacterial infection, unspecified
A49.9 [45590816]
1.4e+00
1.4e+00
2.3e+00
—
—
2.0e+00
1.7e+00
cases:4.01%
controls:1.02%
cases:2.17%
controls:0.57%
cases:0.84%
controls:0.08%
—
—
—
—
cases:2.47%
controls:0.35%
cases:7.38%
controls:1.48%
24
61
574
5909
13
34
585
5936
5
5
593
5965
—
—
14
20
552
5728
35
73
439
4856
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
6.7e-01
9.0e-01
1.1e+00
—
2.1e+00
1.5e+00
1.2e+00
cases:10.87%
controls:5.90%
cases:5.52%
controls:2.33%
cases:1.00%
controls:0.35%
—
—
cases:1.52%
controls:0.18%
cases:8.13%
controls:1.97%
cases:22.78%
controls:7.91%
65
352
533
5618
33
139
565
5831
6
21
592
5949
—
9
11
584
5946
46
113
520
5635
108
390
366
4539
Exposure to other specified factors
X58 [45756411]
9.1e-01
1.2e+00
2.2e+00
—
—
2.0e+00
6.8e-01
cases:3.51%
controls:1.44%
cases:2.51%
controls:0.74%
cases:1.17%
controls:0.13%
—
—
—
—
cases:3.53%
controls:0.47%
cases:4.22%
controls:2.19%
21
86
577
5884
15
44
583
5926
7
8
591
5962
—
—
20
27
546
5721
20
108
454
4821
metformin; oral
A10BA02 [21600747]
1.3e+00
1.1e+00
1.1e+00
—
8.3e-01
1.1e+00
9.9e-01
cases:30.77%
controls:10.92%
cases:25.08%
controls:9.65%
cases:7.02%
controls:2.56%
—
—
cases:6.41%
controls:2.90%
cases:24.56%
controls:9.97%
cases:28.27%
controls:12.80%
184
652
414
5318
150
576
448
5394
42
153
556
5817
—
38
173
555
5784
139
573
427
5175
134
631
340
4298
enalapril and diuretics
C09BA02 [21601804]
1.3e+00
1.3e+00
—
—
1.7e+00
1.2e+00
9.6e-01
cases:5.69%
controls:1.68%
cases:4.52%
controls:1.31%
—
—
—
—
cases:2.19%
controls:0.40%
cases:4.06%
controls:1.30%
cases:4.43%
controls:1.74%
34
100
564
5870
27
78
571
5892
—
—
13
24
580
5933
23
75
543
5673
21
86
453
4843
FISTULA - Fistula
FISTULA-1 [2002330212]
—
2.9e+00
—
—
—
—
3.5e+00
—
—
cases:1.51%
controls:0.08%
—
—
—
—
—
—
—
—
cases:3.16%
controls:0.10%
—
9
5
589
5965
—
—
—
—
15
5
459
4924
Monocytes [#/volume] in Blood
26484-6 [3001604]
6.7e-01
7.6e-01
1.7e+00
—
1.2e+00
9.4e-01
1.1e+00
cases:18.23%
controls:10.20%
cases:12.04%
controls:6.03%
cases:6.52%
controls:1.29%
—
—
cases:4.72%
controls:1.51%
cases:15.55%
controls:6.68%
cases:37.76%
controls:16.19%
109
609
489
5361
72
360
526
5610
39
77
559
5893
—
28
90
565
5867
88
384
478
5364
179
798
295
4131
Basophils [#/volume] in Blood
26444-0 [3006315]
6.9e-01
7.4e-01
1.7e+00
—
1.2e+00
9.4e-01
1.1e+00
cases:18.56%
controls:10.22%
cases:12.04%
controls:6.11%
cases:6.52%
controls:1.31%
—
—
cases:4.72%
controls:1.51%
cases:15.55%
controls:6.70%
cases:37.97%
controls:16.35%
111
610
487
5360
72
365
526
5605
39
78
559
5892
—
28
90
565
5867
88
385
478
5363
180
806
294
4123
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
5.4e-01
8.1e-01
1.6e+00
—
1.5e+00
9.3e-01
9.5e-01
cases:27.42%
controls:18.04%
cases:22.91%
controls:11.69%
cases:9.53%
controls:2.03%
—
—
cases:9.78%
controls:2.43%
cases:25.97%
controls:12.11%
cases:51.27%
controls:28.83%
164
1077
434
4893
137
698
461
5272
57
121
541
5849
—
58
145
535
5812
147
696
419
5052
243
1421
231
3508
Urgent procedure
ZXD05 [2001311386]
1.2e+00
1.4e+00
2.3e+00
—
—
1.9e+00
1.8e+00
cases:14.55%
controls:4.72%
cases:3.68%
controls:0.97%
cases:0.84%
controls:0.08%
—
—
—
—
cases:6.18%
controls:0.94%
cases:14.35%
controls:2.72%
87
282
511
5688
22
58
576
5912
5
5
593
5965
—
—
35
54
531
5694
68
134
406
4795
fluconazole; oral, parenteral
J02AC01 [21603080]
8.5e-01
1.3e+00
1.7e+00
—
2.3e+00
9.7e-01
8.3e-01
cases:10.54%
controls:4.77%
cases:4.85%
controls:1.31%
cases:0.84%
controls:0.15%
—
—
cases:1.18%
controls:0.12%
cases:3.89%
controls:1.51%
cases:7.81%
controls:3.57%
63
285
535
5685
29
78
569
5892
5
9
593
5961
—
7
7
586
5950
22
87
544
5661
37
176
437
4753
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
8.0e-01
8.8e-01
2.4e+00
—
1.5e+00
1.2e+00
1.0e+00
cases:7.86%
controls:3.69%
cases:4.52%
controls:1.93%
cases:1.51%
controls:0.13%
—
—
cases:1.01%
controls:0.22%
cases:5.30%
controls:1.74%
cases:13.92%
controls:5.54%
47
220
551
5750
27
115
571
5855
9
8
589
5962
—
6
13
587
5944
30
100
536
5648
66
273
408
4656
Inpatient Visit
IP [9201]
7.1e-01
9.0e-01
1.3e+00
—
2.2e+00
1.4e+00
1.1e+00
cases:9.03%
controls:4.67%
cases:6.02%
controls:2.55%
cases:1.51%
controls:0.42%
—
—
cases:2.19%
controls:0.25%
cases:8.66%
controls:2.30%
cases:21.94%
controls:8.66%
54
279
544
5691
36
152
562
5818
9
25
589
5945
—
13
15
580
5942
49
132
517
5616
104
427
370
4502
Hypothyroidism, unspecified
E03.9 [45537945]
9.7e-01
1.0e+00
—
—
2.0e+00
1.3e+00
1.0e+00
cases:4.85%
controls:1.89%
cases:2.68%
controls:1.01%
—
—
—
—
cases:1.18%
controls:0.17%
cases:2.83%
controls:0.77%
cases:5.91%
controls:2.25%
29
113
569
5857
16
60
582
5910
—
—
7
10
586
5947
16
44
550
5704
28
111
446
4818
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
8.2e-01
1.2e+00
—
—
2.3e+00
1.1e+00
7.8e-01
cases:4.68%
controls:2.13%
cases:4.01%
controls:1.22%
—
—
—
—
cases:1.01%
controls:0.10%
cases:4.24%
controls:1.44%
cases:11.39%
controls:5.58%
28
127
570
5843
24
73
574
5897
—
—
6
6
587
5951
24
83
542
5665
54
275
420
4654
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
1.2e+00
1.5e+00
—
—
—
1.9e+00
1.6e+00
cases:4.52%
controls:1.34%
cases:1.67%
controls:0.39%
—
—
—
—
—
—
cases:1.77%
controls:0.26%
cases:5.06%
controls:1.10%
27
80
571
5890
10
23
588
5947
—
—
—
10
15
556
5733
24
54
450
4875
Laboratory Visit
OMOP4822461 [32036]
1.8e-01
3.2e-01
1.1e+00
3.2e+00
1.1e+00
4.7e-01
2.3e-01
cases:48.33%
controls:43.82%
cases:50.00%
controls:42.08%
cases:31.10%
controls:12.78%
cases:15.22%
controls:0.72%
cases:30.19%
controls:12.54%
cases:55.65%
controls:43.98%
cases:73.00%
controls:68.17%
289
2616
309
3354
299
2512
299
3458
186
763
412
5207
91
43
507
5927
179
747
414
5210
315
2528
251
3220
346
3360
128
1569
X-ray examination of the lungs in one projection
GD1PA [2001303645]
1.1e+00
1.7e+00
—
—
—
1.7e+00
1.7e+00
cases:3.34%
controls:1.11%
cases:2.01%
controls:0.39%
—
—
—
—
—
—
cases:2.30%
controls:0.42%
cases:5.91%
controls:1.14%
20
66
578
5904
12
23
586
5947
—
—
—
13
24
553
5724
28
56
446
4873
Chronic disorders of vitamin D metabolism
123 [2001600122]
3.3e+00
—
—
—
—
—
2.9e+00
cases:2.68%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:2.53%
controls:0.14%
16
6
582
5964
—
—
—
—
—
12
7
462
4922
Emergency Room and Inpatient Visit
ERIP [262]
8.9e-01
1.4e+00
1.3e+00
1.0e+50
1.8e+00
1.1e+00
1.1e+00
cases:8.86%
controls:3.84%
cases:9.03%
controls:2.46%
cases:1.84%
controls:0.52%
cases:3.18%
controls:0.00%
cases:2.70%
controls:0.45%
cases:7.77%
controls:2.85%
cases:25.53%
controls:10.35%
53
229
545
5741
54
147
544
5823
11
31
587
5939
19
0
579
5970
16
27
577
5930
44
164
522
5584
121
510
353
4419
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
6.6e-01
7.3e-01
1.6e+00
—
1.2e+00
8.8e-01
1.1e+00
cases:18.90%
controls:10.70%
cases:12.37%
controls:6.37%
cases:6.35%
controls:1.34%
—
—
cases:4.72%
controls:1.49%
cases:15.55%
controls:7.10%
cases:38.19%
controls:16.88%
113
639
485
5331
74
380
524
5590
38
80
560
5890
—
28
89
565
5868
88
408
478
5340
181
832
293
4097
Nutritional therapy
R4190 [2001310243]
1.6e+00
2.2e+00
—
—
—
2.4e+00
1.5e+00
cases:1.00%
controls:0.20%
cases:1.51%
controls:0.17%
—
—
—
—
—
—
cases:1.94%
controls:0.17%
cases:2.11%
controls:0.47%
6
12
592
5958
9
10
589
5960
—
—
—
11
10
555
5738
10
23
464
4906
pH of Specimen
17433-4 [3019225]
6.8e-01
1.3e+00
—
—
2.3e+00
1.3e+00
1.3e+00
cases:3.68%
controls:1.89%
cases:3.34%
controls:0.95%
—
—
—
—
cases:1.35%
controls:0.13%
cases:3.89%
controls:1.10%
cases:8.23%
controls:2.45%
22
113
576
5857
20
57
578
5913
—
—
8
8
585
5949
22
63
544
5685
39
121
435
4808
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
5.4e-01
9.6e-01
1.2e+00
—
1.6e+00
9.2e-01
9.2e-01
cases:22.91%
controls:14.77%
cases:17.22%
controls:7.37%
cases:3.51%
controls:1.06%
—
—
cases:5.23%
controls:1.12%
cases:17.49%
controls:7.81%
cases:41.35%
controls:21.99%
137
882
461
5088
103
440
495
5530
21
63
577
5907
—
31
67
562
5890
99
449
467
5299
196
1084
278
3845
Cutaneous abscess, furuncle and carbuncle of limb
L02.4 [45552967]
1.7e+00
—
—
—
1.0e+50
2.8e+00
1.6e+00
cases:1.84%
controls:0.34%
—
—
—
—
—
—
cases:0.84%
controls:0.00%
cases:1.41%
controls:0.09%
cases:2.32%
controls:0.47%
11
20
587
5950
—
—
—
5
0
588
5957
8
5
558
5743
11
23
463
4906
Dentistry
C5 [903277]
1.1e+00
1.9e+00
—
1.0e+50
—
1.8e+00
1.4e+00
cases:5.02%
controls:1.74%
cases:3.85%
controls:0.62%
—
—
cases:3.51%
controls:0.00%
—
—
cases:4.95%
controls:0.87%
cases:7.59%
controls:2.01%
30
104
568
5866
23
37
575
5933
—
21
0
577
5970
—
28
50
538
5698
36
99
438
4830
Other investigative procedure of eye
XCW99 [2001301491]
1.6e+00
1.5e+00
—
—
—
1.9e+00
1.2e+00
cases:7.69%
controls:1.69%
cases:3.18%
controls:0.74%
—
—
—
—
—
—
cases:3.89%
controls:0.63%
cases:6.75%
controls:2.17%
46
101
552
5869
19
44
579
5926
—
—
—
22
36
544
5712
32
107
442
4822
Implantation of vascular injection port
TPX10 [2001309608]
3.0e+00
—
—
—
—
—
3.2e+00
cases:2.51%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:2.32%
controls:0.10%
15
8
583
5962
—
—
—
—
—
11
5
463
4924
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
1.5e+00
2.5e+00
—
—
—
—
2.1e+00
cases:1.67%
controls:0.39%
cases:1.00%
controls:0.08%
—
—
—
—
—
—
—
—
cases:3.80%
controls:0.47%
10
23
588
5947
6
5
592
5965
—
—
—
—
18
23
456
4906
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
9.0e-01
1.3e+00
1.4e+00
—
1.9e+00
1.2e+00
8.3e-01
cases:10.03%
controls:4.32%
cases:4.68%
controls:1.34%
cases:0.84%
controls:0.22%
—
—
cases:1.52%
controls:0.24%
cases:4.95%
controls:1.55%
cases:12.24%
controls:5.72%
60
258
538
5712
28
80
570
5890
5
13
593
5957
—
9
14
584
5943
28
89
538
5659
58
282
416
4647
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
6.4e-01
1.1e+00
2.4e+00
—
1.3e+00
9.8e-01
9.7e-01
cases:13.38%
controls:7.52%
cases:5.52%
controls:1.99%
cases:1.84%
controls:0.17%
—
—
cases:0.84%
controls:0.24%
cases:5.12%
controls:1.98%
cases:17.72%
controls:7.53%
80
449
518
5521
33
119
565
5851
11
10
587
5960
—
5
14
588
5943
29
114
537
5634
84
371
390
4558
Insulin-dependent diabetes diabetic hypoglycemic coma
E10.00 [2000501424]
3.4e+00
—
—
—
—
—
2.7e+00
cases:2.34%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.10%
14
5
584
5965
—
—
—
—
—
7
5
467
4924
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
4.3e-01
8.5e-01
1.7e+00
—
1.4e+00
8.4e-01
7.8e-01
cases:33.78%
controls:24.92%
cases:33.95%
controls:17.99%
cases:11.87%
controls:2.29%
—
—
cases:9.11%
controls:2.50%
cases:36.40%
controls:19.83%
cases:62.87%
controls:43.70%
202
1488
396
4482
203
1074
395
4896
71
137
527
5833
—
54
149
539
5808
206
1140
360
4608
298
2154
176
2775
Occupational therapy
R4120 [2001310234]
1.2e+00
1.2e+00
—
—
—
2.6e+00
2.2e+00
cases:2.17%
controls:0.64%
cases:0.84%
controls:0.25%
—
—
—
—
—
—
cases:1.59%
controls:0.12%
cases:4.43%
controls:0.53%
13
38
585
5932
5
15
593
5955
—
—
—
9
7
557
5741
21
26
453
4903
Supplier / Service Provider
OMOP5117446 [33004]
-4.0e-01
-1.0e-01
6.7e-01
—
—
3.2e+00
3.2e+00
cases:18.39%
controls:25.18%
cases:7.36%
controls:8.07%
cases:1.34%
controls:0.69%
—
—
—
—
cases:9.36%
controls:0.42%
cases:23.84%
controls:1.28%
110
1503
488
4467
44
482
554
5488
8
41
590
5929
—
—
53
24
513
5724
113
63
361
4866
Pharmacy visit
OMOP4822462 [581458]
6.9e-01
1.2e+00
1.1e+00
1.4e+00
9.8e-01
1.3e+00
1.1e+00
cases:96.99%
controls:94.17%
cases:94.98%
controls:85.63%
cases:73.58%
controls:46.92%
cases:9.03%
controls:2.46%
cases:70.66%
controls:47.51%
cases:95.76%
controls:85.72%
cases:98.52%
controls:95.88%
580
5622
18
348
568
5112
30
858
440
2801
158
3169
54
147
544
5823
419
2830
174
3127
542
4927
24
821
467
4726
7
203
spironolactone; oral
C03DA01 [21601534]
1.3e+00
9.3e-01
1.5e+00
—
2.5e-01
1.1e+00
1.1e+00
cases:5.85%
controls:1.71%
cases:3.85%
controls:1.56%
cases:1.67%
controls:0.39%
—
—
cases:0.84%
controls:0.65%
cases:5.30%
controls:1.77%
cases:7.81%
controls:2.66%
35
102
563
5868
23
93
575
5877
10
23
588
5947
—
5
39
588
5918
30
102
536
5646
37
131
437
4798
pantoprazole; oral, parenteral
A02BC02 [21600097]
6.5e-01
1.0e+00
1.2e+00
—
1.1e+00
9.8e-01
8.9e-01
cases:29.43%
controls:17.82%
cases:24.41%
controls:10.20%
cases:6.69%
controls:2.04%
—
—
cases:6.24%
controls:2.18%
cases:24.38%
controls:10.84%
cases:39.66%
controls:21.18%
176
1064
422
4906
146
609
452
5361
40
122
558
5848
—
37
130
556
5827
138
623
428
5125
188
1044
286
3885
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
5.8e-01
6.9e-01
1.2e+00
—
1.4e+00
8.6e-01
1.2e+00
cases:16.56%
controls:9.98%
cases:10.70%
controls:5.64%
cases:3.18%
controls:1.02%
—
—
cases:4.38%
controls:1.14%
cases:12.72%
controls:5.79%
cases:36.92%
controls:14.97%
99
596
499
5374
64
337
534
5633
19
61
579
5909
—
26
68
567
5889
72
333
494
5415
175
738
299
4191
Sepsis due to Staphylococcus aureus
A41.0 [45532832]
2.7e+00
—
1.0e+50
—
—
—
3.2e+00
cases:2.34%
controls:0.17%
—
—
cases:0.84%
controls:0.00%
—
—
—
—
—
—
cases:2.95%
controls:0.12%
14
10
584
5960
—
5
0
593
5970
—
—
—
14
6
460
4923
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
6.5e-01
7.7e-01
1.4e+00
—
1.2e+00
8.2e-01
1.0e+00
cases:21.24%
controls:12.31%
cases:14.55%
controls:7.30%
cases:7.53%
controls:1.93%
—
—
cases:6.07%
controls:1.96%
cases:16.43%
controls:7.95%
cases:39.66%
controls:18.97%
127
735
471
5235
87
436
511
5534
45
115
553
5855
—
36
117
557
5840
93
457
473
5291
188
935
286
3994
calcium (different salts in combination); oral
A12AA20 [21600872]
9.3e-01
8.5e-01
1.1e+00
—
8.0e-01
9.7e-01
1.2e+00
cases:17.89%
controls:7.92%
cases:14.05%
controls:6.52%
cases:5.02%
controls:1.78%
—
—
cases:3.88%
controls:1.78%
cases:16.43%
controls:6.91%
cases:26.37%
controls:9.39%
107
473
491
5497
84
389
514
5581
30
106
568
5864
—
23
106
570
5851
93
397
473
5351
125
463
349
4466
Insulin-dependent diabetes mellitus - Diabetic retinopathy
H36.09*E10.3 [2000502327]
2.9e+00
2.1e+00
—
—
—
—
3.0e+00
cases:2.84%
controls:0.17%
cases:0.84%
controls:0.10%
—
—
—
—
—
—
—
—
cases:2.74%
controls:0.14%
17
10
581
5960
5
6
593
5964
—
—
—
—
13
7
461
4922
Comprehensive monitoring of chronic illness
SPAT1250 [2001700351]
1.1e+00
1.3e+00
1.3e+00
—
7.6e-01
1.2e+00
9.6e-01
cases:17.06%
controls:6.43%
cases:11.20%
controls:3.37%
cases:2.17%
controls:0.59%
—
—
cases:1.35%
controls:0.64%
cases:10.60%
controls:3.62%
cases:17.72%
controls:7.61%
102
384
496
5586
67
201
531
5769
13
35
585
5935
—
8
38
585
5919
60
208
506
5540
84
375
390
4554
INR in Blood by Coagulation assay
34714-6 [3032080]
5.3e-01
6.9e-01
6.2e-01
2.4e+00
7.1e-01
1.1e+00
1.0e+00
cases:15.22%
controls:9.58%
cases:10.87%
controls:5.76%
cases:3.51%
controls:1.93%
cases:1.67%
controls:0.15%
cases:3.88%
controls:1.95%
cases:15.19%
controls:5.41%
cases:31.86%
controls:14.26%
91
572
507
5398
65
344
533
5626
21
115
577
5855
10
9
588
5961
23
116
570
5841
86
311
480
5437
151
703
323
4226
Sedation and analgesia
WX002 [2001310758]
9.0e-01
1.7e+00
2.3e+00
—
—
1.7e+00
1.6e+00
cases:6.02%
controls:2.55%
cases:3.68%
controls:0.72%
cases:0.84%
controls:0.08%
—
—
—
—
cases:3.71%
controls:0.73%
cases:12.03%
controls:2.70%
36
152
562
5818
22
43
576
5927
5
5
593
5965
—
—
21
42
545
5706
57
133
417
4796
Elastase.pancreatic [Mass/mass] in Stool
25907-7 [3000570]
1.3e+00
—
—
—
—
2.3e+00
2.1e+00
cases:1.84%
controls:0.50%
—
—
—
—
—
—
—
—
cases:1.41%
controls:0.14%
cases:4.43%
controls:0.55%
11
30
587
5940
—
—
—
—
8
8
558
5740
21
27
453
4902
Oxygen saturation in Venous blood
2711-0 [3024928]
1.7e+00
2.5e+00
—
—
—
—
1.6e+00
cases:1.34%
controls:0.25%
cases:1.17%
controls:0.10%
—
—
—
—
—
—
—
—
cases:3.59%
controls:0.73%
8
15
590
5955
7
6
591
5964
—
—
—
—
17
36
457
4893
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
5.1e-01
8.8e-01
1.3e+00
—
1.3e+00
8.1e-01
9.5e-01
cases:24.25%
controls:16.15%
cases:17.56%
controls:8.12%
cases:4.18%
controls:1.12%
—
—
cases:4.55%
controls:1.33%
cases:18.02%
controls:8.94%
cases:44.30%
controls:23.45%
145
964
453
5006
105
485
493
5485
25
67
573
5903
—
27
79
566
5878
102
514
464
5234
210
1156
264
3773
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
1.0e+00
2.1e+00
—
—
—
1.7e+00
2.0e+00
cases:1.51%
controls:0.55%
cases:1.34%
controls:0.17%
—
—
—
—
—
—
cases:1.41%
controls:0.26%
cases:3.38%
controls:0.49%
9
33
589
5937
8
10
590
5960
—
—
—
8
15
558
5733
16
24
458
4905

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
92
78
13.62
93.02
8.3
1.9
7.81
—
titre
—
37
0
262
778
5.03
84.11
19.2
5.8
1.13
1.01
mmol/l
6.03
248
726
238
687
4.94
78.41
3.8
1.7
—
—
—
0
0
203
524
5.22
76.42
20.1
7.4
13.33
9.68
mmol/l
8.65
192
502
267
865
4.60
75.47
5.3
2.1
—
—
—
0
0
163
410
5.00
62.21
9.4
3.8
149.49
83.06
ng/l
7.41
144
366
252
886
4.05
61.76
6.4
2.4
2.17
2.31
g/l
3.15
235
823
239
819
4.07
60.58
6.4
2.4
19.56
23.38
%
5.60
227
774
259
944
3.94
59.98
6.3
2.5
10.40
13.59
umol/l
13.11
247
884
403
2048
3.64
54.57
7.2
3.4
6.43
8.05
mmol/l
13.19
368
1736
348
1618
3.54
54.24
8.9
4.4
—
—
—
0
0
385
1938
3.50
52.15
7.4
3.5
188.53
52.57
mg/l
6.02
325
1293
389
1972
3.50
52.06
8.8
4.2
37.82
8.89
mg/mmol
6.28
314
1258
447
2474
3.71
51.85
11.4
5.2
33.95
35.85
g/l
8.83
429
2340
377
1893
3.43
50.88
10.0
6.3
—
—
—
0
0
109
258
4.89
43.90
2.0
2.0
1.65
1.50
g/l
0.87
100
233
181
653
3.48
40.42
3.7
1.6
—
—
—
0
0
89
190
5.28
40.33
4.8
3.0
2.06
1.49
mg/l
5.45
82
170
293
1409
3.00
39.95
3.5
2.1
3.07
2.88
mg/l
0.62
254
1243
152
493
3.74
39.92
13.3
9.4
—
—
—
0
0
232
983
3.14
39.57
4.8
3.4
0.80
0.82
mmol/l
0.85
213
938
153
508
3.65
38.71
4.1
2.6
71.32
71.21
e9/l
0.01
109
382
470
2989
3.19
37.33
10.7
6.7
0.22
0.19
e9/l
1.99
410
2638
463
2920
3.15
37.32
10.0
6.4
0.04
0.04
e9/l
1.38
400
2525
419
2505
2.97
37.20
17.0
6.6
1.21
1.21
mmol/l
0.16
397
2320
467
2966
3.16
37.04
10.0
6.4
1.80
1.90
e9/l
1.11
411
2639
461
2908
3.13
36.99
10.1
6.4
0.62
0.59
e9/l
1.17
398
2513
178
669
3.31
36.86
3.9
2.6
1.88
1.81
%
0.42
162
614
438
2690
3.02
36.84
10.9
6.5
0.68
0.69
%
0.07
415
2535
436
2687
2.98
36.13
10.7
6.5
2.93
2.90
%
0.12
414
2537
52
72
7.78
36.11
3.0
2.8
1.92
1.34
g/24h
0.74
39
47
159
566
3.41
35.86
10.0
3.4
1.08
1.95
mmol/l
1.65
143
489
436
2693
2.97
35.86
10.9
6.5
8.60
8.97
%
2.50
415
2546
373
2124
2.83
35.84
6.6
3.9
66.18
98.71
e6/l
0.60
271
1523
437
2712
2.95
35.44
10.3
6.4
60.49
57.49
%
6.38
417
2600
162
591
3.34
35.05
10.0
3.4
5.92
5.80
kpa
0.74
157
574
161
590
3.31
34.53
10.0
3.4
7.36
7.38
ph
3.43
99
337
299
1546
2.76
34.27
4.3
2.7
363.82
350.86
umol/l
1.08
272
1374
438
2750
2.90
34.22
10.5
6.5
25.02
27.27
%
4.20
419
2625
87
210
4.64
33.90
7.6
3.5
396.36
257.79
mg/l
1.07
73
94
403
2452
2.76
32.96
4.3
2.4
73.08
75.97
nmol/l
1.30
369
2219
439
2794
2.84
32.77
22.0
7.4
1.20
1.21
mmol/l
1.62
386
2437
495
3359
3.14
32.72
11.3
5.3
8.55
6.70
mmol/l
27.14
484
3195
292
1528
2.68
32.18
5.2
3.1
—
0.00
estimate
—
0
9
462
3053
2.88
31.45
8.1
7.1
10.60
11.72
umol/l
0.65
445
2934
310
1690
2.63
31.16
11.5
4.3
7.39
7.40
ph
4.13
247
1200
133
464
3.36
30.61
3.8
2.9
65.84
67.01
g/l
1.11
125
426
331
1879
2.59
30.35
5.5
3.3
46.10
92.33
e6/l
0.64
260
1451
398
2467
2.64
30.34
2.9
2.1
96.60
95.02
pmol/l
0.24
218
1341
474
3232
2.83
29.29
13.0
10.3
4.61
4.15
e9/l
3.10
409
2851
143
537
3.15
29.02
4.2
2.5
39.34
124.90
u/l
0.47
118
453
196
889
2.74
28.04
2.2
1.7
1231.33
1188.63
nmol/l
0.26
149
698
113
380
3.40
27.41
2.1
2.6
—
—
—
0
0
249
1304
2.49
26.18
4.2
2.6
6.17
5.04
e6/l
0.31
234
1192
121
436
3.19
26.15
2.7
1.7
—
—
—
0
0
288
1615
2.43
26.00
5.4
3.2
0.60
0.44
e6/l
0.34
222
1191
112
396
3.22
24.92
8.2
3.1
4.99
5.08
kpa
0.53
106
385
260
1425
2.39
24.33
6.9
4.1
90.18
89.88
%
0.07
254
1406
139
564
2.87
24.23
2.6
2.3
0.20
0.21
g/l
1.22
121
525
58
132
4.73
24.12
8.8
1.8
1.11
0.91
nmol/l
0.71
43
115
109
387
3.19
24.04
8.0
3.2
7.41
7.42
ph
1.90
94
325
272
1527
2.37
24.03
4.6
3.1
—
—
—
0
0
36
52
7.28
23.98
2.2
2.0
31.34
38.60
%
2.17
36
52
191
916
2.55
23.88
4.1
3.0
5.18
1.96
e6/l
1.95
95
460
282
1612
2.35
23.84
2.2
1.7
21.14
20.24
nmol/l
0.48
249
1371
201
999
2.48
23.19
4.0
2.8
1.23
1.03
e6/l
0.36
108
542
553
4300
3.19
23.01
15.4
8.6
95.03
79.19
u/l
4.19
540
4087
65
169
4.17
22.81
1.7
1.4
200.21
275.55
ug/g
2.50
47
100
397
2663
2.31
22.46
19.6
13.3
1.25
1.23
inr
0.36
344
2207
34
50
7.13
22.28
2.7
2.9
27.84
41.46
%
—
7
25
124
495
2.87
22.14
7.0
2.7
5.15
4.43
kpa
2.46
118
480
289
1710
2.26
22.07
9.4
6.3
—
—
—
0
0
71
202
3.83
21.99
2.2
3.8
82.26
73.86
mg/l
0.10
60
171
71
202
3.83
21.99
2.2
3.8
56.64
43.31
mg/l
0.57
60
174
113
433
2.96
21.72
3.2
1.5
—
—
—
0
0
503
3782
2.58
21.28
8.0
4.4
—
1.51
—
0
6
172
824
2.49
21.25
2.6
1.6
—
—
—
0
0
321
2008
2.21
21.09
5.3
3.4
29.39
33.96
u/l
1.77
299
1905
307
1892
2.20
20.88
5.2
3.6
2.35
2.35
mmol/l
0.06
281
1733
481
3561
2.44
20.76
7.5
4.4
104.17
1292.19
e6/l
—
6
59
78
247
3.46
20.58
2.3
2.0
3.73
2.69
ug/l
0.21
70
224
66
187
3.82
20.54
2.2
3.4
2.02
1.83
ratio
0.15
36
105
237
1327
2.25
20.32
5.0
3.6
—
0.20
—
0
15
155
723
2.51
20.16
1.7
1.4
—
—
—
0
0
379
2565
2.18
20.01
6.6
2.9
144.99
139.80
ug/l
0.19
355
2417
206
1099
2.29
19.75
4.2
2.9
480.53
548.06
mosm/kgh2o
5.41
192
966
57
153
3.99
19.11
3.3
2.5
217.22
105.59
ug/min
0.77
36
86
145
679
2.47
18.56
9.9
8.8
1.22
0.89
mmol/l
0.40
130
566
290
1830
2.07
17.70
4.4
2.4
—
—
—
0
0
351
2376
2.07
17.66
4.8
3.4
6.10
6.17
ph
0.63
152
1373
285
1792
2.07
17.52
2.6
2.1
150.16
245.72
u/l
1.46
276
1712
35
69
5.31
17.13
1.5
1.3
0.89
1.54
nmol/l
2.73
26
62
364
2516
2.04
17.07
23.1
11.6
0.00
0.00
e9/l
0.29
286
2071
41
93
4.64
17.07
1.1
1.1
234.88
29.67
iu/ml
—
9
19
51
137
3.96
17.07
2.7
3.5
32.54
34.32
umol/l
0.21
46
127
143
689
2.39
17.06
10.4
8.8
7.41
7.41
ph
0.05
72
396
182
986
2.18
16.35
3.0
1.8
—
—
—
0
0
218
1296
2.04
15.14
1.7
1.3
1.52
1.52
u/ml
0.00
54
379
119
561
2.38
14.76
2.4
2.0
387.49
369.90
nmol/l
0.47
106
530
30
61
5.11
14.18
1.4
2.8
—
—
—
0
0
265
1724
1.92
13.92
4.3
3.2
3809.45
1159.21
ng/l
5.28
226
1475
164
902
2.10
13.89
3.0
2.0
30.00
29.50
s
0.44
158
881
146
768
2.17
13.87
1.4
1.3
—
—
—
0
0
186
1077
2.03
13.67
5.0
4.0
263.23
449.61
ng/l
0.59
151
846
69
259
2.87
13.56
9.0
3.3
—
—
—
0
0
132
676
2.20
13.37
3.2
2.8
7.99
8.92
umol/l
0.14
120
603
61
216
3.02
13.30
1.2
1.3
—
—
—
0
0
277
1849
1.88
13.28
6.3
2.7
54.92
63.08
u/l
1.06
255
1733
360
2618
1.86
13.09
4.5
2.8
—
—
estimate
—
0
0
41
115
3.74
12.91
9.3
4.0
2.75
2.65
mmol/l
0.07
30
79
393
2958
1.86
12.59
6.0
3.7
0.00
0.00
estimate
-0.00
80
619
398
3013
1.86
12.45
6.0
3.8
0.02
0.54
estimate
0.50
62
581
88
390
2.46
12.41
10.8
10.7
1.43
1.30
%
0.54
88
385
42
125
3.53
12.13
2.4
1.4
—
—
—
0
0
394
2994
1.83
11.95
6.0
3.7
15.76
2.78
estimate
0.38
79
629
22
21
10.81
11.84
1.8
1.6
—
—
—
0
0
26
55
4.89
11.75
1.5
1.5
48447.33
25466.72
e6/l
0.36
15
29
185
1120
1.92
11.69
2.2
1.7
460.67
16526746.74
pmol/l
0.69
149
950
15
5
30.66
11.69
10.3
8.0
8.41
6.22
mmol/l
—
15
5
41
125
3.44
11.42
1.6
1.2
309.23
271.17
u/ml
0.26
22
70
45
146
3.24
11.36
4.0
3.5
0.60
2.07
index
2.26
25
89
41
126
3.41
11.28
1.2
1.2
—
—
—
0
0
178
1075
1.91
11.28
2.9
3.0
2.47
2.45
mmol/l
1.30
151
968
27
62
4.50
11.08
1.6
1.4
4715.12
2080.30
e6/l
0.29
17
40
41
129
3.33
10.87
9.2
3.4
—
—
—
0
0
14
5
28.57
10.76
3.9
4.8
34.43
13.80
mg/mmol
—
14
5
37
114
3.38
10.14
2.4
1.4
176.50
163.42
au/ml
—
10
27
39
125
3.26
10.05
1.2
1.7
—
—
—
0
0
35
105
3.47
10.00
1.2
1.3
65.79
58.60
mmol/l
0.51
28
88
185
1169
1.82
9.99
1.8
1.4
2.97
2.54
g/l
1.29
102
736
74
334
2.38
9.98
6.9
2.4
1.10
1.25
%
0.97
74
334
35
106
3.44
9.86
1.1
1.1
—
—
—
0
0
24
56
4.41
9.66
1.7
1.4
—
—
—
0
0
21
44
4.90
9.60
2.8
3.4
2318.71
1073.57
mg
1.68
21
44
91
458
2.15
9.46
3.3
2.4
4.43
7.94
ug/l
3.35
78
419
72
329
2.34
9.44
7.0
2.3
0.56
0.63
%
1.25
72
329
324
2431
1.68
9.30
3.0
2.0
1.54
1.38
mmol/l
1.72
282
2054
37
123
3.13
9.00
8.8
3.5
14.55
9.46
pmol/l
1.07
37
123
23
55
4.30
8.98
1.5
1.7
—
—
—
0
0
18
21
8.79
8.84
5.6
3.8
—
—
—
0
0
24
61
4.05
8.67
1.5
1.1
—
—
—
0
0
40
143
2.92
8.59
3.7
2.1
122.03
129.02
g/l
0.98
32
115
85
434
2.11
8.50
1.3
1.2
—
—
—
0
0
94
499
2.04
8.47
2.3
2.6
10.78
10.88
g/l
0.08
84
462
24
63
3.92
8.31
1.2
1.2
—
—
—
0
0
47
189
2.61
8.10
1.5
1.2
—
—
—
0
0
188
1262
1.70
7.95
1.9
1.7
1.12
1.30
mg/l
0.56
153
998
295
2225
1.61
7.84
6.2
3.8
62.93
65.95
ng/l
0.04
242
1598
594
5416
2.47
7.75
44.9
15.9
26.58
24.67
mg/l
0.82
542
4457
24
67
3.68
7.64
2.4
2.4
33.06
30.93
iu/ml
—
5
6
28
87
3.32
7.61
2.9
3.1
4.58
4.47
e9/l
0.07
28
87
70
346
2.15
7.60
8.0
5.2
—
—
—
0
0
22
58
3.89
7.58
1.3
1.7
53.87
67.30
%
0.78
15
46
79
412
2.05
7.45
3.1
3.3
306.15
175.56
ng/l
1.44
66
371
459
3891
1.65
7.19
4.8
3.5
66.66
51.71
u/l
2.21
425
3701
17
39
4.45
7.00
2.3
2.6
506.80
506.68
min
—
10
25
260
1951
1.56
6.78
4.8
3.6
—
0.71
—
0
7
19
49
3.97
6.75
1.4
1.2
—
—
—
0
0
557
5011
1.90
6.68
7.1
5.0
1.89
1.91
mu/l
0.11
520
4641
575
5229
2.04
6.66
15.2
6.5
50.41
39.44
mmol/mol
42.51
554
4935
87
497
1.87
6.29
14.2
4.0
7.38
7.35
ph
1.94
67
364
31
115
2.78
6.27
1.2
1.1
—
—
—
0
0
32
121
2.73
6.25
3.1
3.0
60.81
57.80
%
0.68
32
121
126
810
1.69
6.10
1.5
1.3
266.67
463.78
titre
1.97
24
180
59
298
2.08
6.07
3.1
3.5
4.23
4.60
pmol/l
2.09
49
269
14
21
6.79
6.06
4.1
2.3
—
—
—
0
0
74
406
1.93
6.05
1.7
1.8
1.16
1.62
g/l
1.38
66
378
57
286
2.09
5.97
1.6
1.2
—
—
—
0
0
29
107
2.79
5.93
1.5
1.2
—
—
—
0
0
38
161
2.45
5.92
1.6
1.6
11340.00
16209.82
e6/l
0.41
25
119
168
2297
0.63
5.89
4.6
3.2
—
—
—
0
0
12
15
8.13
5.86
1.8
1.3
—
—
—
0
0
19
55
3.53
5.77
4.5
2.5
—
—
—
0
0
56
283
2.07
5.76
1.4
1.6
0.35
0.34
mg/l
0.04
21
131
13
20
6.61
5.58
2.8
1.6
3648.40
3813.50
e6/l
—
5
10
14
24
5.94
5.55
3.3
1.6
824.00
1155.79
e6/l
—
9
19
86
509
1.80
5.55
3.0
2.3
0.55
0.27
e6/l
0.74
77
488
17
49
3.54
5.20
2.4
2.4
1074.30
595.31
ml
—
10
29
12
19
6.41
5.10
1.0
1.0
—
—
—
0
0
12
19
6.41
5.10
1.0
1.1
—
—
—
0
0
84
512
1.74
4.90
2.7
2.1
0.00
0.03
estimate
0.50
16
113
15
33
4.63
4.89
1.9
1.8
1.64
1.16
nmol/l
—
9
26
82
497
1.75
4.88
4.9
5.1
0.09
0.15
%
0.42
35
138
36
163
2.28
4.88
1.3
1.4
212.80
245.51
miu/ml
—
8
78
593
5556
2.00
4.71
51.7
18.8
138.81
139.70
mmol/l
13.11
586
5465
85
527
1.71
4.67
4.7
5.0
1.22
0.94
%
0.26
38
169
81
497
1.72
4.62
4.4
4.9
1.00
0.51
%
0.51
35
153
7
5
14.13
4.58
1.1
1.4
—
—
—
0
0
7
5
14.13
4.58
1.0
1.8
—
—
—
0
0
593
5565
1.97
4.55
52.9
19.0
4.09
3.98
mmol/l
13.92
586
5460
32
143
2.30
4.48
1.6
1.2
633.00
487.55
mg/l
1.14
27
135
11
19
5.87
4.45
2.3
1.4
—
—
—
0
0
17
55
3.15
4.39
1.9
1.2
—
—
—
0
0
15
45
3.39
4.35
1.0
1.0
—
—
—
0
0
14
33
4.31
4.34
1.2
2.0
—
—
—
0
0
467
4155
1.47
4.32
5.4
4.1
14.84
14.79
pmol/l
0.16
432
3813
43
220
2.02
4.32
1.7
1.9
20.78
20.75
s
0.02
37
202
23
90
2.61
4.26
3.7
3.3
0.72
0.83
nmol/l
0.74
18
76
11
21
5.31
4.16
2.6
1.5
—
—
—
0
0
20
74
2.76
4.12
1.7
1.9
31.10
33.20
pg
1.24
20
74
12
26
4.68
4.07
2.0
1.8
80.34
58.75
ug/l
0.68
12
26
17
58
2.98
4.03
1.2
1.3
44.35
30.38
ng/l
0.27
17
58
17
58
2.98
4.03
1.6
1.4
—
—
—
0
0
16
54
3.01
3.87
2.6
1.8
11.26
11.20
%
0.02
16
54
5
208
0.23
3.87
1.2
1.1
—
0.70
—
0
27
22
486
0.43
3.83
2.3
1.8
3.18
3.52
mmol/l
0.67
17
357
9
15
6.07
3.82
1.6
1.9
—
—
—
0
0
13
33
4.00
3.81
3.8
1.7
204.77
105.42
ng/l
0.94
13
33
14
44
3.23
3.79
1.1
1.2
79.57
105.27
pmol/l
1.12
14
44
6
5
12.10
3.77
2.8
3.6
—
—
—
0
0
6
218
0.27
3.69
1.2
1.1
1.51
1.51
g/l
—
6
218
16
56
2.91
3.65
1.1
1.1
—
—
—
0
0
105
729
1.53
3.63
1.4
1.3
—
—
—
0
0
100
690
1.53
3.56
1.4
1.4
—
—
—
0
0
264
2177
1.36
3.55
2.4
2.1
—
—
—
0
0
68
434
1.63
3.37
7.8
3.7
—
—
—
0
0
30
149
2.06
3.31
1.6
1.1
—
—
—
0
0
77
510
1.58
3.28
5.2
5.4
0.09
0.13
%
0.14
32
128
21
90
2.38
3.27
1.6
2.0
—
—
—
0
0
20
84
2.43
3.25
1.6
3.0
—
—
—
0
0
13
39
3.38
3.24
1.0
1.1
—
—
—
0
0
105
747
1.49
3.23
3.3
3.3
6.94
5.96
e9/l
0.19
79
667
10
24
4.22
3.20
1.1
1.0
1537.00
1458.46
miu/ml
—
10
24
130
970
1.43
3.12
1.4
1.3
2.53
12.47
u/ml
4.12
36
384
43
247
1.79
3.12
1.2
1.3
—
—
—
0
0
29
146
2.03
3.10
1.4
1.1
—
—
—
0
0
8
16
5.05
3.06
3.6
2.9
0.63
0.59
mmol/l
—
8
16
8
225
0.35
2.98
1.5
1.2
1.05
0.91
g/l
—
8
225
11
32
3.48
2.91
2.8
3.5
25.43
24.91
mu/l
0.02
11
32
46
277
1.71
2.86
3.0
2.2
0.07
2.73
estimate
0.48
15
92
554
5217
1.48
2.80
6.1
4.4
1.50
1.33
mmol/l
5.02
513
4849
84
589
1.49
2.78
2.9
5.1
18.51
31.72
ug/l
0.39
65
495
19
85
2.27
2.73
1.4
1.6
—
—
—
0
0
19
85
2.27
2.73
1.4
1.6
—
—
—
0
0
19
85
2.27
2.73
1.4
1.6
—
—
—
0
0
19
85
2.27
2.73
1.4
1.6
—
—
—
0
0
576
5474
1.55
2.72
7.6
5.2
4.11
4.61
mmol/l
24.49
544
5145
582
5546
1.58
2.68
8.7
5.9
2.25
2.71
mmol/l
28.58
551
5191
437
3975
1.32
2.64
5.7
4.2
—
0.30
—
0
10
13
49
2.69
2.63
7.3
3.0
191.27
15.60
mg/l
—
8
37
15
61
2.49
2.63
1.1
1.1
—
—
—
0
0
18
81
2.26
2.56
1.4
1.1
—
—
—
0
0
573
5456
1.51
2.49
7.6
5.1
1.31
1.42
mmol/l
8.92
538
5096
601
5787
1.70
2.45
52.5
20.8
110.38
78.92
umol/l
13.27
596
5735
43
266
1.66
2.45
2.5
2.3
—
—
—
0
0
72
503
1.49
2.44
1.6
1.4
—
—
—
0
0
9
27
3.37
2.40
1.0
1.3
137.11
146.24
nmol/l
—
9
27
26
140
1.89
2.35
1.8
2.0
2.07
4.44
iu/l
—
9
51
110
1412
0.73
2.30
2.7
3.1
0.75
0.73
ug/l
0.06
72
872
12
47
2.58
2.28
1.9
1.3
483.29
299.30
mu/l
—
7
37
0
59
0.00
2.25
0.0
2.3
—
—
—
0
0
7
18
3.92
2.25
1.1
1.3
8.02
10.14
mmol/l
—
7
18
64
446
1.48
2.21
3.5
2.3
5.95
6.05
ph
0.51
46
300
40
250
1.64
2.21
1.7
1.9
2.47
8.38
iu/ml
—
6
66
13
54
2.44
2.21
5.5
3.8
12.88
12.33
index
—
8
39
8
24
3.36
2.18
1.3
1.0
315.75
262.73
iu/ml
—
8
24
24
130
1.88
2.15
1.7
1.3
805.18
948.61
e6/l
0.05
17
106
5
10
5.03
2.07
1.2
1.0
—
—
—
0
0
15
69
2.20
2.06
1.6
1.2
—
—
—
0
0
23
127
1.84
1.96
1.7
1.2
15.31
15.75
e6/l
0.01
16
99
13
58
2.27
1.92
1.3
1.3
827179.50
320707.65
e6/l
—
6
43
583
5623
1.44
1.79
37.4
14.2
—
—
—
0
0
8
29
2.78
1.79
4.1
3.8
527.75
724.34
u/ml
—
8
29
30
188
1.63
1.69
7.9
4.5
1.20
1.37
mmol/l
0.59
30
181
6
147
0.40
1.66
1.0
1.1
—
—
—
0
0
5
14
3.59
1.62
2.2
2.6
—
—
—
0
0
6
20
3.02
1.58
1.3
1.5
—
—
—
0
0
595
5778
1.46
1.57
22.9
12.3
26.15
27.70
u/l
1.12
585
5642
6
142
0.42
1.53
6.5
4.8
—
—
—
0
0
34
227
1.53
1.50
2.7
2.8
—
—
—
0
0
13
66
1.99
1.44
1.3
1.4
14.93
27.66
u/l
—
7
56
5
16
3.14
1.44
1.6
2.1
—
—
—
0
0
23
141
1.65
1.43
1.8
2.0
9457.94
4431.25
u/l
—
7
53
7
29
2.43
1.39
1.4
1.6
—
—
—
0
0
12
60
2.02
1.39
1.3
1.3
—
—
—
0
0
187
1632
1.21
1.35
7.3
3.7
0.02
0.01
estimate
0.12
64
576
9
42
2.16
1.34
1.6
3.8
16.99
16.82
%
—
9
42
12
62
1.95
1.28
1.7
2.3
—
—
—
0
0
10
48
2.10
1.28
1.6
1.1
—
—
—
0
0
86
694
1.28
1.27
2.0
2.3
103.67
124.24
ug/g
0.50
68
562
13
70
1.88
1.24
1.4
1.2
—
—
—
0
0
8
39
2.06
1.15
8.1
4.3
0.75
0.92
index
—
8
39
26
175
1.51
1.14
1.2
1.3
8.74
7.62
u/l
0.24
19
142
29
200
1.47
1.14
1.5
1.6
—
—
—
0
0
13
73
1.80
1.11
1.0
1.1
—
—
—
0
0
34
244
1.42
1.10
2.0
1.8
—
—
—
0
0
9
46
1.97
1.04
1.6
1.2
—
—
—
0
0
603
5914
1.38
1.01
61.5
24.2
255.18
247.09
e9/l
2.07
598
5824
603
5916
1.37
0.98
61.5
24.2
4.31
4.54
e12/l
17.86
596
5808
603
5916
1.37
0.98
61.6
24.3
7.24
6.74
e9/l
7.03
597
5803
14
84
1.68
0.98
1.5
1.2
2.33
4.18
u/ml
—
6
39
45
346
1.32
0.98
1.2
1.2
156.30
140.79
u/ml
0.05
18
139
17
110
1.56
0.91
2.6
4.5
509.50
535.22
u/ml
0.02
17
104
121
1054
1.18
0.89
1.4
1.3
29.70
32.30
iu/ml
0.07
32
327
30
222
1.37
0.85
1.5
1.5
—
—
—
0
0
6
31
1.94
0.84
1.5
1.1
113.00
199.63
mmol/24h
—
6
31
6
31
1.94
0.84
1.5
1.6
—
—
—
0
0
178
1611
1.15
0.81
1.5
1.4
—
—
—
0
0
29
218
1.35
0.76
1.6
1.6
—
—
—
0
0
45
554
0.80
0.74
1.3
1.4
—
—
—
0
0
29
220
1.33
0.73
1.6
1.5
—
—
—
0
0
29
221
1.33
0.71
1.6
1.5
—
—
—
0
0
18
251
0.71
0.70
1.8
1.7
—
—
—
0
0
45
368
1.24
0.66
1.4
1.2
—
—
—
0
0
28
217
1.30
0.63
1.1
1.1
—
—
—
0
0
542
5300
1.15
0.61
7.3
5.2
7.47
6.00
mmol/l
21.63
495
4905
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
73
641
1.16
0.53
2.0
2.4
12.62
13.97
nmol/l
0.75
62
590
46
389
1.20
0.52
1.5
1.3
876.61
257.38
u/ml
0.44
38
361
11
78
1.42
0.43
1.6
1.3
—
—
—
0
0
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
144
1339
1.10
0.42
5.8
3.7
1.02
1.02
kg/l
0.46
101
896
0
15
0.00
0.41
0.0
1.4
—
26.73
—
0
15
10
72
1.40
0.37
1.2
1.5
—
—
—
0
0
6
42
1.43
0.35
2.5
3.6
10.28
8.41
mmol/l
—
6
42
141
1325
1.08
0.34
6.8
5.0
—
—
—
0
0
15
187
0.80
0.32
10.1
9.5
—
—
—
0
0
21
251
0.83
0.31
1.5
1.9
38.90
39.28
nmol/l
0.03
21
241
27
232
1.17
0.29
1.2
1.3
15.65
24.03
iu/l
0.74
21
193
10
76
1.32
0.28
1.3
1.6
—
—
—
0
0
9
117
0.77
0.27
1.2
1.1
—
—
—
0
0
9
118
0.76
0.27
1.2
1.1
—
—
—
0
0
8
65
1.23
0.27
1.1
1.2
—
—
nmol/l
—
0
0
5
38
1.32
0.23
1.2
1.4
—
—
—
0
0
12
97
1.24
0.23
2.2
2.5
—
—
—
0
0
227
2343
0.95
0.22
4.3
5.3
1.75
2.33
ug/l
1.35
193
2126
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
6
50
1.20
0.19
1.3
1.5
154.77
166.14
pmol/l
—
6
50
6
52
1.16
0.19
1.0
1.1
—
—
—
0
0
7
60
1.17
0.18
1.6
1.2
—
—
—
0
0
5
69
0.72
0.17
1.0
1.2
—
98.12
—
0
6
233
2276
1.04
0.15
6.5
3.6
0.00
0.02
estimate
1.81
66
529
10
86
1.17
0.11
1.4
1.7
—
—
—
0
0
6
58
1.03
0.08
1.5
2.5
—
—
—
0
0
5
61
0.82
0.08
1.4
1.8
—
—
—
0
0
7
65
1.08
0.08
1.1
1.2
—
—
—
0
0
162
1649
0.98
0.08
6.1
3.2
0.00
0.06
estimate
0.61
62
495
6
72
0.83
0.07
1.5
1.4
—
—
—
0
0
8
78
1.03
0.07
1.3
1.2
0.39
0.57
nmol/l
—
8
70
7
82
0.85
0.07
1.0
1.2
—
—
—
0
0
11
118
0.93
0.03
1.5
1.3
—
—
—
0
0
62
628
0.99
0.01
1.5
1.5
—
—
—
0
0
32
313
1.02
0.01
1.1
1.1
—
—
—
0
0
12
125
0.96
0.00
12.1
3.9
28.43
25.45
mg/l
—
7
87
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
64.00
—
0
8
0
5
0.00
-0.00
0.0
11.8
—
0.54
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
40.00
—
0
6

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_LATE_SYPHILIS_WIDE – Late syphilis, including avohilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).